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1 Introduction
1.1 History of vitamins
More than 100 years ago Sir Frederick Gowland Hopkins realized from the results
of his experiments with young rats that the animals could not survive from being
fed with only a mixture of pure protein, fat and carbohydrates [87]. He claimed
there must be some other so called "minor" or "accessory factors" that are essential
for normal growth and development. The term "vitamin" was invented in 1912 by
Casimir Funk. He tried to isolate a substance to heal the Beriberi disease which is
caused by a lack of thiamine. As Funk found out that the substance contained an
amino group he called it vitamin (vita lat. = life, amin from amino-group). Several
at that time uncharacterized growth factors, although not all of them contained an
amino-group were then also designated as vitamins. Today vitamins are defined
as organic substances that are essentiall in small amounts because they can not
be synthesized at all or not in the required quantity. Vitamins are not needed
as an energy-source but fulfill functions as cofactors, antioxidants or hormone-like
substances. Although only very low doses in the mg or µg range of these substances
are necessary, the symptoms of a lack of vitamins can lead to metabolic defects and
severe illness. For humans 13 fat- and water-soluble vitamins are known today. An
overview is shown in table 1.1.
Not all of the listed vitamins are essential for all organisms. Every organism has
its own special set of vitamins. Several plants and microorganisms are still able to
synthesize some or even all of these substances, but most higher organisms dependend
on the uptake of a certain amount from food or in part from microbial synthesis in
the intestine. The relative contribution of intestinal synthesis to vitamin supply may
be different for individual vitamins and in different species and can in many cases
not be precisely quantified.
1
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Vitamin (class) active substance function in metabolsim
fat-soluble:
vitamin A retinol, retinal light perception, antioxidants
vitamin D calciferol regulation of calcium- and
phosphate-metabolism, hormon-
like
vitamin E tocopherol,
tocotrienol
antioxidants for unsaturated
membrane-lipids
vitamin K phyllochinone,
menachinone
γ-carboxylation of glutamate
(blood clotting)
water-soluble:
vitamin B1 thiamine aldehyde-transfer
vitamin B2 riboflavin oxidation and reduction
vitamin B3 (x)(niacin) nicotine acid, nicotinamide oxidation and reduction
vitamin B5 (x) panthotenic acid transfer of acyl-groups
vitamin B6 pyridoxin, pyridoxal, pyri-
doxamin
decarboxylation and trans-
amination of amino acids
vitamin B7 (x) biotin carboxylation, decarboylation
vitamin B9 (x) folic acid transfer of C1-units
vitamin B12 cobalamin transfer of methyl-groups
vitamin C ascorbic acid antioxidant
Table 1.1: Overview over the 13 vitamins. (x) Historic names, not commonly
used today
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1.2 Biotin
E. Wildiers discovered in 1901 that yeasts need, beyond yeast-ashes, ammonium
salts and a fermentable sugar [139], a substance called "bios" for growth [207]. An-
other result of a lack of biotin was discovered by W. G. Bateman who found out rats,
rabbits, dogs and man suffer from so called egg-white-injury from consuming an ade-
quate diet with additional raw egg withe [8]. This can be explained by the fact, that
egg white contains a high amount of the biotin-binding protein avidin that prevented
absorption of this vitamin both from dietary and intestinal sources. Biotin can be
synthesized by bacteria, plants and lower fungi but has to be taken up by higher
organisms. Rich sources of biotin are milk, boiled eggs (or egg-yolk), liver, kidney,
several vegetables and cereals, but the bioavailability can vary greatly between 100
% and 5 %. Pure biotin was isolated for the first time from Kögl an Tönnis, who
purified 1,1 mg of the substance from 250 kg dried egg-yolk in a 16-step-procedure
[96].
1.2.1 Structure and chemistry
The IUPAC-name of biotin is cis-hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric-
acid. With the three asymmetric centers of the molecule eight stereo-isomers are pos-
sible, but only one isomer with the configuration (3aS, 4S, 6aR), called d-(+)-biotin
is biologically acitive and occurs in nature. With its sum formula C10H16N2O3S
biotin has a molecular weight of 244.31 kDa, is good soluble in hot water, dilute
alkalies and 95 % ethanol, but only slightly soluble in cold water, dilute acids and
almost insoluble in organic solvents. Crystalline biotin is stable in air and towards
sunlight, thermally stable, but instable towards UV light, oxidizing agents, strong
acids and strong bases. The structure was solved in 1942 by Kögl and coworkers as
well as by the group of Vigneaud at the same time [53], [20]. The chemical synthesis
of biotin was first established one year later by Harris [79]. Although great efforts
have been made to produce biotin by genetically modified microorganisms, the major
part of industrial production still comes from chemical synthesis based on a protocol
of Gerecke [64].
1.2.2 Physiological role
Insufficient supplementation with biotin can result in hair-loss, brittle nails and
skin rash. This is why biotin was originally called vitamin H (for "Haut" = skin).
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Undersupplementation of biotin is rare and usually caused by genetic defects that
are discussed in chapter 1.5.1. Negative effects of an oversupplementation by intake
of high pharmalogical doses of biotin were not described.
Biotin plays an essential role as a cofactor in enzymes catalyzing carboxylation
reactions, that means it is able to transfer 1-C-bodies. Between one and five dif-
ferent biotin-proteins can be found in one organism [41]. Biotin occurs covalently
bound to the ǫ-amino-group of a lysine residue. These carboxylases are required
for reactions in several branches in cellular metabolism e.g. lipogenesis, gluconeo-
genesis and amino acid degradation and can be classified into three groups [174],
[100]. Transcarboxylase per definition transfers a carboxyl-group from a donor
to an acceptor [215]. The enzyme mainly plays a role in propionibacteria and
catalyzes the reversible transfer of a carboxyl-group from methyl-malonyl-CoA to
pyruvate. Products of this reaction are propionyl-CoA and oxaloacetate. Tran-
scarboxylases enable propionibacteria to metabolize distinct carbohydrates inde-
pendently of ATP [214]. Decarboxylases appear in anaerobic procaryotes that are
able to decarboxylate substrates like oxaloacetate, malonate, methyl-malonyl-CoA
and glutaconyl-CoA. Decarboxylation is coupled to Na+-transport out of the cell
against a concentration gradient and helps the bacteria to accumulate energy by
generating a Na+-gradient [49]. Carboxylases are the most important and most
widely distributed biotinylated enzymes. They transfer a carboxyl-group from bi-
carbonate as a donor to different substrates, mostly organic acids and occur in the
three kingdoms of live. Acetyl-CoA-carboxylase is omnipresent and catalyzes the
irreversible reaction from acetyl-CoA to malonyl-CoA, the first step in fatty acid
biosynthesis. Further the enzyme plays an important regulatory role in fatty acid
pathway. Transcription of yeast ACC1 was reported to be repressed by the soluble
lipid precursors inositol and choline and to be dependent of transcription factors
Ino2p, Ino4p, and Opilp [81]. These results demonstrated that the rate-determining
step of fatty acid synthesis catalyzed by Acc1p is regulated in conjunction with
phospholipid biosynthesis in yeast and so is able to affect membrane properties and
function. More examples for biotin dependent carboxylases from different organisms
are pyruvate carboxylase, 3-methylcrotonyl-CoA-carboxylase and propionyl-CoA-
carboxylase.
The reaction mechanism shared by carboxylases, decarboxylases and transcar-
boxylases is a two-step reaction. In the first step, the carboxyl-group is transferred
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to the N1-atom of enzyme-bound biotin. In carboxylases, the activation of HCO−3
by ATP is necessary for this process, whereas it is not for de- and transcarboxylases
as the carboxyl-group is cleaved from a substrate. In the second step the carboxyl-
group is released as CO2 (HCO−3 ) from decarboxylases or transferred to a specific
substrate by carboxylases and transcarboxylases. Often metal ions such as Mg2+,
K+ or Mn2+ are required for enzymatic activity.
The covalentely enzyme bound biotin results from a post-translational protein
modification catalyzed by biotin protein ligase (BPL) or holocarboxylase-synthase
(HCS). Each organism possesses a BPL that is able to modify different target-
proteins. Catalytic sites in the BPLs are very well conserved throughout biology
[30] (see fig. 1.1). The biotinylation itself is a two-step-process [108]. First BPL
catalyzes an attack of the oxygen atom at the carboxyl group of biotin on a phos-
phate of ATP. Pyrophosphate is released and the intermediate biotinyl-5’-AMP is
generated. In the second step biotin is covalently coupled to the target protein. This
takes place by an attack of the nucleophilic ǫ-amino-group of a distinct lysine residue
on the mixed anhydride of the biotin-adenylate, so that an amide bond is formed
and AMP set free.
Similar to the BPLs, also the biotinylation-domains are strongly conserved from
bacteria to men (see fig. 1.2). These domains mostly locate to the C-terminal end of
the protein with the modified lysine residue about 35 amino-acids from the end [41],
[174]. The primary structures of the biotinylation domains show strong similarity
and all contain the sequence (A)MKM. The two methionine-residues flanking the
lysine are absolutely essential for biotinylation and 35 - 40 further amino acids on
both sides are required for efficient modification by BPL. Other studies showed the
minimal sequence that is sufficient for biotinylation by BirA in vitro is 13 amino acids
long when the peptide is fused to a protein [175]. Minimal sequence requirements
for biotinylation are hard to determine, because the biotinylation domains require
a certain lenght for proper folding. Another groups identified a minimal consensus
sequence of 66 - 87 amino acids occuring in biotinylation domains of biotin proteins
from procaryotes [186], [41] or eucaryotes [110], [195]. Efficiency of biotinylation
requires besides these minimal consensus sequence further properties. Usually each
BPL most efficiently modifies apo-biotin proteins of the own organism but sometimes
cross reactivites allowing modification of biotinylation domains from other organisms
are possible [118], [41], [30]. Nevertheless not all combinations between BPLs and
biotinylation domains of different organisms allow biotinylation [118], [3].
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Figure 1.1: Sequence alignment of different biotin protein lig-
ases/holocarboxylase synthases. The catalytic domains of the
proteins are marked with a grey bar, the residues forming contacts with
biotin (data taken from [208]) are marked with a black square.
Figure 1.2: Sequence alignment of biotinylation domains. H_s_PC (Homo
sapiens pyruvate carboxylase), S_ s_PC (Sus scrofa pyruvate carboxy-
lase), S_c_PYC1/PYC2 (Saccharomyces cerevisae pyruvate carboxylase
1/2), B_l_PC(Bacillus licheniformis pyruvate carboxylase), H_s_AC
(Homo sapiens acetly-CoA carboxylase), S_s_AC (Sus scrofa acetly-
CoA carboxylase), S_c_ACC1 (Saccharomyces cerevisae acetyl-CoA
carboxylase 1), E_c_BCCP (Escherichia coli biotin carboxyl carrier pro-
tein). The modified lysin-residue (K) is indicated by a black rectangle.
Beyond its function as a cofactor of carboxylases, new results suggest biotin plays
also a role in gene regulation via different mechanisms that will be explained in detail
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later in this work.
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1.3 Biotin metabolism in Escherichia coli
Biotin in not essential for E. coli because the bacterium is capable of de novo
synthesis. The only abundant protein covalently modified with biotin is the biotin
carboxyl carrier protein (BCCP) that is part of the three-subunit enzyme acetyl-
CoA-carboxylase (ACC) [71]. ACC catalyzes the carboxylation of acetyl-CoA to
malonyl-CoA and provides the first precursor required in fatty acid synthesis. The
E. coli biotin protein ligase is called BirA (biotin retension) and is a 35.5 kDa protein
with 321 amino acids encoded at 89.9 centisomes on the E. coli chromosome.
1.3.1 Biosynthesis in E. coli
Biotin prototrophy is wide spread among bacteria. The first common intermedi-
ate pimeloyl-CoA originates from different precursors, such as malonyl-CoA [90] or
pimelic acid [16], depending on the organism. In contrast, the following four steps
leading to biotin share common intermediates and enzymes and are well conserved
[189] (see fig. 1.3). Five of the six involved genes (bioA, B, C, D and F) are orga-
nized in an operon at 17 min on the chromosome [72], [134]. Due to the fact that
the operon is located in proximity of the λ-phage attachment site several mapping
experiments have been possible and different biosynthesis mutants have been created
[167], [36].
The sixth gene required for biotin-biosynthesis, bioH, can be found as a single gene
at about 66 min [133], [189]. The first known precursor in the biosynthesis-pathway
in E. coli is pimeloyl-CoA. Its synthesis depends on BioC and H, but the function of
these proteins is not understood in detail yet. Pimeloyl-CoA and alanine are fused
to α-keto-8-amino-pelargonic acid (KAPA) by KAPA-synthase BioF in presence of
pyridoxalphosphate (PLP) as a cofactor. In a next step 7,8 di-amino-pelargonic acid
(DAPA) is generated by DAPA-aminotransferase BioA. Here S-adenosyl-methionine
(SAM) provides the N-atom for the reaction and again PLP serves as cofactors.
BioD that codes for dethiobiotin-synthetase generates dethiobiotin (DTB) and CO2
as well as ATP are required therefore. The last step to biotin is catalyzed by biotin-
synthase encoded by bioB. Here the presence of NADPH, SAM and sulphur in form
of an Fe-S-cluster is mandatory. The mechanism is a relatively uncommon radical
reaction [117], [177], [189].
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Figure 1.3: Biotin biosynthesis in E. coli and S. cerevisiae. Biosynthesis
with the intermediates pimeloyl-CoA, KAPA (7-keto-8-amino pelargonic
acid), DAPA (7,8-diamino pelargnoic acid) and dethiobiotin. Names of
the enzymes and the corresponding genes are shown (bold genes for S.
cerevisiae). The first two reactions catalyzed by BIO1 and BIO6 from
the unknown precursor to pimeloyl-CoA and further to KAPA are only
present in some prototrophic S. cerevisiae strains, but not in most of the
laboratory strains.
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1.3.2 Biotin transport in gram-positive bacteria and E. coli
Although a lot of bacteria are able to synthesize biotin, several of them are also
able to take it up from the environment.
Biotin transport in gram-positive bacteria
The only experimentally confirmed biotin transport system in bacteria envolves
the genes bioY, M, and N [84] (see fig. 1.4). Homologues of BioY with 95 % or more
identity can be found in more than 120 genomes across firmicutes (34 species), α-
proteobacteria (28 species), cyanobacteria (15 species), actinobacteria (15 species),
and archaea (13 species) and form a unique protein family (pfam02632). Expression
of BioY from Rhodobacter capsulatum in a biotin transport deficient E. coli mutant
enables cells to take up the vitamin by facilitated diffusion with a KM of 250 nM and a
vmax of 60 pmol/(mg cells x min). The BioY protein has 6 predicted transmembrane
domains with N- and C-terminus in the cytoplasm [84].
BioY
BioM
BioN
Figure 1.4: Model of the BioMNY-system of gram-negative bacteria. Topo-
logical model of the BioMNY-system with BioY (6 TMDs), BioN (4
TMDs and a cytoplasmic domain) and BioM (cytoplamic protein with
ATPase motif). According to [84].
BioM and N can be found in about one third of the organisms that contain
BioY. Coexpression of BioM and BioN with BioY change the properties of the
biotin transport system: biotin uptake proceeds with a KM of 5 nM and a vmax
of 6 pmol/(mg cells and min), that means with higher affinity but lower capacity.
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BioMNY-catalyzed uptake requires energy that is provided by ATP. BioM contains
Walker A, Q loop, signature (LSGGQ), Walker B, and H motifs that are typical for
ATPases. BioN contains 4 transmembrane domains and a cytoplasmic C-terminal
extension with two amphiphatic helices that resemble to the EAA loop of classical
ABC-transporters. Tripartite complexes of the three components could be experi-
mentally shown, and ATPase-activity could be measured. Dimers of BioN and BioY
as well as BioM and BioY were not found, whereas stable complexes of BioM and
BioN could be purified, but this lacked ATPase-activity in contrast to the ternary
complex [84].
Nevertheless the bioMNY system can be found in various species among bacteria
and archea no homologues in the subdivisions of β-, γ-, δ- and ǫ-proteobacteria
(including E. coli) could be found.
These modular transport systems called energy coupling factor (ECF)-systems
could be identified in various organisms mainly among gram-positive bacteria and
for a variety of substrates [157]. Comparative genome analysis revealed 21 fami-
lies of substrate capture proteins that are responsible for substrate specificity of the
systems, act as binding proteins and in some cases even allow facilitated diffusion
of substrates. Additionally several energy-coupling modules composed of conserved
transmembrane proteins and one or two nucleotide binding proteins similar to those
of ATP binding cassette (ABC) transporters could be identified. Some substrate spe-
cific components interact only with one distinct energy-coupling module. Examples
are systems for the uptake of biotin, cobalt, nickel, queosine, methionine, thiamine
and methylthioadenosine. Some of them were experimentally proven [84], [156].
Other energy-coupling modules are shared by several substrate specific components.
Among them systems for folate, thiamine, and riboflavin transporters were exper-
imentally confirmed and others for pantothenate, niacin, tryptophane, cobalamin,
lipoate, queosine, biotin, thiazole and pyridoxin proposed [84], [156].
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Biotin transport in E. coli
Biotin transport in E. coli was first reported by C. H. Pai in 1972 and 1973 [137],
[138]. He investigated the uptake of radioactively labeled biotin in wildtype cells
and in a strain with a mutation in the operator of the biotin biosynthesis operon
and found that biotin uptake is not affected by this mutation itself, but depends
on how long cells have been starved for biotin before the uptake experiment. Pai
proposed that intracellular content of biotin is the critical factor leading to stronger
or weaker biotin uptake and found out, that growth in medium supplemented with 5
ng biotin per l almost abolished transport completely. In following years, the groups
around Prakash and Eisenberg [151], [55], Cicmanec and Lichstein [35] and Piffeteau
and Gaudry [143], [142] were successful in further characterizing biotin transport
in kinetic parameters, pH- and temperature-optimum, substrate specificity and in
parts energy-requirements. The mapping experiments of Eisenberg located the gene
encoding the biotin transporter in the region between the ilv-operon for isoleucine
biosynthesis and the metE-gene [55].
Another interesting finding was made by Walker and Altman in 2005 [199]. They
reported that E.coli cells are able to take up biotinylated peptides up to a size of 31
amino acids in contrast to a maximum of five to six amino acids for unbiotinylated
peptides. This uptake could be blocked by the extracellular addition of free biotin,
avidin and the protonophore CCCP. In a transport mutant no uptake of biotinylated
peptides could be observed.
Although this system has been exhaustively investigated by several groups the
gene(s) coding for the E. coli biotin transport protein is/are still unknown.
1.3.3 Regulation
Cells have developed many mechanisms for regulation of gene expression in re-
sponse to changing environmental conditions. One way of regulation is binding
of a signal molecule to a kind of receptor that directly mediates the response by
transcriptional regulation. The biotin regulatory system of E. coli that is a good
example for this kind of regulation, was extensively examined and is well understood
[22], [40], [12], [10], [11]. A key player in this process is the biotin-protein ligase
BirA. The first mutants producing biotin at derepressed levels or requiring higher
biotin concentrations have been isolated and described by Campbell [24]. BirA is
not only the enzyme that is responsible for the biotinylation of BCCP, but also is
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able to regulate transcription of biotin biosynthesis operon as a repressor. The N-
terminal part of the protein contains a helix-loop-helix motif, that is able to bind
to the operator sequence (bioO) of the bio-operon [106]. This takes place when
the intracellular biotin concentration is high and most of the apo-BCCP-molecules
are biotinylated. In this case biotinyl-AMP stays bound to BirA and leads to a
conformational change in the molecule that favours homodimerization. The BirA
homodimers are able to bind to bioO and block transcription. A maximal inhibitory
effect could be observed at concentrations of 40 nm biotin [5], [56]. At lower biotin
concentrations or when apo-BCCP accumulates, BirA-bound biotinyl-AMP is used
for modifying apo-BCCP. This prevents dimerization and DNA-binding of BirA.
Thus the transcriptional state of the bio-operon is regulated by intracellular free
biotin, or accordingly, by the amount of unbiotinylated apo-BCCP in cells (see fig.
1.5).
These bifunctional properties of BirA have been conserved - with slight variation-
in the Bacillus/Clostridium group, many proteobacteria, Thermus thermophilus,
Chlorobium tepidum and in some archaea [158]. Apart from this mechanism Rodi-
onov and Gelfand were able to eludicate by comparative genomic analysis that α-
proteobacteria, Rhizobiales and Rhodobacterales use the GntR-family-protein BioR,
that also contains a helix-loop-helix domain, but does not function in biotin trans-
fer, for biotin-dependent gene regulation [156]. This protein binds to a conserved
DNA-element designated the BIOR-box. The exact molecular mechanism and the
ligand(s) binding to BioR still have to be investigated.
In addition to biotin biosynthesis, also the uptake of biotin was regulated by the
biotin supply. It was maximally repressed at concentrations of 20 nM biotin in the
medium resulting in a 50 % reduction of biotin-transport [142]. It is still unclear if
biotin biosynthesis and biotin uptake are regulated by the same mechanism.
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Figure 1.5: Model of biotin dependent regulation by BirA in E. coli. At
low biotin concentrations the majority of BCCP is unbiotinylated and
appears in its apo-form. BirA as well does not carry biotinyl-AMP and
is available in monomers. It is unable to bind to DNA and transcription
from the biotin biosynthesis operon can take place. At high biotin con-
centrations, when most of BCCP is modified biotinyl-AMP stays bound
at BirA and leads to a conformational change in the protein. In this
conformation BirA favours homodimerization, is able to bind to the pro-
moter/operator region of the operon (P/O) and suppresses transcription.
According to [11].
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1.4 Biotin metabolism in Saccharomyces cerevisiae
A quite uncommon situation concerning biotin can be found in yeasts. Most yeast
strains are not able to synthesise biotin de novo, and need to be supplemented with
it. Nevertheless in most cases the cells retained the genes that are required for the
last three steps of biotin biosynthesis. The biotin prototrophic yeasts used in sake
brewing are exceptional as they contain two additional genes that are sufficient for
de novo biosynthesis. These could be identified recently [216], [75]. Saccharomyces
cerevisiae carries six different biotinylated proteins that are except of one all lo-
cated in the cytoplasm. The only essential biotin enzyme is acetyl-CoA-carboxylase
(Acc1p) that catalyses the reaction of acetyl-CoA to malonyl-CoA which is the first
comitted step in fatty-acid elongation [81]. Pyc1p and Pyc2p are two isoforms of
pyruvate carboxylase [190]. They catalyse the reaction from pyruvate to oxaloac-
etate, the first step in gluconeogenesis. Oxaloacetate is also required for being fun-
nelled into the citrate-cycle and therefore has anaplerotic function. Dur1,2p is the
urea-carboxylase and allows yeasts to grow on urea as sole nitrogen source. It has
two catalytic activities and is able to carboxylate urea to allantoate and further hy-
drolases allantoate to CO2 and NH3 [39]. A special biotinylated protein and unique
to S. cerevisiae is Arc1p [97]. It does not require biotin as a cofactor for an en-
zymatic activity, and the reason for biotinylation is still unclear. Arc1p associates
with acyl-tRNA-synthetases metRS and gluRS and the corresponding tRNAs and
is important for cytoplasmic localization of the complex and so enhances efficiency
of the acylation-reaction [46]. The only mitochondrial biotin-protein Hfa1p is an
isoform of the acetyl-CoA-carboxylase. In mitochondria, the produced malonyl-CoA
is predominantly needed for lipoate-biosynthesis [86].
The biotinylation of the different proteins is carried out by biotin-protein-ligase
(BPL) encoded by the gene BPL1 [42]. Concerning the catalytic center Bpl1p shows
homology to bacterial biotin protein ligases like E. coli BirA. The biological and
kinetic properties of the enzyme are well understood [146]. Polyak et al. also in-
vestigated the domain strucutre of the enzyme by limited proteolysis and found two
cleavage sites, one in an interdomain region and one within the catalytic site. In-
terestingly they found that the protein was less sensitive to proteolytic cleavage in
presence of the ATP and biotin, indicating a conformational change after substrate
binding. Another result was, that the N-terminal domain has no DNA-binding abil-
ity, but is essential for catalytical activity of the enzyme [146].
1 Introduction 16
1.4.1 Biosynthesis
In contrast to E. coli most of the commonly used laboratory-yeast-strains are
not capable of biotin de novo biosynthesis. Some fungal species completely lack
biosynthesis like Ashbia gossypii [48], but many S. cerevisae-strains retained the last
three steps of the pathway and are able to use KAPA, DAPA and DTB as precursors
(see fig. 1.3). The first two reaction-steps from KAPA to DTB are identical to the
E. coli pathway and catalyzed by the proteins Bio3p and Bio4p [141], respectively
(see. fig 1.3). In the third and final step DTB is converted into biotin by Bio2p. This
reaction takes place in mitochondria. BIO2 was the first biosynthesis gene that was
discovered in yeast in 1994 by Zhang and coworkers [221]. It shows homology to bioB
of E. coli and Bacillus-strains. BIO3 and BIO4 are encoded an chromosome XIV in
a gene cluster with BIO5. Recently two genes were reported, that promote growth
of certain S. cerevisiae-strains on biotin-free medium [216], [75]. Wu et al. have
found a gene with about 50 % identity to BIO3 called BIO6 in strains used for sake
brewing. BIO6 occurs in different copy numbers in the genome of certain strains and
is involved in prototrophy for biotin. They showed that prototrophic strains became
auxotrophic after a knockout of BIO6, indicating the gene is essential for biotin
biosynthesis. But the authors could only speculate about the function of Bio6p and
proposed it to act somewhere upstream of KAPA in the biosynthesis pathway, maybe
as KAPA synthase, because it contains putative binding sites for SAM and PLP that
are also present in the KAPA synthase bioA of E. coli. In 2007 Hall and Dietrich
showed that BIO6 is essential but not sufficient for biotin prototrophy [75]. They
found an additional gene called BIO1 that when coexpressed with BIO6 enables
an auxotrophic laboratory strains to grow in biotin free medium. Bio1p fullfills the
function of pimeloyl-CoA synthase, like the BioC-H complex in E. coli. However de
novo synthesis with BIO1 and BIO6 seems to be very slow and only promotes slow
growth of cells [75].
1.4.2 Transport
Biotin transport in yeast was already described in 1969 by Rogers and Lichstein
[165]. They reported an energy dependent uptake-system with a KM of 323 nM, a
temperature optimum of 30 ˚C and a pH optimum of 4.0 in S. cerevisiae. Biotin
transport was stimulted by glucose, inhibited by structural analogues of biotin and
was sensitve to iodoacetate and sodium azide. Yeast cells were able to accumulate
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the vitamin until the intracellular concentrations exceeded the concentration in the
medium by a factor of 1000.
S. cerevisae VHT1
Biotin can be taken up by Vht1p (vitamin H transporter 1), that was found by
Stolz et al. [185]. The protein consists of 593 amino acids, has 12 putative trans-
membrane domains, with N- and C-terminus directed towards the cytoplasm. VHT1
shows similarity to plasmamembrane transporter DAL5 for allantoate, that is struc-
turally related to biotin, and to FEN2, a transport protein for pantothenate. The
VHT1-gene is located on chromosome VII and the open reading frame implements
1782 basepairs. Transport by Vht1p was shown to be specific for biotin, as structural
similar substances like allantoin, allantoate, xanthine, uric acid, and urea were not
able to inhibit uptake. Additionally a proton symport mechanism could be proposed,
as uptake was inhibited by the protonophores CCCP and 2,4-dinitrophenol.
Sz. pombe vht1+
Beyond S. cerevisae VHT1, also Sz. pombe biotin transporter encoded by vht1+
could be identified [184]. The protein shows only little sequence homology to S.
cerevisae Vht1p but is able to complement a S. cerevisae vht1-mutant and has
similar biological properties. vht1+ encodes a protein that is predicted to contain
12 transmembrane domains. Like S. cerevisae VHT1 S. pombe vht1+ also belongs
to the familiy of allantoate transporters. Vht1+p as well enables active transport
and biotin accumulation in the cell in a H+-dependent manner and is sensitive to
protonophores. The pH optimum of 4.0 is identical to that of S. cerevisae VHT1
and the KM of 230 nM is very similar, too. Even the substrate specificities of the
two transport systems are comparable [184].
S. cerevisiae BIO5
S. cerevisiae can also utilize KAPA and DAPA in the growth medium as biotin
precursors. The protein responsible for KAPA and DAPA transport across the plas-
mamembrane was shown to be Bio5p [141]. Bio5p contains 12 transmembrane do-
mains and enables energy dependent uptake of the two substrates, demonstrated by
glucose stimulation [141]. The KM for KAPA is 0.8 µM. An interesting feature of
BIO5 is that it lies in a gene cluster with BIO3 and BIO4 on chromosome XIV. Re-
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calling the biological meaning this clustering makes sence, because Bio5p enables the
uptake of KAPA and DAPA that can be converted into DTB by Bio3p and Bio4p.
Another reason for clustering might be that both genes were probably aquired by
horizontal gene transfer [74]. So S. cerevisiae has, beyond taking up biotin, another
alternative to obtain the vitamin, although it is not capable of de novo biosynthesis.
One transport component of biotin metabolism in yeast is still missing for complete
understanding. Because the last step of biosynthesis from DTB to biotin, catalyzed
by Bio2p is taking place in mitochondria, there has to be one or more transport
protein(s) that enable(s) the cells to transport DTB into the mitochondria and biotin
out of them, as it seems unlikely this exchange occurs via passive diffusion. So efforts
to find the responsible gene and to characterize it still have to be made.
1.4.3 Regulation
Like in E. coli also in S. cerevisiae several genes that are associated with transport
and biosynthesis of biotin are regulated by the vitamin. First evidence was shown
by Rogers and Lichstein who reported, that biotin uptake was low in cells grown in
medium with excess of biotin (25 µg/l), whereas high transport rates were measured
in cells from medium with low biotin (0,25 µg/l) [166]. The results could be confirmed
by Stolz et al. who showed a biotin-dependent regulation of the S. cerevisiae biotin
transporter VHT1 [185] and biotin transporter vht1+ from Sz. pombe [184]. Hints
for a regulation of the biosynthesis genes BIO3, BIO4, BIO5 and again VHT1 were
found with a genome wide expression study by Wodicka et al. [210]. They showed
higher abundance of mRNAs of the four genes in cells from minimal medium in
contrast to a rich medium. This result was confirmed by Pirner and Stolz [144].
The same authors, as well as Weider et al. [201] additionally demonstrated the
existence of a promoter element called BRE or VHRE (biotin response element or
vitamin H response element) that mediates biotin dependent transcription of BIO3,
4 and 5, as well as VHT1 in a biotin dependent manner. The BRE is a conserved
20 bp [144], VHRE a 18 bps [201] palindromic upstream activating sequence (UAS)
located between 250 and 370 bps upstream of the start codons of BIO2, BPL1 and
VHT1 in S. cerevisiae, but also in related species like Saccharomyces paradoxus,
Saccharomyces mikatae, Saccharomyces kudriavzevii, Saccharomyces bayanus, and
Saccharomyces castellii.
Another factor required for biotin dependent regulation is VHR1 (VHT1 regulator
1) [201]. Beyond VHR1 another necessary protein for biotin sensing is Bpl1p. Miss-
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Figure 1.6: Biotin response element (BRE) (from Pirner and Stolz [144]).
The BRE was identified in the genes of biotin permease VHT1 (A),
biotin synthase BIO2 (B), and biotin-protein ligase BPL1 (C) of the
related yeast species S. cerevisiae, Saccharomyces paradoxus, Saccha-
romyces mikatae, Saccharomyces kudriavzevii, Saccharomyces bayanus,
and Saccharomyces castellii. The numbering indicates the position rel-
ative to the start ATG (where A is +1) of the gene. Positions that are
identical in at least 16 of the 17 sequences are printed in bold. D: Webl-
ogo (available online) was used with default settings to create a graphic
representation of the sequences displayed in A, B and C.
ing Bpl1p-activity leads to a low-biotin signal even if high concentrations of biotin
are available. If biotinyl-5’-AMP that is built by Bpl1p, is the crucial metabolite for
biotin sensing, like in E. coli is still unknown. Another important point is that biotin
sensing is independent of extracellular biotin concentration and of VHT1. This was
experimentally proven by Pirner and Stolz with a vht1-mutant lacking biotin trans-
port [144]. The mutant requires very high levels of biotin in the medium to grow,
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whereas is has very a low content biotin inside the cell. Reporter assays showed
that these cells behaved like in low-biotin medium, demonstrating that the intracel-
lular concentration is crucial for low biotin sensing. Adding biotin precursors like
KAPA or DAPA to the medium that and can be converted into biotin abolished the
low-biotin signal. Vht1p takes no influence on the sensing [144].
In summary, yeast cells are able to sense the intracellular biotin concentration and
are able to react with increased transcription of transporter genes VHT1 and BIO5,
as well as biosynthesis genes BIO2, 3and 4 on low intracellular biotin concentration.
The mentioned genes and BPL1 contain the UAS element BRE in their promoters.
Proteins essential for the biotin sensing process are the biotin protein ligase Bpl1p
[144], [183] and Vhr1p [201]. Knockout mutants of VHR1 were shown to be unable
to activate expression from promoters containing the BRE element in low biotin
medium. Further experiments with yeast one hybrid assays using the transcription
factor Gal4p were performed by Weider. Gal4p contains a DNA binding domain
(DBD) and an activating domain (AD) that are both required to drive expression
from Gal4p-dependent promoter [50]. A fusion protein of the N-terminal part of
Vhr1p that contains a predicted helix-turn-helix motive and the AD of Gal4p was
shown to be able to activate transcription from a promoter containing the BRE. Thus
Weider suggested the N-terminus of Vhr1p to be able to bind to a BRE. Activation
also seemed to be biotin dependent on biotin concentrations, with weaker expres-
sion at high biotin concentrations and stronger expression at low biotin levels [202].
Fusing the DBD of Gal4p to the C-terminal part of Vhr1p resulted in expression
from the GAL1-promoter containing four Gal4p binding sites, demonstrating the
function of Vhr1p C-terminus as an AD [202]. Different biotin requirements for wt
yeast cells and vhr1∆ cells could not be observed [202]. However, it is unclear which
information is recieved by Vhr1p and this is missing for a complete understanding
of the S. cerevisiae biotin sensing pathway.
1.5 Biotin in mammals
Biotin is, in contrast to bacteria essential for mammals and man. Although the
metabolic function and metabolism is well understood, not much is known about
nutritional requirements. Studying requirements is difficult, as resorption of biotin
from dietary intake and from intestinal synthesis by the microbial gut flora can not be
quantified or discriminated. A new field besides the functions of biotin as a cofactor is
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coming up recently and there are several indications for a participation of biotin and
its metabolic degradation products in different regulatory processes. Biotinylation
of histones as a epigenetic modification was not established since about ten years
ago. Meanwhile several biotinylation sites have been identified, but understanding
of the function of this modifications is still quite scarce.
1.5.1 Biotin as a vitamin
Adults should obtain 30-100 µg biotin per day. The intake of young Brithish
adults was estimated at about 35 µg per day [21], whereas intake in Switzerland was
suggested to be about twice as high [78]. The vitamin can not only originate from
food, but also from bacterial synthesis in the intestine [38], but how much of this
biotin can be absorbed is still discussed [18], [170].
Mammalian cells contain five proteins that carry biotin as a cofactor [100], [214].
One of them is like in bacteria and yeasts acetyl-CoA-carboxylase. Cells possess
one mitochondrial (ACC-1) and one cytoplasmic isoform (ACC-2). Biotin-enzymes
except the ACC2-protein are located in mitochondria, which is in contrast to S.
cerevisiae, where all biotin proteins except Hfa1p (mitochandria) are located in
cytoplasm. For replenishing the citric acid cycle pyruvate-carboxylase (PC) gen-
erates oxaloacetate from pyruvate. Methylcrotonyl-CoA-carboxylase (MCC) is in-
volved in degradation of the branched-chain amino acid leucin to acetoacetate.
Methylmalonyl-CoA that can enter the citric acid cycle after being converted to
succinyl-CoA results from a carboxylation of propionyl-CoA that is catalysed by
propionyl-CoA-carboxylase (PCC).
In mammals the enzyme responsible for post-translational modification with bi-
otin is called holocarboxylase synthetase (HCS) [217] and shows homology to biotin
transfer-domains of E. coli BirA and yeast Bpl1p [191], [111]. An enzyme that is not
present in E. coli and yeast, but in man and mammals is biotinidase. It is able to
cleave biotin from the lysin residue of biotinylated proteins, peptides and biotinyl-
lysin (biocytin) and so to set free covalentely bound biotin from dietary intake, as
well as to recycle biotin in metabolism [37], [99]. The protein contains a signal se-
quence and six sequons for N-glycosylation and enables secretion of the protein to
serum and pancreas where it can fulfill its function [128]. Apart from releasing bi-
otin, biotinidase is also speculated to serve as a biotin binding an transport protein
in serum [31].
Mutations in HCS or biotinidase can lead to multiple carboxylase deficiency (MCD)
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which results from reduced biotinylation of the biotin-dependent carboxylases lead-
ing to reduced enzyme activities. The consequence is metabolic ketoacidosis with
lactic acidosis that manifests in neurological deficiencies, skin rash and hair loss.
MCD can also result from mutations in biotinidase presumably because of reduced
absorption, recycling and reutilization of biotin [9], [193], [212]. Several mutations
in HCS and biotinidase have been described in the literature [15], [131], [130], [129],
[149], [150], [148]. HCS deficiency can be life threatening in infancy, whereas the on-
set of MCD with biotinidase defects tends to occur later and with milder symptoms
than a loss of function of HCS [211]. MCD may also result from protein malnutrition
[198], [197]. After timely diagnosis by presymptomatic screening a therapy of MCD
by pharmacological doses of biotin is possible and effective.
1.5.2 Transport
Biotin can only be taken up efficiently in its free form. Biotinyl-lysine, result-
ing from breakdown of biotinylated proteins can not be transported, so biotinidase
activity is required to release free biotin from the diet. Biotin was shown to be
co-transported with sodium in a 1:1 stochiometry and transport is driven by a
sodium-gradient. Competition was observed with structural analogs of biotin, such
as dethiobiotin [169]. Maximal biotin absorption takes place in the jejunum, lower
affinity is found in ileum and less in proximal colon [170]. The gene responsible
for biotin uptake was found in 1998 by Prasad and coworkers [152]. They identi-
fied a cDNA from rat placenta termed sodium dependent multi vitamin transporter
1 (SMVT1) that is predicted to encode a 634 amino acid protein with about 69
kDa and 12 putative transmembrane domains and N-, as well a C-terminus facing
the cytosol. Apart from biotin transport the protein is also capable to translocate
pantothenic acid when overexpressed in Caco-2 cells [168], whereas the affinity is
highest for pantothenate followed by lipoate and lowest for biotin after overexpres-
sion in HeLa cells [152]. The KM -values for biotin and pantothenic acid are 15.1 and
4.9 µM, respectively. SMVT1 belongs to the familiy of sodium dependent glucose
transporters and shows significant homology to other vitamin transport proteins,
like the sodium-dependent pantothenate-transporter of E. coli, PanF [92] and of
Hemophilus influencae [61]. Highest similarity is found to the mammalian iodide,
glucose and myo-inositol transporters. In rat SMVT is distributed in several tissues
with highest abundance of the mRNA in absorptive tissues like intestinal mucosa,
kidney and placenta but also easily detectable in liver, brain, heart, lung and skele-
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tal muscle [152]. An additional biotin transporter to SMVT in human peripheral
blood mononuclear cells (PBMCs) has been proposed by Mardach et al. [115]. Pos-
sibly also monocarboxylate transporter 1 (MCT1) plays a role in biotin uptake in
lymphoid cells [43], but this has not been shown for other tissues. One improtant
function of MCT1 may be the transport of biotin into mitochondria as the protein
was detected in mitochondrial membranes [23], [73].
1.5.3 Regulation
Regulation of gene expression by biotin is not unique to bacteria and yeasts. One
of the first hints in this field came from Dakshinamurti and co-workers 40 years ago,
who showed biotin deficiency caused a 40 % decrease of liver glucokinase activity
in rats [44]. As expected, biotin-regulated genes include biotin transporters and
biotin-dependent carboxylases [164]. Up to now the data of DNA microarrays with
mostly HepG2 cells and PBMCs showed that expression of more than 2000 human
genes is dependent on biotin [160], [205], [206]. It was observed that the distribu-
tion and function of the biotin-dependent genes is not at random, but genes are
often clustered and e.g. genes playing a role in signal transduction and gene prod-
ucts locating in the nucleus are overrepresented among regulated genes. The most
prominent transcription factors mediating biotin effects are nuclear factor (NF) -κB
[163], the Sp/Krüppel-like factor (KLF) familiy proteins SP1, SP3 [70] and recep-
tor tyrosine kinases [159]. The exact mechanisms and target genes following biotin
signals on these transcription factors are quite complex, miscellaneous and only par-
tially explored. Metabolites that direct a biotin signal downstream the the above
mentioned mechanisms are biotinyl-AMP and cGMP [180]. According to Solorzano-
Vargas biotinyl-AMP that is provided by HCS activates guanylate cyclase and so
increases cGMP-levels by a yet unknown mechanism. This leads to subsequent stim-
ulation of protein kinase G and activation of downstream targets by phosphorylation.
Coincident with this model Singh and Dakshinamurti reported increased activity of
guanylate cyclase in HeLa cells and fibroblast upon biotin addition to cells grown
in biotin-deficient medium [179]. Apart from effects of biotin and biotinyl-AMP on
gene expression there is evidence that biotin catabolites also might play a role in cell
signalling [161]. The most prominent degradation products of biotin are bisnorbi-
otin, tetranorbiotin, biotin-d,l-sulfoxides and biotin-sulfone [119]. These can occur
in similar concentration like biotin in body fluids and cells, but the mechanisms by
which they can affect cell signaling are unknown. What can be excluded is competi-
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tion with biotin for binding to HCS or a conversion into AMP-esters by this enzyme
[194].
1.5.4 Biotinylation of histones
A quite new and interesting aspect is modification of histones with biotin. Other
histone-modifications like lysine and arginine methylation, lysine acetylation, serine
and threonine phosphorylation, lysine ubiquitination and poly-ADP-ribosylation are
well known and their functions are at least in part understood [91], [14], [222],
[32]. These modifications that can be found in various eucaryotic cells [62] occur
predominantely at the N-terminal ends of the histone proteins, the so called "tails"
that protrude in chromatin and are quite well accessible in contrast to the globular
C-termini of the proteins that make up the protein core of the nucleosome structure.
Using synthetic peptides with the amino acid sequence of histone tails [25] and
incubation with biotinidase or HCS meanwhile following distinct biotinylation sites
could be identified (see tab. 1.2).
Histone Biotinylated amino acid Reference
H1
H2A K9, K13, K125, K127, K129 [33]
H2B
H3 K4, K9, K18, (K23) [101], [102]
H4 K8, K12 [28]
Table 1.2: Overview over biotinylated amino acids in histones
Insight into biological functions of biotinylated histones is still quite scarce, al-
though some functions like regulating the expression of human SMVT [220], marking
heterochromation [27] and others have been reported [34], [103],[220].
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1.6 Aims of this work
The ability of E. coli cells to take up biotin is known for more than 35 years. Sev-
eral groups collected lots of data about substrate specificity, pH- and temperature-
optimum, kinetic parameters and the mode of transport but not all of these results
are consistent. Although E. coli is one of the best understood model organisms,
nevertheless until today the gene(s) for the E. coli biotin transporter(s) still is/are
unknown.
One goal of this work was to identify the gene encoding the biotin transport pro-
tein and to further characterize it by cloning and overexpression. Therefore knockout
mutants and cells overexpressing the transport gene have been used and been tested
in uptake experiments with radiolabelled substrate in whole cells and membrane
vesicles. Additionally the regulation of the transporter gene and biotin transport in
general was studied. These assays used luciferase reporter constructs for biosynthesis
genes as a reference for the transporter gene. As biotin transport genes from mam-
malian cells, eucaryotic unicellular organisms (S. cerevisiae, Sz. pombe) and from
gram-positive bacteria and archaea are already known, the E. coli biotin transporter
will add to the set of biotin-transporters.
In the last years new insights into biotin dependent gene regulation in yeast have
been gained but some parts of the sensing pathway are still missing. Thus another
aim of the present work was to fill the existing gaps of this pathway in S. cerevisiae.
Special attention was dedicated to biotin-dependent pyruvate carboxylases 1 and 2
by investigating knockout and overexpression mutants and examining the full length
and truncated versions of the protein. Monitoring expression, biotinylation and
enzyme activities was part of the present work.
A third approach was to investigate protein biotinylation in S. cerevisae, as biotiny-
lated histones have been found in several mammalian cells during the last decade.
2 Material and methods
2.1 Material
2.1.1 Instruments
Manufacturer Device
Amersham Photometer Ultrospec 3100 pro
Beckman Coulter Allegra 64R Centrifuge
Bio101 Thermo Savant Fast Prep FP 120 (Ribolyser)
Bioblock Scientific UV-handlamp
Biometra T3-Thermocycler, gel documentation
BiodocAnalyze
BioRad power supplies, mini protean II gel chambers
Christ SpeedVac RVC 2-18
Clean Air Sterile hood CA/RE 4
Edmund Bühler TH30, SM30-Control (Thermo Shaker)
Eppendorf Centrifuge 5417R, Centrifuge Minispin plus,
Thermomixer 5436, Thermostat 5320
Epson Epson Scanner Epson Perfection 3200
Heidolph Magnet Stirrer MR3000, MR3001
Hettich Centrifuge Rotina 35R
Hielscher GmbH (Ultrasound processor)
ICN Biomedicals sterile hood BSB 4A
ISA Instruments Fluoromax-2
Jouan Speedvac RC 10.10, EB 18
Leica Microscope DMLS
LTF Labortechnik PP-IP-008SD gel documentation
Mettler Balance PJ3000
Millipore Milli Q biocel A10
Perkin Elmer TriCarb counter
Pharmacia Gene Power Supply GPS 200/400
Protec Optimax 2010
Sartorius Accuracy Balance R160P
Schott Glass wares
Scientific Industries Vortex Genie 2
26
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Manufacturer Device
Singer System 300 Tetrad Dissection Mikroscope
Tecan Multimode Microplate Reader Infinite 200
Thermo Varioscan
Wolf SANOclav table autoclav
WTB Binder Thermo Cabinets
WTW Digital-pH-meter pH525, Digital pH-Meter
pH540 GLP
Table 2.1: Instruments
2.1.2 Databases, websites and software
Chemical structure drawing ISIS Draw 2.3
Diagramms and tables Micorosoft Excel
DNA melting point calculations http://nature.berkeley.edu/z˜immer/oligoTMcalc.html
E. coli Genetic Stock Center http://cgsc.biology.yale.edu/
ExPASy / Swiss-Prot http://kr.expasy.org/
Graphics Adobe Photoshop
Hydropathy-analysis TOPCONS http://topcons.net/
Literature search http://www.pubmed.com
NCBI Blast http://www.ncbi.nlm.nih.gov/BLAST/
Saccharomyces genome database SGD http://www.yeastgenome.org/
Statistics GraphPad Prism
Text LaTeX
Working with DNA-sequences DNA Strider, ApE-Plasmideditor v1.09.1
Table 2.2: Databases, websites and software
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2.1.3 Chemicals and enzymes
If not otherwise stated chemicals were purchased from Merck (Darmstadt) in ana-
lytical grade. Cosumables were purchased from Greiner, Roth, Sarstedt and Schubert
& Weiss.
Manufacturer Chemicals
Applichem (Darmstadt) IPTG, glycerol (87%)
Amersham Bioscience (Braunschweig) D-(carbonyl)-14C biotin
Becton Dickinson (LePont de Claix,
Frankreich)
Yeast Extract, Trypton, Bacto Pepton,
Bacto Casaminoacids, BactoAgar (Difco)
Biomol (Hamburg) d-biotin
Calbiochem (San Diego, USA) G418
Fluka (Buchs) myo-inositol, tryptophane (nr. 93659), me-
thionine
Fujifilm Europe GmbH (Düsseldorf) Fuji medical X-ray film (100 NIF) Super RX
MBI Fermentas (St. Leon-Rot) dNTPs, restriction enymes and buffers, T4-
DNA ligase and buffer, Taq DNA polymerase
and buffer, GeneRuler 1 kb
Millipore (Molsheim, Frankreich) Steritop-sterile filter (500 ml), Steriflip (50
ml vacuum sterile filtration)
MP Biomedicals/Qbiogene (Heidel-
berg)
YNB without amino acids and vitamins
neoLab (Heidelberg) plastic picks, sterile
New England Biolabs (Schwalbach) alkaline Phosphatase (CIP), restriktion en-
zymes and buffer, Phusion High-Fidelity
DNA polymerase, protein marker broad
range, T4 DNA polymerase
Operon Biotechnologies GmbH (Koln) oligonucleotides
Pall (Dreieich) GN-6 Metricel Membran (0,45 µm pores)
Peqlab (Erlangen) Universal agarose
Perbio Science Deutschland GmbH
(Bonn)
Streptavidin Horseradish Peroxidase con-
jugated (Pierce), SuperSignal West Pico
Chemiluminescent substrate (Pierce), Super-
Signal West Dura Extended Duration Sub-
strate (Pierce)
Qiagen (Hilden) QIAprep Spin Miniprep Kit (50), QIAquick
Gel Extraction Kit (50), MinElute Gel Ex-
traktion Kit (50), Ni-NTA Agarose, Penta-
His antibody (nr. 34660)
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Manufacturer Chemical
Roth (Karlsruhe) acrylamide, ampicillin (Na-salt), Agar-Agar,
BSA (Albumin Fraktion V), 2-ml cry-
otubes, ethidiumbromide, glass beads (0,25-
0,5 mm), microtiterplates rotilabo 96U,
0,2-ml PCR-MikroUltraTubes, RotiR-Aqua-
Phenol, RotiR-Phenol, RotiszintR eco plus,
sterile filters (Rotilab 0,22 µm), tryptophane,
X-Gal
Santa Cruz Biotechnology Inc. (Santa
Cruz, USA)
polyclonal HA-probe (Y-11) antibody (sc-
805), monoclonal HA-probe (F-7) antibody
(sc-7392)
Sarstedt (Numbrecht) 3-ml fluorescence-cuvettes
Schleicher and Schuell (Dassel) nitrocellulose-transfer-membran "Protran"
Serva (Heidelberg) APS
Sigma-Aldrich (Steinheim) amino acids, Anti-Mouse IgG-Peroxidase an-
tibody (A9044), anti-Rabbit Horseradish
Peroxidase conjugated (A6154), lysozyme
(L2879), Triton X-100, TEMED, Ponceau S,
RNAse A
Thermo Electron GmbH (Ulm) oligonucleotides
USB (Bad Homburg) Tris Base
Table 2.3: Chemicals
2.1.4 Buffers and solutions
Acrylamide (for gels) 30% (w/v) acrylamide
0.8% (w/v) bisacrylamide
Bradford (5x) 0.05% (w/v) Coomassie brilliant blue G-250
24% (v/v) ethanol
50% (v/v) H3PO4
Buffer A 15 mM Tris-HCl (pH 7,4)
80 mM KCl
2 mM EDTA
10 mM PMSF (in DMSO) added before use
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Chemiluminescence solutions:
ECL1 2,5 mM luminol (in DMSO)
0,4 mM p-coumaric acid (in DMSO)
0,1 M Tris/HCl pH 8,5
ECL2 0,019 % hydrogenperoxide
0,1 M Tris/HCl pH 8,5)
Cell breaking buffer 2 % (w/v) Triton X-100
1 g (w/v) SDS
100 mM NaCl
10 mM Tris/HCl, pH 8,0
1 mM EDTA
Coomassie staining solution 0.05% (w/v) Coomassie blue R
10% (v/v) acetic acid
25% (v/v) isopropanol
Loading dye (agarose gels)(10x) 100 mM EDTA
60% (w/v) glycerol
0,25% (w/v) bromphenolblue
0,25% (w/v) xylencyanol
PBS(T) (10x) 8% (w/v) NaCl
0,2% (w/v) KCl
1,44% (w/v) Na2PO4
0,24% (w/v) KH2PO4 pH 7.4
(0,1% (v/v) Tween 20)
RNase A 10 mg/ml Ribonuclease A
0,01 M NaAc, pH 5.2
15 min at 100 ˚C, cool to RT,
adjust pH with 0.1 volumes
1M Tris/HCl pH 7.4
store at -20 ˚C
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Stacking gel buffer 0,139 M Tris/HCl, pH 6.8
0,11% (w/v) SDS
SDS-running buffer 25 mM Tris/HCl
192 mM glycerol
0,1% (w/v) SDS
SDS-sample buffer (4x) 250 mM Tris/HCl, pH 6.8
8% (w/v) SDS
20% (w/v) glycerol
20% (w/v) β-mercaptoethanol
0,4% (w/v) bromphenolblue
Separating-gel-buffer(3x) 1,126 M Tris/HCl, pH 8,8
0,3 % (w/v) SDS
STET-buffer 8% (w/v) sucrose
5% (v/v) Triton X-100
50 mM EDTA
50 mM Tris/HCl, pH 8.0
TB-buffer 10 mM Pipes
15 mM CaCl2
250 mM KCl, adjust pH to 7.6
55 mM MnCl2, steril filtered
TBE-buffer(5x) 445 mM Tris/HCl, pH 8,0
445 mM boric acid
5 mM EDTA
Transfer-buffer(2x) 0,48 % (w/v) Tris
2,24 % (w/v) glycin
40 % (v/v) methanol
0,04 % (w/v) SDS
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Uptake-buffer 50 mM KPO4 pH 6.0
10 mM MgSO4
Z-buffer 40 mM NaH2PO4
60 mM Na2HPO4
10 mM KCl
1 mM MgSO4 pH 7,0 (adjusted
with NaOH or HCl)
40 mM β-mercaptoethanol
(added before use)
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2.1.5 Culture media
Media for E. coli
2TY (rich medium) 16 g/l bacto trypton
10g/l yeast extract
5 g/l NaCl
M9 (minimal medium) 6 g/l Na2PO4
3 g/l KH2PO4
1 g/l NH4Cl
0.5 g/l NaCl
pH 7.4
11 mg/l CaCl2
0.25 g/l MgSO4 x 7 H2O
0.34 g/l thiamine HCl
20 mg/l proline
2 g/l glucose
SOB 20 g/l tryptone
5 g/l yeast extract
0.584 g/l NaCl
0.186 g/l KCl
SOC (50x) 180 g/l glucose
47.6 g/l MgCl2
60 g/l MgSO4
2TY plates were prepared with 2 % agar and M9 plates with 2 % bacto agar.
For selection purposes the media were supplied with ampicillin (100 mg/l), chloram-
phenicol (33 mg/l) or kanamycin (10 mg/l). In case of blue/ white screening on 2TY
plates, 10 mg/l IPTG and 0.004 % X-gal were used.
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Media for S. cerevisiae
YPD (rich medium) 1 % (w/v) yeast extract
2 % (w/v) Bacto peptone
2 % (w/v) glucose
MMA (synthetic medium) 0,67 % (w/v) YNB w/o amino acids
2 % (w/v) glucose
Plates were prepared with 2 % agar. For selection purposes YPD was supplied
with 100 mg/l G418. For cultivation with galactose medium, glucose in media has
been replaced by the same ammounts of galactose.
Amino acids and nucleobases:
For synthetic media required amino acids and nucleobases were added after au-
toclaving the media. Therefore 100-fold concentrated stock solutions were prepared
and autoclaved seperately. Stock solutions for tryptophane were sterile filtered and
stored dark. Final concentrations of the components were: adenin, uracil, histidin,
methionine und tryptophane: 20 mg/l; leucin und lysin: 30 mg/l.
Vitamins:
In synthetic media YNB without vitamins has been used and several vitamins
added in standard concentrations [203], [204]. These are calcium-panthothenate
(400 µg/l), folic acid (2 µg/l), inositol (2 mg/l), niacin (400 µg/l), p-aminobenzoic
acid (200 µg/l), pyridoxin/HCl (400 µg/l), riboflavin (200 µg/l) and thiamin/HCl
(400 µg/l). Biotin has been added as indicated. For plates with defined vitamin
concentrations Difco Bacto agar was used.
Aspartate (+Asp):
Pyruvate carboxylase mutants required L-aspartate for growth that was added 40
mM with additionally 15 mM potassium hydrogenphtalate. pH was adjusted to 5.0
with KOH.
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2.1.6 Organisms
E. coli strains
Strain Genotype Source
BL21(DE3) F ompT gal dcm lon hsdSB(rB mB) λ(DE3) Invitrogen
DH5α F endA1 glnV44 thi-1 recA1 relA1 gyrA96
deoR nupG φ80dlacZC∆M15 ∆(lacZYA-
argF) U169 hsdR17(rK mK+) λ
[76]
XL-1 blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44
relA1 lac
Stratagene
BW25113
Keio-wt
F−, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3),
λ−, rph-1, ∆(rhaDrhaB)568, hsdR514
EGSC No.
10756; The Keio
Collection [2]
yigM772∆::kan F−, ∆(araD-araB)567, ∆lacZ4787(::rrnB-
3), λ−, rph-1, ∆yigM772::kan,
∆(rhaDrhaB)568, hsdR514
EGSC No.
10756; The Keio
Collection [2]
bioA746∆::kan F−, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3),
λ−, rph-1, ∆bioA746::kan, ∆(rhaDrhaB)568,
hsdR514
EGSC No.
10756; The Keio
Collection [2]
bioB747∆::kan F−, ∆(araD-araB)567, ∆lacZ4787(::rrnB-
3), λ−, rph-1, ∆bioBB747::kan,
∆(rhaDrhaB)568, hsdR514
EGSC No.
10756; The Keio
Collection [2]
yifK746∆::kan F−, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3),
λ−, rph-1, ∆yifK746::kan, ∆(rhaDrhaB)568,
hsdR514
EGSC No.
10756; The Keio
Collection [2]
rarD764∆::kan F−, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3),
λ−, rph-1, ∆rarD764::kan, ∆(rhaDrhaB)568,
hsdR514
EGSC No.
10756; The Keio
Collection [2]
birA1 F−, [araD139 ]B/r, ∆(argF-lac)169, λ−,
TP(bioF-lacZ)501, flhD5301, ∆(fruK-
yeiR)725(fruA25), relA1, rpsL150(strR),
rbsR22, birA1, ∆(fimB-fimE)632(::IS1),
deoC1
[7]
birA85 F−, [araD139 ]B/r, ∆(argF-lac)169, λ−,
TP(bioF-lacZ)501, flhD5301, ∆(fruK-
yeiR)725(fruA25), relA1, rpsL150(strR),
rbsR22, birA1, ∆(fimB-fimE)632(::IS1),
deoC1
[7]
Table 2.5: E. coli strains
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S. cerevisiae strains
Strains VHR1-3HA, -ZZ and -GFP were generated by transformation of PCR-
products 3HA-kanMX4, ZZ-kanMX4, GFP-kanMX4, respectively and homologous
recombination of the pcr-products into yeast genomes. Colonies were selected for re-
sistance to G418 on YPDG418-plates. Correct integration of constructs was confirmed
by PCR with specific primers.
Strain Genotype Source
W303-1A MATa, ade2-1, ura3-1, his3-11,15, trp1-1,
leu2-3,112
[192]
VHR1-3HA MATa, ade2-1, ura3-1, his3-11,15, trp1-1,
leu2-3,112, VHR1-3HA-kanMX4
this work
VHR1-ZZ MATa, ade2-1, ura3-1, his3-11,15, trp1-1,
leu2-3,112, VHR1-ZZ-kanMX4
this work
VHR1-GFP MATa, ade2-1, ura3-1, his3-11,15, trp1-1,
leu2-3,112, VHR1-GFP-kanMX4
this work
YGALSNU13 MATa, his3∆1, leu2∆0, met15∆0, LYS2,
ura3∆0, kanMX6 :PGAL1-SNU13
[51]
arc1∆ MATa, ura3∆0, leu2∆0, his3∆1, lys2∆0,
arc1∆::kanMX4
EUROSCARF
hfa1∆ MATa, ura3∆0, leu2∆0, his3∆1, lys2∆0,
hfa1∆::kanMX4
EUROSCARF
dur1,2∆ MATa, ura3∆0, leu2∆0, his3∆1, lys2∆0,
dur1,2∆::kanMX4
EUROSCARF
pyc1∆ MATa, ura3∆0, leu2∆0, his3∆1, lys2∆0,
pyc1∆::kanMX4
EUROSCARF
pyc2∆ MATa, ura3∆0, leu2∆0, his3∆1, lys2∆0,
pyc2∆::kanMX4
EUROSCARF
vhr1∆ MATa, ura3∆0, leu2∆0, his3∆1, lys2∆0,
vhr1∆::kanMX4
EUROSCARF
pyc1∆pyc2∆ MATα, ade2-1, ura3-1, his3-11,15,
trp1-1, leu2-3,112, pyc1∆::kanMX4,
pyc2∆::kanMX4
Jürgen Stolz
pyc1∆acr1∆ MATα, ade2-1, ura3-1, his3-11,15,
trp1-1, leu2-3,112, pyc1∆::kanMX4,
arc1∆::kanMX4
Jürgen Stolz
pyc2∆arc1∆ MATα, ade2-1, ura3-1, his3-11,15,
trp1-1, leu2-3,112, pyc2∆::kanMX4,
arc1∆::kanMX4
Jürgen Stolz
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Strain Genotype Source
H2B-3HA ade2-1, ura3-1, leu2-3,112, trp1-1, his3-11,
can1-100, HTB2-MNase-kanMX6-3HA
YKM01 [122]
H3-3HA ade2-1, ura3-1, leu2-3,112, trp1-1, his3-11,
can1-100, HHT1-MNase-kanMX6-3HA
YKM04 [122]
H4-3HA ade2-1, ura3-1, leu2-3,112, trp1-1, his3-11,
can1-100, HHF2-MNase-kanMX6-3HA
YKM25 [122]
c13-ABYS-86 MATα, pra1-1, prb1-1, prc1-1, cps1-3,
ura3∆5, leu2-3,112, his−
[85]
Table 2.6: S. cerevisiae strains
2.1.7 Plasmids
E. coli plasmids
Name Description Source
pUC19 pMB1 replicon rep, ori, bla, lacZα; used for
subcloning of PCR-products
[218]
pPCR-Script Amp
Sk(+)
pUC ori, f1(+) ori, AmpR, P-lac, lacZ ; used
for subcloning of blunt end PCR-products in
EcoRV-site
Stratagene
pBluescript II SK(-) ori, bla, lacZα Stratagene
pBS-PR PR promotor of the λ-phage (PCR-product
Daniela ) ligated over SalI -HindIII -sites into
pBluescript II SK(-)
Daniela
Kolmeder,
TUM
pBS-PR-yigM Ligation of yigM-ORF (PCR-product SR62-
SR64, HindIII -NcoI)and T7-terminator
(PCR-product SR67-SR69 NcoI -EagI) into
HindIII - and EagI -sites of pBS-PR
this work
pBS-PR-yigM-HA Ligation of yigM-HA (PCR-product SR62-
SR63, HindIII -NcoI)and T7-terminator
(PCR-product SR67-SR69 NcoI -EagI) into
HindIII - and EagI -sites of pBS-PR
this work
pBS-PR-HA-yigM Ligation of HA-yigM-T7-terminator (PCR-
product SR69-SR64, HindIII -EagI) into
same sites of pBS-PR
this work
pBS-PR-yigMCO Codon-optimized version of yigM cloned
as HindIII -NcoI -fragment into pBS-PR
HindIII -NcoI -fragment after restriction of
pBS-PR-yigM
this work
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Name Description Source
pBS-PR-yigM-S28R PCR-products S1039-yigM SR70-SR85
(HindIII -PstI) and pcr wt-yigM SR84-SR64
(PstI -NcoI) ligated into same sites of
pBS-PR
this work
pBS-PR-yigM-P243S PCR-products wt-yigM SR70-SR85
(HindIII -PstI) and pcr S1039-yigM SR84-
SR64 (PstI -NcoI) ligated into same sites of
pBS-PR
this work
pBS-PR-yigM-S28R
P243S
PCR-product S1039-yigM SR70-SR64
(HindIII -NcoI) ligated into same sites of
pBS-PR
this work
pET24a(+) expression vector, pBR322 origin, f1 ori-
gin, kanR, lacI, T7 promoter, T7-epitope (N-
terminal), His-epitope (C-terminal), T7 ter-
minator
Novagen
pET24-yigMCO XbaI -SacI fragment of yigMCO ligated into
same sites of pET24a(+)
this work
pET24-yigMCOw/o C NdeI -NcoI fragment from PCR-product T7-
SR97 ligated into same sites of pET24a(+)
this work
pQE60 Expression vector, T5 promoter, lac operator
element, 6His-taq coding sequence, mcs, λt0
terminator, rrnB T1 terminator, ColE1 ori,
AmpR
Quiagen
pQE60-birA-6His birA-PCR-product (SR90-SR92) cloned in
pQUE60 over NcoI - and BglII -site; fusion of
BirA with 6His
this work
pDEW20 Reporter construct with promoterless lux-
CDABE gene-cluster from Photorhabdus lu-
minescens for bioluminescence emission, ori
from pBR322, bla, T14 terminator
[196]
pDEW201-PbioB PCR product of the bioB-promoter (SR77-
SR74) inserted into pDEW201 as BamHI -
EcoRI fragment
Carina Mann,
TUM
pDEW201-PyigM PCR product of the yigM-promoter (SR75-
SR76) inserted into pDEW201 as BamHI -
EcoRI fragment
this work
Table 2.7: Plasmids used in E. coli
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S. cerevisiae plasmids
Name Description Source
YCplac33 ori, CEN, AmpR, URA3 [67]
YEplac195 ori, 2µ, AmpR, URA3 [67]
YEplac195-GFP plasmid for C-terminal GFP fusions Jürgen Stolz
p416-Met25 CEN, URA3, AmpR, MET25-promoter,
CYC1-terminator
ATCC 87324
[124]
pUG36 ori, CEN, AmpR, URA3 [127]
p3HAT-kanMX5 cloning vector with 3HA epitope and
kanMX -cassette
Jürgen Stolz
pZZT-kanMX5 cloning vector with ZZ epitope and kanMX -
cassette
Jürgen Stolz
pGFPT-kanMX5 cloning vector with GFP and kanMX -
cassette
Jürgen Stolz
pMELβ2-fragment D VHT1-promotor PCR-fragment (bp -286 to
-223) in pMELβ2
Heike Stüer
YEplac112-pMEL-
VHT1-lacZ
pMEL-VHT1 promotor (HindIII -SphI)-
fragment from PCR-product HP15-HP16
of pMELβ2-fragment D fused to lacZ
(SphI -XbaI) in YEplac112-lacZ
Heike Stüer
YEplac195-pMEL-
VHT1-GFP
HindIII -BamHI -fragment (pMEL-VHT1) of
PCR-product JST83-SR19 integrated into
same sites of YEplac195-GFP
this work
p416-Met25P-pyr1+ Ligation of AvrII -XhoI -fragment for PCR-
product JST361-JST362 into XbaI - and
XhoI -sites of p416-MET25.
this work
YCplac33-3HA YCplac33 with 3HA inserted as HindIII -
MfeI fragment into HindIII -EcoRI of YC-
plac33
Jürgen Stolz
YCplac33-PYC1-3HA Ligation of PYC1 SalI -NcoI -fragment
from pRS316-PYC1, PYC1 NcoI -XbaI -
fragment from PCR-product SR27-SR28
and YCplac33-3HA XhoI -XbaI -fragment
this work
YCplac33-PYC2-3HA Ligation of PYC2(HindIII -Mph1103I)-
fragment from pRS316-PYC2 and
(Mph1103I -XbaI)-fragment from PCR-
product SR25-SR26 in YCplac33-
3HA(HindIII -XbaI)-fragment
this work
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Name Description Source
pUG36-Met25P-3HA N-terminal 3HA tagging plasmid. CEN
URA3. Carries the MET25 promotor. Con-
structed by ligation of XbaI -BamHI frag-
ment from PCR product JST363-JST364
into the same sites of pUG36
Jürgen Stolz
pUG36-Met25P-3HA-
VHR1
VHR1 cloned as NotI -XhoI fragment from
PCR-product JST366-JST367 into same
sites of pUG36-3HA-MET25P
this work
pUG36-Met25P-3HA-
PYC2
PYC2 cloned as NotI -XhoI fragment from
PCR-product SR34-SR35 into same sites of
pUG36-3HA-MET25P
this work
pUG36-Met25P-3HA-
PYC2-(-2)
BamHI -XhoI -fragment from PCR-product
SR42-SR47 ligated into same sites of pUG36-
Met25P-3HA-PYC2
this work
pUG36-Met25P-3HA-
PYC2-(-6)
BamHI -XhoI -fragment from PCR-product
SR44-SR47 ligated into same sites of pUG36-
Met25P-3HA-PYC2
this work
pUG36-Met25P-3HA-
PYC2-(-10)
BamHI -XhoI -fragment from PCR-product
SR46-SR47 ligated into same sites of pUG36-
Met25P-3HA-PYC2
this work
Table 2.8: Plasmids used in S. cerevisiae
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2.1.8 Oligonucleotides
Name Sequence (5’→ 3’) Description
HP15 ATATGCATGCCGTCGTTGC
TTTTATTACCG
antisense primer before lacZ-
Startcodon in pMELβ2 with
SphI -site
HP16 ATTCCCGAATTGGGAAGC sense Primer at HindIII-site in
pMELβ2
JST83 GCGGATAACAATTTCACACAGG forward primer binds 25 bp
away fromHindIII -site in pUC19-
polylinker
JST361 ATATAGCGGCCGCCTAGGATGA
CTTCTAAATATGATGCGTTGTTGC
for cloning S. pombe pyr1+ with
NotI - and AvrII -sites for cloning
into XbaI - and XhoI -sites of
p416-MET25; used with JST362
JST362 ATATGCGGCCGCTCGAGTTACTC
GTGTTCAAGAACAGCACAC
for cloning S. pombe pyr1+ with
NotI - and XhoI -ends; used with
JST361
JST363 ATTCTAGAAAAAATGGCATACCC
GTACGACGTCC
upstream oligo for amplification
of 3HA tag for making N-terminal
fusions in pUG36
JST364 ATGGATCCTGCGGCCGCGCCGG
CGTAATCCGG
downstream oligo for amplifica-
tion of 3HA tag for making N-
terminal fusions in pUG36
JST366 ATATGCGGCCGCAAACGGTCCT
CCAACATTCACTC
used with JST367 to amplify
VHR1 (NotI/XhoI) for cloning
into pUG36-3HA
JST367 ATATCTCGAGTTATCAAAGTAAA
GGCTGGAAAACCG
used with JST366 to amplify
VHR1 (NotI/XhoI) for cloning
into pUG36-3HA
SR19 ATATGGATCCCATTTTCGTCG
TTGCTTTTATTACCG
reverse primer for amplifying
VHT1-promoter to fuse with
GFP in frame over BamHI -site
(contains AAA-ATG directly up-
stream of BamHI -site)
SR25 GATACTGGGATTAACGTTGAGC forward primer for amplification
of C-terminal PYC2-fragment;
used with SR26
SR26 TATATCTAGACTTTTTTTGGGA
TGGGGGTAGGG
reverse primer for C-terminal
3HA-tagging of PYC2, for liga-
tion in YCplac33-3HA over XbaI -
site
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Name Sequence (5’→ 3’) Description
SR27 GGAAAGATTCTTGGACAAGCC forward primer for use with SR28
to amplify C-terminal end of
PYC1 with natural NcoI - and
introduced XbaI -site for fusion
with 3HA, used with SR28
SR28 TATATCTAGATGCCTTAGTTTCA
ACAGGAACTTG
reverse primer for C-terminal
3HA-tagging of PYC1, for liga-
tion in YCplac33-3HA over XbaI -
site; used with SR27
SR34 ATATATGCGGCCGCCAGTAGCAA
GAAATTGGCCGG
forward primer for ampfication
of PYC2 from YCplac33-PYC2
for N-terminal tagging in pUG36-
Met25p-3HA; contains NotI -site,
starts after ATG of PYC2
SR35 ATATCTCGAGTTATTACTTTTT
TTGGGATGGGGG
reverse primer for ampfication of
PYC2 from YCplac33-PYC2 for
N-terminal tagging in pUG36-
Met25p-3HA; with natural plus
additional stop-codon just before
XhoI -site
SR42 ATATCTCGAGTTATTATTGGGAT
GGGGGTAGGGTTTC
reverse primer for deletion of last
two amino acids of PYC2p, used
with SR47
SR44 ATATCTCGAGTTATTATAGGGTT
TCTTCTTCTAGGACAACCAAC
reverse primer for deletion of last
six amino acids of PYC2p, used
with SR47
SR46 ATATCTCGAGTTATTATTCTAGG
ACAACCAACAAATCTGATGC
reverse primer for deletion of last
ten amino acids of PYC2p, used
with SR47
SR47 CGCTTTAGAATGTTGGGGTGG forward primer for C-terminal
truncated versions of PYC2 in
pUG36-3HA-PYC2, used with
SR42-46
SR62 ATATAAGCTTGTGGCGCTACTTA
TCATCACC
forward primer for amplification
of E. coli yigM, contains HindIII -
site, used with SR63
SR63 ATATCCATGGTTACGCGTAGTCA
GGCACGTCGCCTTCGCTCAGC
GCGC
reverse primer for amplification of
E. coli yigM with HA-tag, con-
tains NcoI -site, used with SR 62
SR64 ATATCCATGGTTATTCGCTCAGC
GCGC
reverse primer for amplification of
E. coli yigM, contains NcoI -site,
used with SR 62
SR67 ATATCCATGGAATAACTAGCATA
ACCCCTTGGG
forward for amplification of T7-
terminator, contains NcoI -site,
used with SR68
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Name Sequence (5’→ 3’) Description
SR68 GCCACGCTTCCCG reverse for amplification of T7-
terminator, binds at 3770-3784 in
PR-YjdL behind SapI - and EagI -
sites, used with SR67
SR69 ATATAAGCTTATGGGCGACGTGC
TTGACTACGCGGGCGCGGGCGC
GGCGCTACTTATCATCACCACG
forward primer for amplifi-
cation of HA-yigM, ATG-
start-tag(MGDVLDYA)-
linker(GAGA)-yigM, natural
start-GTG of yigM deleted,
contains HindIII -site, used with
SR64
SR70 ATATAAGCTTTCTAGAATGGCG
CTACTTATCATCACC
forward primer for amplification
of yigM, with natural start-
GTG replaced by ATG-start-
codon, contains HindIII -site and
XbaI -site, used with SR64
SR74 ATATGGATCCGGGGCTTCTCC
AAAACG
reverse primer for amplification of
bioB-promoter, contains BamHI -
site, used with SR73
SR75 ATATGAATTCTCTAGATCGTTC
TTTATTTGGTCAGTTGT
forward primer for amplifica-
tion of yigM-promoter, contains
EcoRI -site, used with SR76
SR76 ATATGGATCCAATGGAAAACTCT
TTGATTAACGG
reverse primer for amplification of
yigM-promoter, contains BamHI-
site, use with SR75
SR84 GCAAACCACGCTGCAGTGGGG
CATTCTGGTGTT
mutation primer for cloning yigM
from S1039, introduces PstI -site
in yigM ORF over silent muta-
tion, used with SR64
SR85 AACACCAGAATGCCCCACTGCA
GCGTGGTTTGC
mutation primer for cloning yigM
from S1039, introduces PstI -site
in yigM ORF over silent muta-
tion, used with SR70
SR90 TATACCATGGATGAAGGATAAC
ACCGTGCC
forward primer for amplification
of birA, used with SR92
SR92 ATATAGATCTTTTTTCTGCACTA
CGCAGG
reverse primer for amplification of
birA, used with SR90
SR97 TATACCATGGTTATTATGCGGTC
TGGCTGCTAC
reverse primer for C-terminal
deletion of yigMCO (last 11
aa DDRRRDCALSE missing),
used with T7 primer on pET24-
yigMCO
T7 GCGTAATACGACTCACTATAGGGC forward primer for amplification
of yigMCO from pET24-yigMCO,
used with SR97
Table 2.9: Oligonucleotides
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2.2 Methods
2.2.1 Cell maintainence
Culturing cells
Liquid cultures for E. coli were grown aerobically in shakers at 37 ˚C, plates
aerobically in incubators at 37 ˚C over night on 2TY rich, or for 24 h on M9 minimal
media. Cultures for S. cerevisiae were grown aerobically on plates incubated at 30
˚C for several days, and liquid cultures aerobically under shaking at 30 ˚C. Cells
from glycerol stocks were thawed and grown on YPD rich medium before cultivating
them on MMA minimal media. Cell concentrations were measured over optical
density at 600 nm (OD600). For S. cerevisiae cells 1 ml of an OD600 corresponds to
about 107 cells.
Glycerol stocks of E. coli - and S. cerevisiae- strains
Freshly grown cells from 2TY- or YPD-plates for E. coli and S. cerevisiae, respec-
tively, were resuspended in the same medium with 15 % glycerol, frozen in liquid
nitrogen and stored at -80 ˚C.
2.2.2 Molecular biology methods
Standard methods
Molecular biology standard methods (agarose-gel-electrophoresis, digestion with
restriction enzymes, ligation) were performed as described in [173]. DNA was ex-
tracted from agarose gels QIAGEN gel exctraktion kits as indicated by the manu-
facturer.
Chemical preparation of competent E. coli cells
3 ml 2TY medium were inoculated with the strain and incubated under shaking
overnight at 37 ˚C. From each strain 50 ml SOC medium were inoculated with 0.5
ml overnight culture and incubated till an OD600 of 0.2 - 0.3. 35 ml of these cultures
were transfered into a sterile 50 ml tube and kept on ice for 15 min. Afterwards
cells were centrifuged for 5 min at 4 ˚C and 3500 g. The supernatant was discarded
and cells were carefully resuspended in 35 ml ice cold 100 mM CaCl2 solution. After
an 20 min incubation on ice the cells were centrifuged for 5 min at 4 ˚C and 3500
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g. Supernatant was again discarded and cells were resuspended in 3 ml ice cold 100
mM CaCl2 solution. Cells are then ready for transformation. In case the competent
cells were stored at -80 ˚C, 105 µl DMSO were added, cells kept on ice for 15 min,
then aliquoted in 100 µl and finally frozen in liquid nitrogen.
Preparation of highly competent E. coli cells
10 ml 2TY were inoculated with a single colony of cells and incubated in a shaker
at 37 ˚C over night. 250 ml SOB-medium with SOC was inoculated to an OD600
from this overnight culture and incubated in a shaker at 18 ˚C until an OD600 was
reached (12-18 h). Cultures were cooled on ice/water under slow shaking for 10 min
and harvested (10 min, 2500 g, 4 ˚C). Cells were resuspended in sterile TB-buffer,
incubated on ice for 10 min and centrifuged again (10 min, 2500g, 4 ˚C). Cell pellets
were resuspenden in 20 ml of cold, sterile TB-buffer, 20 % glycerol were added, cells
frozen in liquid nitrogen in 400 µl aliquots and stored at -80 ˚C.
Transformation of E. coli cells
Competent cells were thawed on ice and stored for 5-10 min on ice after addition
of DNA. After at 30 sec heat pulse at 42 ˚C cells were cooled for 1 min on ice and
subsequently mixed with 1 ml 2TY. Incubation at 37 ˚C for was performed, cells
centrifuged 1 min at 13,200 g, resuspended in 100 µl 2TY and plated on selective
plates.
Integration of T7 polymerase into the E. coli chromosome
For expression of yigM from the T7-based expression system of pET24 λDE3
prophages were introduced into the E. coli chromosome using a λDE3 Lysogenization
Kit (Novagen) according to manufacturers instructions.
Transformation of S. cerevisiae cells
Transformation of yeast cells was performed as described previously [66], [68].
High efficiency transformation: 50 ml YPD were inoculated to an OD600 of 0.5
from an overnight culture and incubated in a shaker at 30 ˚C until OD600 of 2 was
reached. Cells were harvested (RT, 4000 g, 3 min) washed with water, resuspended
in 1 ml 100 mM LiAc and transfered to a 1.5 ml Eppendorf tube. After pelleting cells
(RT, 13,200 g, 10 sec) supernatant was discarded and pellets resuspendend in 400 µl
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100 mM LiAc. For each transformation 50 µl of these cells were used. 240 µl of 50
% PEG, 36 µl 1 M LiAc, 50 µl carrier DNA (2 mg/l in TE, freshly boiled) 34 - x µl
H2O and x µl DNA (usually 2 µl plasmid DNA or 20 µl PCR-product) were added
and mixed thoroughly by vortexing. Tubes were incubated for 30-60 min at 30 ˚C,
20 min at 42 ˚C and cooled on ice. Cells were pelleted by centrifugation (RT, 5,000
g, 2 min), supernatant discarded, pellets carefully resuspended in 100 µl sterile H2O
and plated on selective plates. If cells were selected in G418 transformation assays
were mixed with 1 ml YPD and incubated for 4 h at 30 ˚C before plating.
Quick transformation: For quick transformation of plasmid-DNA the protocol
given before was modified. Freshly grown yeast cells from a plate were resuspended in
1 ml H2O, pelleted and resuspended in 1 ml 100 mM LiAc. After a 5 min incubation
at 30 ˚C, cells were distributed to 1.5 ml tubes, mixed with PEG, LiAc, carrier-DNA
and DNA as describes above and carefully resuspended. Heat shock and plating was
again performed as described before.
2.2.3 Methods with DNA
Plasmid isolation from E. coli
1 ml of an overnight culture with cells containing the plasmid was transfered to
an Eppendorf tube, centrifuged 1 min at 13,200 g and supernatant discarded. 500
µl STET buffer were added to the cells and vortexed until the pellet was completely
resuspended. For cell lysis 100 µl lysozyme (10 mg/ ml in STET buffer) were added,
the cells were resuspended and suspension was incubated at 95 ˚C for 2 min. Tubes
were then centrifuged for 5 min at 13,200 g and afterwards pellets were removed with
a sterile toothpick and discarded. 400 µl isopropanol were added to the supernatant
containing the DNA and the latter precipitated. Samples were vortexed and cen-
trifuged for 5 min at 13,200 g. Supernatant was discarded and the pellet was washed
with 200 µl 70 % ethanol and subsequently centrifuged for 5 min at 13,200 g. The
pellet containing DNA was then dried in the Speedvac. 100 µl ribonuclease A (100
µg/ ml) in TE-buffer were added and incubated for 5 min at 65 ˚C shaking. Tubes
were centrifuged for 3 min at 13,200 g and supernatants containing plasmid DNA
used for further analysis. For more pure plasmid purifications (e.g. for sequencing)
QIAprep Spin Miniprep Kits were used according to manufactureres instructions.
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Isolation of genomic DNA
5-10 ml culture in 2TY medium was grown overnight at 37 ˚C to saturation.
Cells were harvested, resuspended in 0.5 ml H2O, transferred into an Eppendorf
tube and centrifuged for 30 s at 13,200 g. Supernatant was discarded and the pellet
resuspended in the remaining liquid. 200 µl lysis buffer, 200 µl phenol : chloroform
: isoamylalcohol (25 : 24 : 1) and 0.3 g glass beads with 0.5 diameter were added
before the sample was placed in the ribolyser for 30s at level 5. Subsequently 200 µl
TE buffer (10 mM Tris pH 7,0; 1 mM EDTA) were added and the cell lysate mixed
carefully. Afterwards tubes were centrifuged for 5 min at 13,200 g. 200 µl from the
aqueous supernatant were mixed with 1 ml 100 % ethanol by inverting the tube.
Precipitated DNA was centrifuged for 2 min at 13,200 g and supernatant discarded.
The humid pellet was resuspended in 400 µl TE buffer with 4 µl RNAse A (10 mg/
ml) and incubated at 65 ˚C for 5 min. After incubation 1 ml 100 % ethanol and 10
µl 4M NH4Ac were added and mixed by inverting the tube. Pellet were collected by
centrifugation for 2 min at 13,200 g and dried in the speedvac. Dried genomic DNA
was resuspended in 50 µl water.
Polymerase Chain Reaction (PCR)
PCR-assays with Taq-Polymerase contained 50-100 ng DNA, 1x ThermoPol-buffer
(New England Biolabs), dNTPS (0.25 mM each), primer (100 pmol, each) and 0.5
µl polymerase in a 25 µl-assay. Reactions with Phusion High-Fidelity PCR Kit
(Finnzymes) were performed according to manufacturers instructions.
Colony-PCR
Colony-PCR was used for fast control of E. coli transformants. Single colonies were
collected from plates with sterile toothpicks and transfered to PCR-tubes. With
the same toothpick a 2 ml 2TY overnight cultures with corresponding antibiotic
was inoculated for plasmid isolation. PCR assays for cells were completed with
1x ThermoPol buffer, 0.25 mM dNTPs (each), 30 pmol primer (each) and 1U Taq
polymerase in a final volume of 15 µl. Subsequently a PCR with 20 cycles was run.
Measurement of DNA concentration
DNA was diluted in water (1:20) and concentration was measured in a quartz
cuvette with a UV-photometer from 240 nm to 290 nm. The quotient A260(DNA)
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/ A280(protein) informs about the purity of the DNA sample. Ratio should ideally
be 1.8.
DNA ethanol precipitation
PCR products for EMSAs were purified by ethanol precipitation. 1/10 volume 3
M NaAc pH 5.0 and 3 volumes 100 % ethanol were added to the PCR samples. DNA
was precipitated by storage for 2 h at -80 ˚C or overnight at -20 ˚C. The samples
then were centrifuged at 4 ˚C and 25,000 g for 15 min supernatant was discarded.
Pellets were washed with 70 % ethanol and samples centrifuged at 4 ˚C and 25,000
g for 5 min. Supernatants were discarded and the DNA pellet dried in a speedvac.
DNA was resuspended in 30 µl water.
DNA-sequencing
DNA-samples were sequenced by SEQLAB (Göttingen) or GATC (Konstanz).
E. coli mutant S1039 [199], [84] was sequenced by Prof. Dr. Thomas Eitinger
(Humboldt-Universität zu Berlin, Institut für Biologie/Mikrobiologie) who kindly
shared the sequences with us.
Codon optimization of yigM
The yigM-ORF was codon-optimized for expression in E. coli. Optimization and
and synthesis of the optimized gene yigMCO were performed by GENEART Regens-
burg.
2.2.4 Methods with proteins
S. cerevisiae protein extracts
For preparation of S. cerevisiae protein extracts all steps were performed on ice
and with cold solutions and centrifuges. 5 OD600 of cells were harvested and washed
with TE-buffer (25 mM Tris pH 7.0, 5 mM EDTA) and transfered to a 1.5 ml tube.
Supernatant was discarded and about 3 g glass beads (diameter 0.5 mm), 100 µl
SDS-sample buffer and 1 µl 1 M PMSF (in DMSO) added. Cells were broken in
a ribolyser (30 sec, level 5). Subsequently again 1 µl 1 M PMSF (in DMSO) was
added and samples boiled for 2 min at 95 ˚C. For analysis of membrane-proteins
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(Vht1P, Bio2P) samples were only heated to 42 ˚C for 2 min. After centrifugation
(1 min, 13,200 g) supernatant was removed and used for further analysis.
Preparation of S. cerevisiae nuclear extracts
Yeast nuclear extracts were prepared with slight modifications according to [176].
All steps were carried out on ice and with cold buffers and centrifuges. 50ml YPD
were inoculated to an OD600 of 0.1 from an overnight culture and grown at 30 ˚C
with shaking until OD600 reached 0.6. Cells were washed with water, three times
with buffer A and were transfered to a 1.5 ml tube. After resuspension in 350 µl
buffer A and addition of 350 µl glass beads (diameter 0,75 - 1 mm) cells were broken
in a ribolyser (30 sec, level 5). A hole was drilled into lid and bottom of the 1.5 ml
tube and the tube placed onto a 15 ml Falcon tube. Nuclear extracts were collected
by centrifugation (2000 g, 2 min), resuspended, transfered to a new 1.5 ml tube and
again centrifuged (13,200 g, 2 min). Supernatant was discarded. Nuclear extracts
were washed with 1 ml buffer A and used immediately for further analysis or frozen
in liquid nitrogen and stored at -80 ˚C.
SDS-polyacrylamide-gelelectrophoresis (SDS-PAGE)
Proteins were analysed by (SDS-PAGE) as described previously [107]. Gels were
run with 120 V until the dye had reached the seperating gel and subsequently run
with 200 V. Molecular weight marker was purchased from New England Biolabs
(Protein Marker Broad Range). Staining of gels with Coomassie was performed as
described [173].
Determination of protein concentrations
The Bradford protein assay was applied for spectrometric protein concentration
measurements. In a cuvette 1 ml Bradford solution, 90 µl water and 10 µl protein
were mixed for concentration measurements. The sample was incubated for 5 min
at 25 ˚C and afterwards absorption was measured at 595 nm. As reference 1 ml
Bradford solution with 100 µl water were applied. Protein concentration was deter-
mined with the help of a calibration curve which was established with known protein
concentrations of BSA.
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Western-blot analysis
Immunologic determination of proteins was performed by western-blot analysis.
After separation by SDS-PAGE proteins were transfered to nitrocellulose membranes
by wet-blot for 25 min at 360 mA. Membranes were stained with Ponceau S for
loading control and detection of protein molecular weight maker. Membranes were
blocked for 1 h in PBST with 1 % (w/v) skim milk powder. Antibodies/antisera or
streptavidin-peroxidase were incubated for 1 h at room temperature or overnight at
4 ˚C in PBST with 1 % (w/v) skim milk powder in following dilutions (see tab.
2.10). Membranes were subsequently washed 3x 15 min with PBST with 1 % (w/v)
skim milk powder. If necessary secondary antibodies were incubated 1 h at room
temperature on the membranes and again washed 3x 15 min with PBST with 1
% (w/v) skim milk powder. Finally membranes were washed for 5 min with PBS
and detected with home made chemiluminescence-solutions (1 ml of ECL1 and 1
ml ECL2 mixed for each membrane) or SuperSignal West Dura Extended Duration
Substrate (Pierce) on X-ray films.
antibody/serum dilution source
primary:
anti-HA polyclonal (sc-805) 1:2500 Santa Cruz Biotechnology
anti-Bio2p 1:2500 U. Mühlenhoff and R. Lill;
Marburg
anti-Vht1p 1:1000 [144]
penta-His 1:2500 Quiagen
anti-biotin-peroxidase 1:2500 Sigma-Aldrich
secondary:
anti-rabbit IgG 1:5000 Sigma-Aldrich
anti-mouse IgG 1:5000 Sigma-Aldrich
streptavidin-peroxidase 1:5000 Pierce
Table 2.10: Antibodies, antisera and strepatvidin-peroxidase
Expression and purification of BirA-6His
BirA-6His was expressed from a pQE60-vector under control of a lac-inducable
promoter. 500 ml 2TY medium containing 100 µM biotin were inoculated with an
OD600 of 0.1 and incubated at 25 ˚C until an OD600 of 0.6 was reached. Induction
was accomplished by addition of 0.1 mM IPTG and cells were further incubated at
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25 ˚C for 4 h. After expression the 500 ml cell culture were transfered into 50 ml
tubes and centrifuged at 3,500 g and 4 ˚C for 15 min. Supernatants were discarded
and the pellets were stored at -20 ˚C. Pellets of 500 ml culture were resuspended
in 50 ml ice cold buffer (20 mM KPO4 pH 7.0, 500 mM NaCl, 30 mM imidazole)
and centrifuged at 4 ˚C and 3,500 g for 10 min at 4 ˚C. The pellet was again
resuspended in 50 ml ice cold buffer (20 mM KPO4 pH 7.0, 500 mM NaCl, 30 mM
imidazole, 1 mg/l lysozyme) and divided into two 50 ml tubes and cells kept on ice
for 15 min. Cell lysis was performed with an ultrasound processor with pulses of 0.5
s and amplitude of 0.6 for 30s on ice. This procedure was repeated a several times
until turbidity of the cell suspension disappeared. Lysates were centrifuged twice
for 15 min at 10,000 g, supernatant collected and filtered through a filter with 45
µm pore size. His-tagged protein was purified by affinity chromatography with a Ni-
Sepharose column (Ø 0.9 mm) on an Amersham ÄKTA-FPLC. Column was washed
with buffer (20 mM KPO4 pH 7.0, 500 mM NaCl, 30 mM imidazole) and protein
was eluted with the same buffer containing 300 mM imidazole. Protein expression
and purification was carried out with assistance of Carina Mann de Oliveira during
her Bachelor thesis.
2.2.5 Reporter-genes
Luciferase measurements
3 ml M9 minimal medium with appropiate biotin concentraions were inoculated
to an OD600 of 0.1. Cells were grown under shaking at 37 ˚C to an OD600 of 0.7,
harvested (13,200 g for 30 sec) and transferred to a 1.5 ml tube. Cell pellets were
washed by resuspending the pellet in 1 ml uptake buffer followed by centrifugation
as above. Cells were then resuspended in uptake buffer at desired OD600 for biolu-
minescence measurements. Detection was performed in a white 96 well polystyrene
plate with a transparent flat bottom and each well contained 100 µl sample. Samples
were mearsured in a TECAN Multimode Microplate Reader Infinite 200. Plates were
shaken for 10 s with a 2 mm amplitude before readout of the OD600 and luminescence
with an integration time of 6000 ms. Luminescence values are given as luminescence
per OD600.
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GFP-reporter assays
A 63 bp sequence of the VHT1-promoter inserted in a pMELβ2-minimal promoter
as described [183] was used for driving expression of GFP. Cells containing GFP-
reporter plasmids were inoculated in MMA minimal medium with indicated biotin
concentrations from an overnight culture in MMA + 2 mg/l biotin to an OD600 of
0.1. After growth for 6 h under shaking at 30 ˚C cells were harvested (3 min, 3500
g), washed with water and adjusted to an OD600 of 10 in water. GFP-fluorescence
of 100 µl of these cells were measured in 96 well polystyrene plates in a Varioscan
plate reader. Fluorescence was excited with light of 396 nm and emission measured
at 518 nm. Signals are given in fluorescence per OD600. Cells with an empty vector
were substracted as control.
β-galactosidase- (lacZ)-reporter assays
LacZ-reporter assays were performed after modifications of Kaiser [94] as originally
described previously [123]. A 63 bp sequence of the VHT1-promoter inserted in a
pMELβ2-minimal promoter as described [183] was used for driving expression of the
lacZ-reporter-gene. Corresponding yeast strains from an overnight culture in MMA
minimal medium with 2 mg/l biotin were inoculated in MMA minimal medium and
different biotin concentrations (as indicated) to an OD600 of 0.1. After incubation
under shaking for 6 h at 30 ˚C cells were harvested. β-galactosidase-activities were
measured from yeast protein extracts that were prepared as described before, unless
cells were broken in KPO4-buffer and extracts not boiled. Protein concentrations
of extracts were determined with Bradford-assays as described. For β-galactosidase
acitivity measurement 800 µl Z-buffer, 200 µl ONPG (4 mg/ml in Z-buffer) und
100-x µl KPO4-buffer were mixed in 1.5 ml tubes and preincubated for 5 min at 37
˚C. Tests were started with addition of x µl protein extract and incubated at 37
˚C until solutions turned to yellow. Reactions were stopped by addition of 400 µl 1
M Na2CO3 and samples centrifuged (1 min, 13,200 g). Absorptions of supernatants
were measured at 420 nm in a photometer. One unit (U) of β-galactosidase acitivity
is defined as hydrolysis of 1 µmol ONPG per min and mg protein bei 37 ˚C. Activity
was calculated according to Lambert Beer’s law. Therefore reaction volumes of 1.5
ml and the molar extinction coefficient of ONP (ǫ420 = 4500 M−1cm−1) were taken
into account.
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2.2.6 Electrophoretic mobility shift assays (EMSA)
EMSA was performed in a 12 % polyacrylamide gel in TBE buffer (see tab. 2.11
for composition of gels).
Component Ammount
TBE 3 ml
30 % acrylamide 1.8 ml
80 % glycerol 187.5 µl
water 840 µl
10 % APS 45 µl
TEMED 3 µl
Table 2.11: Composition of native gels for EMSA
For binding of BirA to promoter fragments indicated ammounts of promoter-DNA
and BirA-6His-protein were used. Binding buffer contained final concentrations of
10 mM Tris/HCl pH 7.5, 200 mM KCl, 100 µM biotin, 1 mM ATP, 2.5 mM MgCl2
according to the protocol of Abbott and Beckett [1]. Samples were incubated on ice
for 45 min before addition of 10x loading buffer (40 % glycerol, 0.35 % bromophenol
blue 250 mM Tris/HCl pH 7.5). 20 µl of samples were loaded on each lane and
electrophoresis was performed at a constant voltage of 200 V at 4 ˚C for 1.5 h.
DNA was stained with ethidiumbromide on the shaker for 20 min and afterwards
gels were destained with water. Bands were detected under UV light.
2.2.7 Pyruvate carboxylase activity measurements
Pyruvate carboxylase activities were determined from S. cerevisiae according to
Duggleby et al. [54]. Yeast protein extracts were prepared as described. Buffer used
for activity tests contained final concentrations of 100 mM Tris/HCl pH 7.5, 2.5 mM
ATP, 7 mM MgCl2, 10 mM pyruvate, 20 mM NaHCO3, 0.24 mM NADH and 1.2
mU malate dehydrogenase (MDH). 950 µl of this mixture were mixed with 50 µl
of protein exctract in a polystyrene cuvette and degradation of NADH determined
by measuring absorption at 340 nM every 20 sec for 20 min at room temperature.
Slopes of linear parts of the resulting diagramms were calculated. Controls for inter-
nal oxidation of NADH by other factors that pyruvate carboxylases that are present
in yeast cell extracts were made by repressing biotin dependent acitvity of pyru-
vate carboxylases with avidin. Therefore each extract was in parallel to standard
assays preincubated with avidin (1U per 50 µl extract) for 5 min, NADH oxidation
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monitored as described and slopes for this curves substracted from slopes for corre-
sponding standard assays. Pyruvate carboxylase activites were calculated according
to Lambert-Beer’s law directly from these corrected slopes with taking into account
the molecular extinction coefficient of NADH (ǫ340 = 6,000 M−1cm−1. Acitivties are
given in units (1 U = synthesis of 1 µmol oxaloacetate per min) per mg protein.
2.2.8 Biotin uptake experiments
Overnight cultures with E. coli wt or yigM∆ cells (containing expression plasmids)
were grown im M9 minimal medium without biotin (containing appropriate antibi-
otics) under shaking at 37 ˚C. Cultures for uptake experiments were inoculated from
these overnight cultures in M9 minimal medium without biotin to an OD600 of 0.1
and grown under shaking at 37 ˚C until and OD600 of 0.7 was reached. If necessary
cultures containing yigM on a pET24-plasmid and controls were induced with 0.5
mM IPTG at OD600 of 0.2. Cells were pelleted at 4 ˚C for 3 min at 3500 g, washed
with cold water and cold uptake buffer and pelleted again as before. Subsequently
they were resuspended in uptake buffer to an OD600 of 10 and stored on ice. Uptake
assays were performed in uptake buffer in volumes of 500 µl with an appropriate
ammount of cells. Tubes were incubated under stirring at 37 ˚C for 1 min before
adding 1 mM glucose to energize cells. After one more min tests were started by
addition of 100 nM [14]C- or [3]H-biotin if not stated otherwise. Samples of 60 µl
were taken at indicated timepoints, cells filtered on GN-6 Metricel membranes (pore
size 0.45 µm), washed with 100 mM NaCl and filtered again. Radioactivity was
determined with a liquid scintillation counter.
2.2.9 Isolation of membrane fractions of E. coli and reconstitution in
membrane vesicles
Cells with appropriate strains were grown overnight in M9 minimal medium with-
out biotin under shaking at 37 ˚C. Cultures for membrane fraction isolation were
inoculated to an OD600 of 0.05 im M9 minimal medium without biotin. Expression
of yigM from pET24 was induced with with 1 mM IPTG at an OD600 of 0.1 and cells
further incubated in the shaker at 37 ˚C until OD600 of 1 was reached (≈ 3 - 4 h).
Cells were harvested (4500 g, 10 min, 4 ˚C) and washed with lysis-buffer (10 mM
Tris pH 6.5, 1 mM DTT, 0.5 mM EDTA, 10 mM PMSF). Subsequently cells were
resuspended in lysis buffer, 1 mg/l lysozyme added and cells kept on ice for 15 min.
Lysis of cells was accomplished by sonification (0.5 sec pulses, amplitude 0.6) until
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lysates became clear. Membranes were seperated by centrifugation (30 min, 110,000
g, 4 ˚C), washed with lysis buffer and centrifuged as before. Supernatant was dis-
carded and membranes resuspended in 10 mM Tris pH 6.5, 20 % glycerol, 1 mM
DTT and protein concentrations determined with Bradford-reagent as described.
To generate a proton gradient, prepared membranes were fused with proteolipo-
somes containing cytochrome c oxidase ([52], [187]). Cytochrome c oxidase (1 mg,
purified from bovine heart) was reconstituted with 40 mg E. coli lipids (total extract,
Avanti Polar Lipids, Alabaster, AL, USA) as described previously [77].
These proteoliposomes with cytochrome c oxidase, or E. coli lipids without cy-
otochrome c oxidase were mixed with E. coli membrane preparations (2 mg lipid +
100 µg membrane protein) a final volume of 250 µl. 1 mM MgSO4 was added and
samples freezed in liquid nitrogen and thawed at room temperature. Subsequently
sonication for 3 sec at low energy followed. Uptake assays were performed with 500 µl
samples (proteoliposomes diluted in uptake buffer) at 37 ˚C under stirring. After 1
min of preincubation uptake was started by addition of 100 mM (final concentration)
radiolabeled [3]H-biotin if not stated otherwise.
In case of use of proteoliposomes with cyotochrome c oxidase proton gradients were
established by addition of 20 mM ascorbate, 200 µMTMPD (N,N,N’,N’,Tetramethyl-
p-phenylenediamine) and 20 µM cytochrome c (from equine heart, Sigma), which
energizes the cytochrome c oxidase to transport H+ outside of vesicles. Only cy-
tochrome c oxidase inserted in the right orientation will interact with the cytochrome
c, which is applied outside. Fresh ascorbate was added (1:50) when the assay solution
had turned blue due to oxidized TMPD.
Aliquots of 25 µl were drawn at indicated timepoints, diluted with 2 ml 100 mM
LiAc and filtered on GN-6 Metricel membranes (pore size 0.45 µm). Filters were
washed again with 2 ml 100 mM LiAc and radioactivity counted with a liquid scin-
tillation counter. Uptake rates are given in pmol biotin per mg membrane protein.
2.2.10 Statistics
Biotin uptake experiments were analyzed by non-linear regression. Ammounts
of uptaken biotin from 0.5 to 2 min of each experiment were tested for linearity
(≥ 95%) and the resulting uptake velocities (represented by the slopes of uptake
curves) analyzed for significant differences. Values from reporter assays with GFP
were tested on signifcancy by t-test or one-way ANOVA (Tukey-test).
3 Results
3.1 Biotin uptake in E. coli
To identify candidate genes for the E. coli biotin transporter, homology searches
with genes encoding biotin transport systems from other organisms like SMVT from
mammals, VHT1 from S. cerevisae, vht1+ from Sz. pombe in the E. coli genome
were performed. Searches did not lead to high-scoring homologues.
For modular transport systems that were identified among many species in gram-
positive bacteria and archea no homologues in the subdivisions of β-, γ-, δ- and
ǫ-proteobacteria (including E. coli) could be found [157]. Homology search with B.
subtilis bioY in E. coli did not lead to genes with high homology. In conclusion this
results suggested, E. coli must contain a new transport system for biotin.
3.1.1 Candidate genes
Eisenberg et al. were able to generate four classes of E. coli mutants resistant to
α-dehydrobiotin, a toxic structure analogon of biotin via random mutagenesis with
nitrosoguanidine [55]. One group showed derepressed levels of the biotin biosynthetic
enzymes, the second one showed lesions in the bio-operon and a third one general
permeability defects and weak growth. The fourth one was affected in biotin uptake
and desiganted bioP. Mapping by P1-phage transduction experiments revealed the
bioP-mutation lying at 75 min on the E. coli chromosome between the ilv-operon
and the metE-gene, but much closer to metE [55]. So a search for genes encoding
proteins with at least 10 predicted transmembrane-domains as candiadate-genes for
the biotin-transport protein in the ilv-metE region was carried out. Transmembrane
domains were predicted by TOPCONS. As shown in fig. 3.1 and tab. 3.1 three
candidate genes were identified.
To analyze if these candidate genes have any influence on biotin transport, uptake
experiments with [14]C-labeled biotin and knockout-mutants for the three mentioned
genes and a corresponding wt-strain were performed. In this experiment yifK∆ and
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Figure 3.1: Region between ilvG and metE on the E. coli chromosome.
Open reading frames between ilvG and metE. Candiate genes for the
biotin transport protein with 10 or 12 TMDs are marked with a red box.
gene name TMDs annotation on ECOCYC
yifK 10 uncharacterized member of the APC superfamily of
amino acid transporters
rarD 10 predicted chloramphenicol resistance permease
yigM 10 putative uncharacterized transport protein
Table 3.1: Candidate ORFs for the E. coli biotin transporter. Candidate
genes from the ilv-metE region with their predicted TMDs and annotated
predicted gene functions from the ECOCYC-database (www.ecocyc.org)
rarD∆ showed similar uptake to the wildtype, whereas biotin uptake in yigM∆, that
lies closest to metE, was abolished (see fig. 3.2).
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Figure 3.2: Uptake experiments with E. coli wt cells and single knockout
mutants of the candidate genes. Biotin uptake in E. coli wt, yifK∆,
rarD∆ and yigM∆ mutants cells has been measured. The experiments
were performed in 50 mM KPi-buffer pH 6.0 with 10 mMMgCl2 and with
100 nM [14]C-biotin. Tests were started by adding biotin and aliquots
taken every 30 seconds for 3 min. The mean values of three independent
experiments are shown. Bars indicate standard deviations. Mutants were
purchased from Coli Genetic Stock Center (CGSC).
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3.1.2 In silico analysis of YigM
The YigM-protein consists of 299 amino acids with a molecular weight of 33727
Da. The 12 negatively and 20 positively charged amino acids result in an isoelectric
point of 9.64. 211 of the 299, representing 71 % of all amino acids are part of
the 10 predicted transmembrane domains. YigM C- and N-terminus are predicted
to be located in the cytoplasm (see fig. 3.3) and the protein contains only very
small hydrophilic streches. No similarity of YigM to other known biotin transport-
proteins were found. There are no motifs that could give hints to the function of the
protein. One domain that can be found is a domain of unknown function (DUF6) and
the protein can be classified into the subfamiliy of carboxylate/amino acid/amine
transporters (CAAT family TC 2.A.78) [172]. CAATs are one of ten subfamilies
belonging to the family of secondary amino acid transporters found exclusively in
bacteria [172]. Members of the CAAT family represent integral membrane proteins
with sizes from 287 to 310 amino acids and 10 putative TMDs. CAAT proteins can be
found in phylogenetically divergent bacteria and archaea, e.g. in E. coli, B. subtilis
and Aspergillus fulgidus multiple paralogues are present. Representatives of the
CAAT family show low degrees of sequence similarity with members of the ubiquitous
L-rhamnose transporter (RhaT) family (TC 2.A.9) and with the eukaryotic triose
phosphate transporter family (TC 2.A.50) [172].
The CAAT family probably arose from an internal gene-duplication event as the
first halves of these proteins are homologous to the second halves. None of these
prokaryotic proteins of CAATs is functionally characterized. Nevertheless functions
have been ascribed to some members like the MttP protein of the Methanosarcina
barkeri that is supposed to transport methylamine [60] and YtfF of Chlamydia tra-
chomatis that may transport basic amino acids [182]. Additionally, MadN that is
part of the malonate utilization operon ofMalonomonas rubra and was speculated to
be an acetate-efflux pump [13], as well as PecM of Erwinia chrysanthemi controlling
pectinase, cellulase and blue-pigment production are members of CAATs [155].
Homologous genes of yigM can be found in different Shigella, Citrobacter, Salmonella,
Klebsiella and Yersinia-strains (Fig. 3.4). These are mostly annotated as (inner)
membrane or putative transport proteins, but the function of none of them has been
experimentally shown.
The yigM-open reading frame can be found as a single gene on the chromosome
and is not part of an operon (see fig. 3.1).
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Figure 3.3: Predicted transmembrane-domains of yigM. Predictions were
made by TOPOCONS (http://topcons.net/), that gives consensus pre-
dictions of five single topology prediction programs. Boxes indicate
transmembrane regions, red lines predicted cytoplasmic and blue lines
predicted periplasmic parts of the protein.
3 Results 61
1 1I III 1V
V V1 VI1
VIII IX X
Figure 3.4: Alignment of YigM-homologous proteins from different bacte-
ria. Predicted transmembrane domains for E. coli YigM are indicated
by boxes with roman numbers. Predictions were made by TOPOCONS
(http://topcons.net/).
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3.1.3 Immunological detection
As YigM seemed to be the most promising candidate it was cloned into a pBS vec-
tor under control of the constitutively active PR-promoter of the phage λ. Versions of
YigM with a C-terminal or N-terminal HA-epitope-tag have also been cloned in this
vector for detection of the protein on a western-blot (see fig. 3.5). These plasmids
were transformed in wt- and yigM∆-strains and uptake experiments performed in
intact cells (see fig. 3.6).
control YigM YigM-HA HA-YigM
Figure 3.5: Western blot of yigM-with HA-epitope. Membrane-proteins of
yigM∆-cells with empty pBS-PR (control) and with pBS-PR-yigM, -
yigM-HA and -HA-yigM were run on a 15 % SDS-gel, western blotted
and detected with an α-HA-antiserum.
The western-blot in fig. 3.5 showed expression of both tagged versions of YigM.
Bands appeared at the expected molecular weight of about 35 kDa. The western-blot
shows similar expression of HA-YigM and YigM-HA, independent on which end of
the protein the tag is added. The untagged protein YigM has as expected not been
detected.
3.1.4 Uptake experiments
The uptake experiments showed the unlabeled version is able to significantly en-
hance uptake in wt-cells in comparison to cells with an empty vector by a factor
of 2. Both versions with the HA-tag showed smaller uptake rates than YigM ex-
pressed without HA-epitope, but still significantly higher uptake rates than the wt
cells with empty plasmid (factor 1.5). Concerning the yigM∆-mutant similar results
were observed. All three plasmids expressing YigM showed significantly higher up-
take rates that the control with the empty vector. Differences in uptake rates were
bigger than in wt with 3.5-fold increase of uptake velocity in pBS-PR-yigM , 2-fold in
pBS-PR-yigM-HA and 3-fold in pBS-PR-HA-yigM compared to control, respectively.
Thus overexpression of YigM leads to increased uptake rates in both, wt and the
yigM∆-mutant. The acitvity of YigM is decreased by the fusion of the HA-epitope
to the protein, no matter on which end of the protein the tag is added (see fig. 3.6).
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Figure 3.6: Uptake experiments with tagged and untagged yigM in pBS-
PR. The experiments were performed in 50 mM KPi-buffer pH 6.0 with
10 mM MgCl2 and with 100 nM 14C-biotin. Tests were started by adding
biotin and aliquots taken every 30 seconds for 3 min. The mean values
of three independent experiments are shown. Bars indicate standard
deviations. A: wt; B: yigM∆; C: uptake velocities. **: P < 0,001, *: P
< 0.05 vs corresponding pBS, by ANOVA.
One general result of these experiments was that yigM is not strongly expressed
from the plasmids. Due to the weak expression and increase of uptake rates a yigM
version with codons optimized for expression in E. coli (yigMCO) was tested. Uptakes
assays again were performed in intact cells, but a markedly increased uptake rate also
has not been observed with the codon-optimized gene. So finally, another expression
system was tested and yigM was cloned into pET24 under control of a lac-inducible
T7-promoter.
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3.1.5 Expression of a codon-adapted yigM from pET24
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Figure 3.7: Uptake experiments with yigM in two different expression vec-
tors. Uptakes were measured in E. coli BL21(DE3) with an empty
pET24 vector (control), pET24-yigMCO (pET24-yigMCO) and pBS-PR-
yigMCO (pBS-yigMCO). A: Uptake 0.5 until 3 min, B: Uptake velocities.
The mean values of three independent experiments are shown. Bars in-
dicate standard deviations. ***: P < 0.001 by ANOVA.
The overexpression of yigM in pET24 showed highly significant and 18-fold higher
vmax compared to expression from pBS-PR (see fig. 3.7). Biotin uptake in the control
with an empty vector is neglegible although experiments have not been performed
in a yigM-knockout-strain but in wt-cells. So the (over)expression of yigM seems to
be the limiting factor for biotin uptake in E. coli.
3.1.6 KM -value of YigM for biotin uptake
To compare the properties of YigM to the published data for biotin uptake in E.
coli K12 wt-strains the KM -value and vmax were determined. In these experiments
yigM∆-mutant with pBS-PR-yigM were used.
From this experiments a KM of 74 ± 14 nM and a vmax of 2,3 pmol/min for 1
OD600 that correspondes to 7,0 pmol/min for 1 mg dry weight of cells was measured
(see fig. 3.8). Additional experiments to characterize substrate specificity as well
as pH- and temperature-optimum of the transport were not performed. This is due
to the fact that many previously used substrate analogons are not commercially
available and that biotin uptake in E. coli wt cells, which is shown here to be solely
dependent on YigM, has been extensively studied before [138], [142], [143]
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Figure 3.8: Determination of the KM -value of YigM. Uptakes were measured
in E. coli yigM∆-cells with pBS-PR-yigMCO. Uptakes were performed at
biotin concentrations of 20, 40, 80 and 300 nM of [3]H-biotin and uptake
velocites determined from 0.5 until 2 min after starting the experiment.
The mean values of two independent experiments are shown. Bars indi-
cate standard deviations.
3.1.7 Energetization of biotin transport
One still open question is the energy dependence of the transport system, because
of contradictory results of different groups in the 70s and 80s. Piffeteau and coworkers
reported energy dependent uptake of biotin and proposed a proton-symport mech-
anism for transport [143], [142]. In contrast Cicmanec and Lichstein claimed no
energy requirement [35]. So further efforts were made to clarify this point and gain
insight into the transport mechanism. Uptake experiments with BL21(DE3) carrying
pET24-yigMCO in absence of glucose, the presence of the protonophors CCCP and
FCCP and the respiratory chain inhibitor NaN3 were performed. The uptake rates
were lowered to about 60 % of the levels of standard assasy with addition of CCCP
and FCCP and to 80 %, but not significantly with addition of NaN3 or without glu-
cose compared to the standard assay (see fig. 3.9). All values differ highly significant
form the control assay (P < 0.0001). This results suggest biotin is transported via
facilitated diffusion.
Another possibility, beyond a H+-gradient to energize transport in bacteria is
a sodium-symport mechanism that is e.g. used for the uptake of proline, meli-
biose, glutamate, serine and threonine, citrate or branched chain amino acids [209].
Sodium-cotransport would probably not directly be affected by the protonophors
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Figure 3.9: Effects of uncouplers on biotin uptake over YigM. Uptakes were
measured in E. coli BL21(DE3) with an empty pET24-vector (control),
pET24-yigMCO (standard) with standard uptake assays as described in
materials and methods. CCCP and FCCP were added in a concentration
of 100 µM, NaN3 1 mM. One series of experiment has been performed
without addition of glucose (w/o glucose) and cells were incubated for 3
min before starting the experiment by adding radiolabeled biotin. The
mean values of three independent experiments are shown. Bars indicate
standard deviations. *: P < 0.05 by ANOVA.
and NaN3 during the short time uptake-assays are performed. Therefore generating
an artificial sodium gradient by adding different concentrations of NaCl (10, 50, 100
and 200 mM) to the uptake buffer was tried, but no effects on biotin uptake were
observed (data not shown). Also changing the uptake-buffer from 50 mM KPi pH 6
to 50 mM NaPi pH 6 did not bring different results (data not shown). Additionally
countertransport assays showed there is an exchange of biotin between the cells and
the medium. For this assay cells were incubated for 30 min with 50 nM [3]H-labeled
biotin. After this period, the cells were washed and then competed with 500 nM
unlabelled biotin after this 30 min. Radioactivity in the cells goes back to about 20
% after competition with unlabelled biotin compared to the maximum before adding
the unlabelled substrate. Alternatively, cells preincubated for 30 min with 50 nM un-
labelled biotin, washed and shifted to 50 nM [3]H-biotin demonstrated rapid uptake
of the radiolabelled substrate (see fig. 3.10). These results also support a facilitated
diffusion mechanism.
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Figure 3.10: Counterflow experiments with YigM. Experiments were per-
formed in wt cells with pBS (control) and with pBS-PR-yigM (YigM).
A: Cells were incubated with 50 nM [3]H-biotin from 0 to 30 min. At
30 min 500 nM non-radioactive biotin was added (indicated by the ar-
row). B: Cells were preincubated for 30 min with 50 nM non-radioactive
biotin. At time t=0 min 50 nM [3]H-biotin was added. Figures show
representative results from one of three independent experiments.
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3.1.8 Uptake experiments in membrane vesicles
To circumvent perturbing influences like unknown internal biotin concentrations,
attachment of biotin to biotin-proteins and metabolic state of cells that all might
influence uptake in intact cells, experiments with membrane vesicles were carried out.
A further advantage of the in vitro system is the ability to generate a completely
artificially energized system and to start in an unenergized situation.
These vesicles were prepared by breaking of cells, isolating the membrane fraction
by ultracentrifugation and fusing these membranes with artificial E. coli membrane
lipids. Energy in form of a proton gradient and a membrane potential can be sup-
plied by using membranes containing purified cytochrome c oxidase and addition of
ascorbate, TMPD and cytochrome c. The whole procedures are described in more
detail in chapter 2 of this work.
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Figure 3.11: Uptake experiments in membrane vesicles. Membrane vesicles
were prepared and uptake experiment performed as described in "Ma-
terial and methods" for membranes overexpressing YigM from pET24-
yigM (YigM OE) and for a strain carrying an empty pET24-plasmid
(control). At time t=0 min 50 nM 3H-biotin was added. The figure
shows representative results from one of three independent experiments.
For overexpression of YigM rapid increase of radioactivity and saturation at about
4 min after starting the experiment has been observed (see fig. 3.11). The control-
experiment did not show an increase of radioactivity over the same time range.
Energizing membrane vesicles with cytochrome c oxidase did not reveal different
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results (data not shown).
In summary, the uptake experiments in intact cells and membrane vesicles sug-
gested biotin is taken up by facilitated diffusion. Destroying proton gradients by
protonophores CCCP and FCCP, depleting cells of energy by blocking the respira-
tory chain with NaN3 or detaining glucose did not show markedly effects on biotin
uptake rates in intact cells. Membrane vesicles showed uptake of biotin without en-
ergization and uptake did not increase after supplying energy. So energy seems not
to be necessary to take up biotin via YigM.
3.1.9 Sequence of YigM from the E. coli biotin transport mutant S1039
Another evidence that YigM is the essential factor for biotin uptake was shown
through E. coli strain S1039 [199], [84]. This strain originates from random mu-
tagenesis and lacks intrinsic high-affinity biotin-uptake activity. As this strain was
not available to us, but was used in previous experiments by the group of Prof. Dr.
Thomas Eitinger, Humboldt-Universität zu Berlin, Institut für Biologie/Mikrobiologie,
Prof. Dr. Eitinger did the sequencing and kindly shared the results with us. Se-
quencing revealed the yigM-open reading frame of this strain contains two point
mutations (AGC to AGA and CCG to TCG in nucleotides 85 and 729) that lead to
two amino-acid exchanges (S28R and P243S, respectively) (see fig. 3.12).
These two resisues are well conserved in most homologues of yigM (Fig. 3.12).
To find out which of both mutations was responsible for the decrease in transport
activity they were separately introduced in pBS-PR-yigM and uptake assays were
carried out.
The experiment showed that both single mutations lead to a severe and significant
reduction of biotin uptake. The remaining activites were 25 % or 27 % for S28R or
P243S compared to the wt, respectively. Additionally the mutations show synergistic
effects when they are both present in the protein and reduce transport activity
significantly in comparison to the single mutations. Transport activity for the double
mutant does not differ significantly from control (see fig. 3.13).
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Figure 3.12: Sequence alignment of yigM amino acid sequences of different
bacteria. The alignment shows that S28 is very well conserved except
for some of the shown organisms and P243 is perfectly conserved in all
of them (S28 and P243 marked with arrows). Transmembrane domains
predicted by TOPCONS (http://topcons.cbr.su.se/) for E. coli YigM
are indicated by boxes and roman numbers.
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Figure 3.13: Biotin uptakes in yigM∆ cells expressing YigM the mutations
S28R and P243S. Standard uptake experiments in E. coli yigM∆
with wt, yigM (control), yigMS28R (S28R), yigMP243S (P243S) and
yigMS28R,P243S (S28R P243S) in pBS-PR and an empty pBS-PR-
vector (control). Values indicate uptake velocities in % with wt yigM
set to 100 %. The mean values of three independent experiments are
shown. Bars indicate standard deviations. *: P < 0.05 by ANOVA.
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3.1.10 C-terminal truncation of yigM
The reduction of transport activity in the HA-tagged versions of yigM suggested
that the termini of the protein might be essential for its function. The predicted
topology of the protein suggests that the first transmembrane domain begins with
amino-acid two or three. Thus an impact on function by adding an epitope-tag
right before is not astonishing. At the C-terminus of the E. coli protein about
20 amino acids can be found in the cytoplasm according to topology-predicitions.
Some YigM orthologs have shorter C-termini (see fig. 3.4), suggesting this part of the
protein might not be essential for the activity. Also striking is the quite uncommon
accumulation of seven charged amino acids among the last eleven in the protein (see
fig. 3.14).
gctccg cgc tct tca caa acg gca gat gat cgc agg cgt gat tgc gcg ctg agc gaa taa
A P R S S Q T A D D R R R D C A L S E -
Figure 3.14: Truncation of yigM at the C-terminus. The open reading frame
of yigM was truncated by 33 bps resulting in loss of 11 amino acids,
corresponding to the length of the shorter homolouges. The truncation-
site is indicated by the grey bar.
To get evidence for an implication of the C-terminus uptake experiments with
YigM truncated by eleven amino acids were performed.
Truncation of the C-terminal end of the protein results in a significant reduction
of transport-activity by 70 % (see fig. 3.15), similar to the findings made with a
C-terminal HA-epitope tag added to the full-length protein (see fig. 3.6).
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Figure 3.15: Uptake experiments with full-length and C-terminally trun-
cated YigM. Standard uptake experiments in E. coli yigM∆ with
empty pET24 (control), full-length YigMCO (full-length) and C-
terminally truncated YigMCO (truncated) expressed from pET24. Val-
ues indicate uptake velocities. The mean values of three independent
experiments are shown. Bars indicate standard deviations. *: P < 0.05,
**: P < 0.001 by ANOVA.
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3.1.11 Gene regulation of yigM
Experiments of Piffeteau and Gaudry showed that biotin uptake activity is in-
versely correlated with the biotin concentration in the medium [142]. Prof. Dr.
Thomas Eitinger found that the promoter region of yigM contains a sequence rather
similar to the binding site of BirA in the biotin operator of the bio-operon (see fig.
3.16). Due to this observation a regulation of the yigM-promoter by BirA seems
plausible. Sequence comparisons of promoters from E. coli yigM and homologues
showed at least partial conservation of the BirA-binding sites (see fig. 3.16).
yigM
bioB
tTGTcAACCtgatacttcgctacaatGGATaCCCgt
t aattgaaaagattta agTGTaAACC GGTTtACA
E.coli yigM
Shigella dysenteriae yigM
Salmonella typhi yigM
Citrobacter koseri CKO_00168
Phytobacterium carotovorum PC1
Yersinia pseudotuberculosis madN
Yersinia pestis y0440
A
B
Figure 3.16: Promoters of bioB and yigM. A: The BirA-binding site in PbioB
is marked in red, conserved bases shown in upper case. Corresponding
bases in PyigM are also shown in upper case. B: Sequence alignment of
promoter regions of yigM homologes. Potential BirA-binding sites are
indicated by boxes.
3.1.12 Luciferase-reporter constructs
Luciferase-reporter-constructs for both promoters (PbioB and PyigM) were cloned
to investigate regulation of these genes at various biotin concentrations. To get evi-
dence if both promoters are regulated by biotin luciferase activities in wt-strain, the
biosynthesis-mutant bioB∆ and the transport-mutant yigM∆ were measured. Cells
carrying reporter plasmids were grown in liquid cultures in M9 minimal medium
without biotin overnight with shaking at 37 ˚C. Freshly from thes overnight cul-
tures inoculated cultures in M9 containing indicated concentrations of biotin were
inoculated to an OD600 of 0.1 and incubated in the shaker at 37 ˚C until an OD600 of
approx. 0.7 was reached. Cells were washed with PBS and OD600 and luminescence
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for each biotin concentration measured in 96-well plates. Reporter acitivities were
calculated as luminescence/OD600 .
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Figure 3.17: Measurements of luminescence in wt, bioB∆ and yigM∆. Ex-
pression of luciferase was driven by the promoter of bioB (PbioB) or
yigM (PyigM). Luminescence values are given in %. For A and B values
of wt at 0 nM biotin were set to 100 %. For C and D values at 0 nM
biotin were set 100 % for each of the three strains. The mean values of
two independent experiments are shown. Bars indicate standard devia-
tions. Luciferase values for bioB∆ with PbioB have only been measured
once.
Fig. 3.17 shows that luminescence decreases with rising concentrations of biotin for
both promoters in wt and bioB∆. In yigM∆ luminescence is more or less constant
over the biotin-concentration range tested for both promoters. Concerning PbioB at
0 nM biotin about 6-fold higher values for bioB∆ in comparison to wt and yigM∆ was
observed achieved. The expression levels for wt and bioB∆ at 10 nM are equal and
about 2-fold lower than for yigM∆ at this concentration, as well as for wt at 0 nM bi-
otin. Promotor activites are highest in bioB∆ at 0 nM biotin with a two- to threefold
higher expression compared to yigM∆ and wt for PyigM. For yigM∆ luminescence
is 1.5-fold higher without biotin than for wt. At 10 nM biotin bioB∆ and yigM∆
both reach a level that is about threefold higher than for wt. But for both, wt and
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bioB∆ expression from PyigM at 10 nM is about the half compared to 0 nM biotin.
In conclusion regulation of both promoters is similar in all three tested strains. A
difference between PbioB and PyigM is, that lower concentrations of biotin are suf-
ficient to repress expression from PbioB. Reporter activity decreased to about 50
% of maximal activity at 0.82 nM biotin and stays at that level until up to 10 nM
in wt. In bioB∆ cells luminescence drops to approximately 10 % of the maximum.
Expression from PyigM in contrast is downregulated at higher biotin concentration,
still keeps 80 to 90 % of its maximal activity in 1.5 nM and 0.82 nM biotin, respec-
tively and reporter acitivty decreases to 30 % at 10 nM. This is true for both wt and
bioB∆ cells. The results of the luciferase reporter assays showed that PbioB and
PyigM both are regulated by biotin. Dependence of gene expression on the strain
background was demonstrated, too. This aspect will be further discussed in chapter
4 of this work.
In addition to the experiments described above different previously characterized
BirA-mutants [7], [57] were tested with the luciferase reporters (see fig. 3.18). These
analyses were carries out to test if expression from PyigM is also regulated by BirA
as for PbioB. That seem likely because the BirA-binding site is in parts present in
PyigM and both promoters are regulated by biotin, as shown before. As birA is
essential for E. coli and no knockout for the gene is available, the tested strains all
carry point-mutations in the birA gene.
Again luciferase-tests with PyigM and PbioB were carried out to see if both pro-
moters are regulated in a similar manner or with the same tendencies in the BirA-
mutants and in contrast to the measurements in a wt background.
The results of these experiments demonstrated reporters with PyigM show the
same tendency of activation in both BirA-mutants just like PbioB. Overall levels
for activation are higher for PbioB compared to PyigM in all three tested mutants.
However results suggest BirA-dependent regulation of PyigM.
3.1.13 Electrophoretic mobility-shift assays
To directly test a possible binding of BirA to PyigM, as it was shown for PbioB
[106], electrophoretic mobility-shift assays were performed. Fragments of about 100
bps from PbioB and PyigM that were also used as promoters for the luciferase
reporter plasmids and different concentrations of purified BirA-6His-protein were
tested. BirA-6His was purified in coopreation with Carina Mann de Oliveira as
described in chapter 2. To ensure the presence of biotinyl-AMP that is a prerequesite
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Figure 3.18: Luciferase activities of PbioB and PyigM in wt, bioA∆ and
birA1- and birA85-mutant. Expression of luciferase was driven by
the promoter of bioB (PbioB) or yigM (PyigM). Cells were grown for 6
h in 10 nM biotin as this biotin concentration was the lowest one where
all tested strains were able to grow. Luminescence values are given in
%. Values of wt were set to 100 %.
for BirA-binding to DNA, experiments in presence of biotin and ATP as described
in [188] as well as in absence of both as negative control were carried out. The
assays contained 12 nmole (800 ng) of each promoter fragment and protein from
6 nmole to 70 nmole (800 to 2400 ng). The molar ration (protein : DNA) varied
between 0.5 and 5.8. As an additional negative control the promoter of the yeast
biotin-transporter VHT1 was used, that did not show a shifted band with the highest
protein concentration used for PbioB and PyigM (data not shown). After incubation
on ice for 45 min samples were loaded on the native gel. For PbioB beginning at a
ratio 2:1 protein:DNA a shift of promoter-DNA was observed. For PyigM no shift
was detectable even with higher protein concentrations of BirA-6His (see fig 3.19).
To detect the BirA-6His-protein the EMSA gels were western-blotted followed by
detection with α-His-antibody. Here again a clear band for PbioB-BirA-complex
was observed, but a PyigM-BirA-6His-complex has not been detected. The BirA
protein stays in the wells of the gel.
Thus the experiments confirmed that BirA binds to PbioB, whereas a direct in-
teraction of PyigM and BirA was not detected under the conditions used here.
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Figure 3.19: EMSA with PbioB, PyigM and BirA-6His. A: EMSA with PbioB
and PyigM (12 nmole) and rising concentrations of BirA-6His (0 nmole,
6 nmole, 15 nmole, 70 nmole), gel stained with ethidiumbromide; B:
Western blot of the EMSA gel, detected with α-His-antibody.
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3.2 Biotin sensing in S. cerevisiae
It was extensively shown by several groups that S. cerevisae is able to sense the
biotin status and to react with enhanced expression of genes involved in biotin biosyn-
thesis and transport when a lack of the vitamin is detected [210], [185], [144], [201].
However we are far from understanding the whole process of biotin sensing. In this
work two different experimental strategies were used to find missing parts of the
pathway.
One strategy started with VHR1 that was shown to be involved in biotin sensing
and was proposed to be a candidate for the transcription factor [201]. With the
second approach different biotin-proteins, especially the pyruvate carboxylases PYC1
and PYC2 were investigated in more detail.
To find a suitable timepoint and biotin concentration when cells still grow normaly,
but show an undersupply of biotin, samples of yeasts grown in "normal" biotin
concentrations (2 mg/l) and in low biotin medium (0,02 mg/l) were collected in a time
series every two hours. Cells were broken and protein preparations were analyzed
for protein biotinylation by western-blot analysis. Detection of biotinylation was
performed with streptavidin-peroxidase (strep-PO) (see fig. 3.20).
Growth appeares to be normal up to 10 h in medium with 0,02 mg/l biotin (data
not shown). Weaker biotinylation of Acc1p and Hfa1p, Dur1,2p can already be
observed after 2h. At this time Arc1p is not detectable on the blot any more. A
decrease in biotinylation of Pyc1p and Pyc2p appears at 4 h and becomes more
evident after 6 and 8 h. For further experiments the cells were grown for 6 h and
used for subsequent analysis.
In general there are two different ways to detect yeasts response to decreased biotin
concentrations. Two assays to analyze biotin sensing were established in this work.
One assay detects expression of transport- and biosynthesis-genes that increases in
low biotin concentrations in wt cells and can be detected by higher abundance of
the proteins on a western-blot. This analysis in the following will be shown for the
Bio2 protein. Reporter constructs with β-galactosidase (lacZ) or GFP under the
control of a minimal-promoter containing the BRE-element plus further about 20
bps on each side of the VHT1-promoter [183] were performed as a second tool for
visualizing biotin sensing. This analysis allows a more quantitative analysis of the
cellular reaction to different biotin concentrations.
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Figure 3.20: Western-blot of biotinylated proteins in S. cerevisiae W303.
Cells from an overnight culture with 2 mg/l biotin were inoculated in
0.02 and 2 mg/l biotin. Samples were taken at indicated time points and
whole-cell-protein extracts prepared. Extracts from 0.5 OD600 per lane
were run on a 10 % SDS-gel and western-blots were performed. Blots
were incubated with streptavidin-peroxidase. Bands on the blot rep-
resent the biotinylated proteins Acc1p, Hfa1p, Dur1,2p, Pyc1p, Pyc2p
and Arc1p as indicated.
3.2.1 VHR1 and biotin sensing
With VHR1, as the transcripion factor, taking a central role in biotin sensing
further efforts were made based on the findings of Weider et al. [201]. First of all
growth experiments with wt-cells and a vhr1∆-mutant were performed in medium
with low (0.02 µg/l) and normal (2 µg/l) biotin concentration, but a difference in
growth was not observed (data not shown). vhr1∆-mutants were tested with the
BRE-lacZ-reporter-assays and on Bio2p-expression by western-blot. These experi-
ments showed that an increase in expression of Bio2p (see fig. 3.21) or increased
reporter gene expression (see fig. 3.22) in low biotin concentrations can not be ob-
served in a vhr1∆ mutant in contrat to wt cells and confirmed the findings of Weider
et al. [201].
A complementation of the vhr1-knockout by expressing the protein from a single-
copy (YCplac) and an multi-copy (YEplac) vector under control of the endogenous
promoter was successful as shown by increased expression of Bio2p in cells grown
in low biotin medium (see fig. 3.22). However, according to results of the GFP-
reporter-tests (see fig. 3.23) wt-levels were not achieved.
For further analysis like detection by antibodies or purification, epitope tags were
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Figure 3.21: Western-blot of W303 wt and vhr1∆ with anti-Bio2p. Cells
from an overnight culture with 2 mg/l biotin were inoculated in 0.02
and 2 mg/l biotin. Samples were taken after 6 h for whole-cell-protein
extracts. Extracts from 0.5 OD600 per lane were run on a 10 % SDS-
gel and western-blots performed. Blots were detected with anti-Bio2p-
antibody.
wt vhr1D YC-VHR1 YE-VHR1
Figure 3.22: Complementation of vhr1∆-mutant. Cells from an overnight cul-
ture with 2 mg/l biotin were inoculated in 0.02 and 2 mg/l biotin. Sam-
ples were taken after 6 h for whole-cell-protein extracts. Extracts from
0.5 OD600 per lane were run on a 10 % SDS-gel and western-blots per-
formed. Blots were detected with anti-Bio2p-antibody. W303 wt (wt),
vhr1∆ (vhr1∆), single-copy plasmid YCplac33-VHR1 (YC-VHR1) and
multi-copy plasmid YEplac-VHR1 (YE-VHR1).
fused to the protein. As BLAST searches indicated the C-terminus of the Vhr1
protein to be less conserved than the N-terminus a HA-, a ZZ- tag and GFP were
fused to the C-terminal side of the protein. To provide the natural expression level
of the protein the fusions were made in the genome, so that the promoter and the
environment of the VHR1-gene are not changed. Functionality of the tagged protein
was tested by western blot and lacZ-reporter assays. Both experiments revealed that
the function of Vhr1p was compromised when the protein contained an epitope tag
(see fig. 3.24). Reporter acitivtiy in wt was increased significantly in cells from 0.02
mg/l compared to 2 mg/l. Neither in vhr1∆ cells, nor in any of the three tagged
versions lacZ-activities increased significantly in cells from 0.02 mg/l compared to 2
mg/l. Reporter activities for wt cells grown 0.02 mg/l biotin differ highly significant
from all other strains grown in the same biotin concentration, whereas values of
cells grown in 2 mg/l biotin do not differ significantly for any of the tested strains.
Altogether results of this experiment indicated all three tagged Vhr1p-versions are
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Figure 3.23: Fluorescence measurements with a GFP-reporter plasmid of
the complementation of vhr1∆. Cells from an overnight culture
with 2 mg/l biotin were inoculated in 0.02 and 2 mg/l biotin. Samples
were taken after 6 h and GFP-fluorescence measured as described in
"Materials and methods". GFP-fluorescence is given in %. Values for
wt from 0.02 mg/l biotin were set to 100 %. Values for W303 wt (wt),
vhr1∆ (vhr1∆) and single-copy plasmid YCplac33-VHR1 (YC-VHR1)
are shown.
not functional in sensing. Some results of Weider et al. [201] and [202] are based on
fusing Vhr1p with epitope tags or protein domains and so have to bee seen critical as
findings made in this work showed. Discussion in this context is provided in chapter
4 of this work.
In spite of higher conservation of the N-terminus, fusions with a 3HA-epitope were
additionally constructed at this side of the protein. Expression of the constructs from
the low-copy-plasmid pRS416 under control of the Met25-promoter again showed
loss of function for 3HA-Vhr1p in β-galactosidase reporter assays (see fig. 3.24),
as 3HA-Vhr1p is not able to induce lacZ-expression of the reporter in low biotin
concentrations.
The experiments show that obviously the integritiy of both termini of Vhr1p is
essential for correct function. Thus, tagging of the protein on one of the termini
while preserving the biotin sensing activity seems to be impossible. Due to the
limited options with the analysis of Vhr1p further experiments focussed on the biotin
proteins, especially Pyc1p and Pyc2p.
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Figure 3.24: Measurements of β-galactosidase-activities with a BRE-lacZ-
reporter in wt, vhr1∆ VHR1-3HA, -ZZ and -GFP. Cells from
an overnight culture with 2 mg/l biotin were inoculated in 0.02 and 2
mg/l biotin. Samples were taken after 6 h and β-galactosidase-activities
measured as described. Activities are given in %. wt from 0.02 mg/l
biotin was set 100 %. The mean values of two independent experiments
are shown. Bars indicate standard deviations. ***: P < 0.0001 vs. wt
at 0.02 mg/l by ANOVA.
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3.2.2 The function of pyruvate carboxylases in biotin sensing
Beyond the known functions of Vhr1p and Bpl1p in biotin sensing it is not yet clear
if the proteins carrying biotin as a cofactor are involved in sensing. To adress this
question single knockouts of PYC1, PYC2, HFA1, DUR1,2 and ARC1 were tested
with a GFP-reporter on sensing low biotin (see fig. 3.25). Similar experiments
have been carried out by Pirner and Stolz with a β-galactosidase-reporter construct
[144]. They observed reduced biotin sensing in arc1∆ and pyc2∆ cells. ACC1 was
not included in the experiments in this work. The ACC1 gene is essential and a
knockout is lethal. Effects of Acc1p on biotin sensing have already been investigated
in a strain expressing ACC1 from the galactose inducible GAL1-promoter but only
weak impact on biotin sensing could be found [144]. In parallel protein extracts of
wt-cells were made and analysed by western-blot to detect protein biotinylation (see
fig. 3.25).
The measurements show a clear and significant induction of reporter activity for
wt, dur1,2∆ and hfa1∆ cells grown in low biotin medium. Also for arc1∆ a sig-
nificant induction at low biotin concentrations compared to normal concentrations
can be observed, although the absolute values are smaller than for the wt and the
mutants mentioned above. A different reaction can be seen in pyc∆ cells. Induction
in low biotin is much smaller but still significant for pyc1∆ but not significant in
pyc2∆. Fluorescence values for cells from medium with 0.02 mg/l biotin all differ
highly significant except between wt and dur1,2∆, whereas values from cells grown
in 2 mg/l biotin do not differ significantly. Induction factors of fluorescence at 0.02
mg/l compared to the mean values of all six tested strains at 2 mg/l biotin were
calculated:
Strain Induction factor
wt 31
arc1∆ 7
dur1,2∆ 31
hfa1∆ 18
pyc1∆ 7
pyc2∆ 0
Table 3.2: Reporter gene activities in biotin protein knockout mutants. In-
duction factors of fluorescence values for cells grown in 0.02 mg/l and the
mean fluorescence values of cells grown in 2 mg/l biotin are indicated.
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Figure 3.25: Measurements of fluorescence with a BRE-GFP-reporter in wt
and knockouts of biotin proteins in S. cerevisiae. Cells from an
overnight culture with 2 mg/l biotin were inoculated in 0.02 and 2 mg/l
biotin. Samples were taken after 6 h for A: GFP-fluorescence measure-
ments. Fluorescence values are given in %. wt from 0.02 mg/l biotin
has been set to 100 %. Mean values of three independent experiments
for wt, arc1∆ (arc1), dur1,2∆ (dur1,2), hfa1∆ (hfa1), pyc1∆ (pyc1) and
pyc2∆ (pyc2) are shown. Bars indicate standard deviations. (***: P <
0.0001, ** P < 0.001 by t-test). B: Whole-cell-protein extracts from 0.5
OD600 wt-cells per lane were run on a 10 % SDS-gel and western-blots
performed. Blots were detected with streptavidin-peroxidase.
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3.2.3 Single and double knockouts of PYC1 and PYC2
To get further insight into the function of PYCs in biotin sensing double knock-
outs of the two genes were made. The double mutants require aspartate for growth
as a source for oxaloacetate, because this cannot be generated from pyruvate any
more. Pyruvate carboxylases catalyze carboxylation of pyruvate to oxaloacetate that
is funneled into the citric acid cycle. There is serves as precursor for gluconeoge-
nesis and anaplerotic purposes. Biotin sensing in the pyc1pyc2 double mutant is
completely abolished and cells show the same phenoptype as vhr1∆-mutants, that
means no reaction on low biotin concentrations. One explanation for this observation
are higher cytoplasmic biotin levels caused by a knockout of the two Pyc proteins
that are major targets of biotinylation. To adress this possibility arc1∆pyc1∆- and
arc1∆pyc2∆-mutants were generated. As Arc1p is the most abundant biotinylated
protein in the cells, a knockout should result in higher cytoplasmic biotin content and
reduce the response to low biotin. This indeed could be observed in reporter gene
assays (see fig. 3.25). Bio2p-expression was detected by western-blot as an indicator
for biotin sensing. The arc1∆pyc∆-mutants do not show the same pattern as wt
and are still affected in biotin sensing. Again, as already seen in single knockouts
for pyc1 and pyc2 the effect is more pronounced in a pyc2∆-mutant. Pyc1∆pyc2∆-
mutants show the most severe phenotype and no difference between low and high
biotin concentrations.
wt pyc1 pyc2D D pyc1 arc1D D pyc2 arc1D D
biotin
Figure 3.26: Western-blot for Bio2p-expression in wt, pyc1∆pyc2∆,
pyc1∆arc1∆ and pyc2∆arc1∆. Cells from an overnight culture
with 2 mg/l biotin were inoculated in 0.02 and 2 mg/l biotin. Samples
were taken after 6 h for whole-cell-protein extracts. Extracts from 0.5
OD600 per lane were run on a 10 % SDS-gel and western-blots performed.
Blots were detected with anti-Bio2p-antibody.
Additionally a complementation of pyc1∆pyc2∆-mutants by expressing one of
the proteins from a plasmid was tested. The two genes including their endogenous
promoters were cloned on the low-copy-plasmid pRS316. Western-blots were de-
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tected with α-Bio2p-antiserum. Again cells with the pyc1∆-genotype (pyc1∆pyc2∆
pRS316-PYC2) showed a milder phenotype than pyc2∆-cells (pyc1∆pyc2∆ pRS316-
PYC1)(see fig. 3.27).
PYC1 PYC2 plasmid
strain
biotin
pyc1 pyc2DDwt
Figure 3.27: Western-blot for Bio2p-expression in wt, pyc1∆pyc2∆ and
doubleknockout with plasmids pRS316-PYC1 and -PYC2.
Cells from an overnight culture with 2 mg/l biotin were inoculated
in 0.02 and 2 mg/l biotin. Samples were taken after 6 h for whole-
cell-protein extracts. Extracts from 0.5 OD600 per lane were run on a
10 % SDS-gel and western-blots performed. Blots were detected with
anti-Bio2p-antiserum.
3.2.4 Complementation of pyc1∆pyc2∆ with pyr1+ from
Schizosaccharomyces pombe
The fisson yeast S. pombe contains only a single pyruvate carboxylase gene, pyr1+.
A complementation-experiment in a S. cerevisae pyc1∆pyc2∆-mutant was per-
formed, by transforming the double-knockout with pyr1+ expressed from a low-copy-
number plasmid under the control of the Met25-promoter (p416-MET25P-pyr1+).
The resulting strain was tested for biotin sensing by western-blot with anti-Bio2p an-
tiserum and for biotinylation with streptavidin-PO (see fig. 3.28). The transformed
cells were able to grow in the absence of aspartate, indicating the S. pombe protein
was functional and catalytically active in S. cerevisiae. pyc1∆pyc2∆ cells were not
able to grow in minimal medium without supplementation of aspartate. Biotiny-
lation of the Pyr1 protein has been detected with streptavidin-PO. Cells were not
responding to low biotin concentrations by increasing expression of Bio2p. Thus, the
defect in biotin sensing was not complemented by expression of Pyr1p, suggesting
biotinylation and enzymatic activity of pyruvate carboxylase can not be crucial for
biotin sensing. S. cerevisiae Pyc2p so must have other features that contribute to
functional sensing.
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Figure 3.28: Western-blot for Bio2p-expression and protein biotinylation
in wt, pyc1∆, pyc1∆pyc2∆pyr1+ and pyc1∆pyc2∆. Cells from
an overnight culture with 2 mg/l biotin were inoculated in 0.02 and 2
mg/l biotin. Samples were taken after 6 h for whole-cell-protein ex-
tracts. Extracts from 0.5 OD600 per lane were run on a 10 % SDS-gel
and western-blots were performed. Blots were detected with anti-BIO2-
antiserum and strep-PO.
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3.2.5 Truncation of Pyc2p C-terminus
For further analysis of Pyc1p and Pyc2p the proteins were tagged with a 3HA-
epitope-tag. As the C-termini of the proteins seemed to be less conserved (see fig.
3.31) these parts were selected for the fusion with the tags. PYCs were expressed
under control of their endogenous promoters on single-copy plasmids YCplac. Re-
quirement for aspartate of the pyc1∆pyc2∆ was abolished by expression of Pyc1-
3HAp as well as Pyc2-3HAp. Functionality in biotin sensing was tested with GFP-
reporter-assays. In the test both tagged Pyc-proteins show fluorescence values like
the pyc1∆pyc2∆-mutant at low biotin concentrations, meaning the 3HA-tag some-
how inhibits the function of both proteins in biotin sensing. This loss of function has
to be due to the tag, because the two proteins expressed under the same promoter
and on the same plasmid show functional sensing (data not shown). Missing expres-
sion or biotinylation has been excluded by western-blot analysis and detection with
strep-PO where both proteins were detected(see fig. 3.29).
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Figure 3.29: Measurements of fluorescence intensities with a BRE-GFP-
reporter and western blot for cells with C-terminally tagged
PYCs. A: Fluorescence values are given in %. Cells from an overnight
culture with 2 mg/l biotin were inoculated in 0.02 and 2 mg/l biotin.
Samples were taken after 6 h for GFP-fluorescence measurement. wt
from 0.02 mg/l biotin was set to 100 %. Values for wt, 3HA-PYC1,
3HA-PYC2, pyc1∆, pyc2∆ and pyc1∆pyc2∆ are shown. B: Western
blot detected with strepavidin-PO for wt and pyc1∆pyc2∆-strains with
empty vector (pyc1∆pyc2∆), YCplac-PYC1-3HA (PYC1-3HApyc2∆)
and YCplac-PYC2-3HA (pyc1∆)PYC2-3HA.
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As C-terminal tagging negatively affected biotin sensing, N-terminally tagged ver-
sions under control of the MET25-promoter on the low-copy vector pUG36 were
created (pUG36-MET25P-3HA-PYC). This plasmid also complements aspartate re-
quirement of pyc1∆pyc2∆ mutants. GFP-reporter assays showed tagging on this
terminus has weaker influence on biotin sensing than with tagged C-terminus. Highly
significant differences in fluorescence between cells grown in 0.02 mg/l and 2 mg/l
biotin can only be observed for wt. Nevertheless an increase in reporter activity in
cells from low biotin is clearly visible for both N-terminally tagged Pyc-proteins like
for wildtype, indicating functional sensing (see fig. 3.30).
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Figure 3.30: Measurements of fluorescence intensities with a BRE-GFP-
reporter in cells with N-terminally tagged PYCs. Fluorescence
values are given in %. Cells from an overnight culture with 2 mg/l
biotin were inoculated in 0.02 and 2 mg/l biotin. Samples were taken
after 6 h for GFP-fluorescence measurement. Values for wt from 0.02
mg/l biotin have been set 100 %. The mean values of three independent
experiments are shown for wt, 3HA-PYC1, 3HA-PYC2, pyc1∆, pyc2∆
and pyc1∆pyc2∆. Bars indicate standard deviations. ***: P < 0.0001
by t-test.
Functional N-terminally and infuntional C-terminally tagged pyruvate carboxy-
lases suggest an involvement of the Pyc C-termini in biotin sensing. Sequence align-
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ments with Pycs from other organisms showed that the S. cerevisiae Pyc-proteins
contain additional 9 or 10 amino acids compared to mammalian and 7 or 8 amino
acids compared to Sz. pombe and Bacillus pyruvate carboxylases for Pyc1p and
Pyc2p, respectively (see fig. 3.31). So C-terminal truncations in two- or four-amino-
acid steps as indicated were created to find residues essential for sensing. The trun-
cations were only generated for Pyc2p as this protein appeared to have the bigger
impact on biotin sensing in all previous assays.
gttgtc cta gaa gaa gaa acc cta ccc cca tcc caa aaa aag taa
V V L E E E T L P P S Q K K -
-2-6-10
Figure 3.31: C-terminal ends of different pyruvate carboxylases and trun-
cations in S. cerevisae Pyc2p. Sequence alignments of pyruvate
carboxylases from Sc (Saccharomyces cerevisiae), Hs (Homo sapiens),
Ss (Sus scrofa), Bl (Bacillus licheniformis), Gg (Gallus gallus), Stc
(Streptomyces coelicolor), Xl (Xenopus laevis), Dr (Danio rerio), Rs
(Rhodobacter sphaeroides), Kl (Kluyveromyces lactis), Dh (Debary-
omyces hansenii), Cg (Candida glabrata), Yl (Yarrowia lipolytica), Ag
(Ashbya gossypii), Sp (Schizosaccharomyces pombe), Pp (Pichia pas-
toris). The arrow indicates lysine residues modfied with biotin in holo-
proteins. In Pyc2p from S. cerevisae three different truncations lacking
2 (-2), 6 (-6 and 10 (-10)) amino acids as shown were constructed.
Truncations were made in the context of the N-terminally tagged Pyc2 protein
analyzed before. Again GFP-reporter-assays were utilized to determine the sensing
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ability and measurements indicated an increased induction of fluorescence the shorter
the C-terminus of Pyc2p was. Differences for cells from 0.02 mg/l biotin were not
significant from wt for 3HA-PYC2-full-length and 3HA-PYC2-(-2), but significantly
higher fluorescence values were observed for 3HA-PYC2-(-6) and 3HA-PYC2-(-10)
(see fig. 3.32). To exclude impact of the truncations on expression and biotinylation
of Pyc2p western-blots were made and detected with α-HA-antibody and strep-PO.
No difference in biotinylation or expression of full-length and any of the truncated
Pyc2p-versions was obvious (see fig. 3.32) .
wt pyc1
pyc2
D
D
pyc1 pyc2 pUG36-MET25P-PYC2-D D
fl -2 -6 -10
anti-HA
strep-PO
biotin
Figure 3.32: Expression level and biotinylation of full-length and truncated
Pyc2p. Cells from an overnight culture with 2 mg/l biotin were in-
oculated in 0.02 and 2 mg/l biotin. Samples were collected after 6 h
for whole-cell-protein extracts. Extracts from 0.5 OD600 per lane were
run on a 10 % SDS-gel and western-blots been performed. Samples for
wt, pyc1∆pyc2∆ without plasmid and with pUG36-MET25P-PYC2-
full length (fl) and truncated by 2 (-2), 6 (-6) and 10 (-10) amino acids
were analyzed. Upper part detected with anti-HA-antibody. Lower part
detected with strep-PO.
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Figure 3.33: Measurements of fluorescence intensities with a BRE-GFP-
reporter in cells with truncated Pyc2p. Fluorescence values are
given in %. Cells from an overnight culture with 2 mg/l biotin were
inoculated in 0.02 and 2 mg/l biotin. Samples were collected after
6 h for GFP-fluorescence measurement. wt from 0.02 mg/l biotin
has been set to 100 %. The mean values of three independent ex-
periments are shown for pyc1∆pyc2∆ without plasmid (-) and with
plasmids pRS416-pyr1+ (pyr1+), YCplac33-PYC2-3HA (PYC2-3HA)
and pUG36-MET25P-3HA-PYC2 in full length (3HA-PYC2), and trun-
cated by 2 (3HA-PYC2-(-2)), 6 (3HA-PYC2-(-6))and 10 (3HA-PYC2-
(-10))amino acids. Bars indicate standard deviations. ***: P < 0.0001
vs wt 0.02 mg/l by ANOVA, +++ : P < 0.0001 value for 0.02 mg/l vs
value for 2 mg/l for each plasmid by ANOVA.
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Additionally, pyruvate-carboxylase-activities of pyc1∆pyc2∆ double-knockouts
expressing full-length and truncated Pyc2p-versions were measured. Therefore pro-
tein extracts of yeasts grown for 6 h in minimal medium with low biotin concentration
(0.02 mg/l) were made. Protein concentrations were determined and enzyme activ-
ities measured in a coupled enzyme test with malate dehydrogenase [54]. Finally
oxidation of NADH in the test was measured photometrically and pyruvte carobxy-
lase activites calculated in units/mg yeast protein extract.
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Figure 3.34: Pyruvate carboxylase enzyme activity measurements with
truncated versions of Pyc2p. Cells from an overnight culture with 2
mg/l biotin were inoculated in 0.02 mg/l biotin. Samples were collected
after 6 h for sample preparation. Values for pyc1∆pyc2∆ with plasmids
pUG36-MET25P-3HA-PYC2 in full length (PYC2-FL), and truncated
by 2 (PYC2-(-2)), 6 (PYC2-(-6))and 10 (PYC2-(-10))amino acids are
shown.
No clearly different pyruvate carboxylase activities were measured for the four
tested plasmids, suggesting that the truncations do not affect enzyme activity. Thus,
the effects observed in sensing seem not to be caused by a change in enzyme activity
(see fig. 3.34).
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3.2.6 Co-immunoprecipitation of Pyc2p
To identify possible interaction partners of Pyc2p that might play a role in biotin
sensing, a co-immuno precipitaion was carried out. To avoid possible interfering
protease acitivity the strain c13-ABYS-86 that carries deletions of four proteases
was used. The strain was transformed with pUG36-Met25P-PYC2 and pUG36-
Met25P-PYC2(-10) and grown in medium containing 2 mg/l and 0.02 mg/l biotin.
3HA-Pyc2p was purified from the cell extracts with monoclonal anti-HA-antibodies
and bound to a protein-A-column to which the FC-region of the antibodies binds.
Wt-strain was used as control. Elution of all binding proteins was performed by
boiling with SDS-loading-buffer and the eluates were analysed on a 17 % SDS-gel
(see fig: 3.35).
M (kDa)W PM PYC2(-10)wt PYC2-fl wt PYC2-fl PYC2(-10)
212
0.02mg/l 2 mg/l
158
116
97
66
56
43
27
20
14
Pyc2p
H
L
Figure 3.35: Co-immunoprecipitation of full lenght and (-10) Pyc2p.
Coomassie-stained gel with protein extracts from c13-ABYS-86 cells
grown in 0.02 mg/l and 2 mg/l biotin. Cells contained no plasmid (wt)
or pUG36-MET25P-3HA-PYC2- full length (PYC2-fl) or truncated by
10 amino acids (PYC2(-10)). Samples were prepared as described in
the text.
As expected the bands for 3HA-Pyc2p and 3HA-Pyc2p-(-10) appear at a molec-
ular weight about 130 kDa. The other prominent two bands at 56 and 27 kDa
correspond to the heavy and light chain of the anti-HA-antibody used for purifica-
tion, respectively. Apart from these three bands no other protein-band that might
represent an interaction partner of Pyc2p was obvious. All other bands were rather
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weak compared to Pyc2p and appeared in all lanes, so they most likely represent
proteins binding unspecifically tho the column .
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3.3 Histone biotinylation in S. cerevisiae
Biotinylation of histones has been shown in different mammalian cells and seems
to fulfill several functions [14], [32], [91]. As S. cerevisae is also a eucaryotic or-
gansim it is conceivable that histones might be biotinylated here, too. To proove
this hypothesis, strains with chromosomally 3HA-tagged histones H2B, H3 and H4
were used. Fusion proteins additionally contained a MNase on the C-terminal end
of the histones, followed by the 3HA-epitope. Strains were generated by Katharina
Merz [122] and kindly provided for analysis in this work. Nuclear extracts were iso-
lated as described in material and methods and samples analysed by SDS-page and
western-blot. Blots were detected with anti-HA- and anti-biotin-antibody and with
strep-PO.
H2B- H3- H4-
3HA
H2B- H3- H4-
3HA
H2B- H3- H4-
3HA
anti-HA anti-biotin strep-PO
212
158
116
97
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34
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(kDa)
Arc1p
Figure 3.36: Western-blot of yeast nuclear extracts with 3HA-tagged hi-
stones H2B, H3 and H4. The blot was detected with anti-HA-,
anti-biotin-antibody and strep-PO. Bands on the blot detected with
anti-biotin -antibody that show the same molecular weight as bands for
histones detected with anti-HA-antibody are marked with arrows.
Additionally to the known biotin-proteins in the extracts, bands corresponding
to all three tested histones could be detected with anti-biotin-antibody (marked in
fig. 3.36), but not with strep-PO. In general more unspecific reactions were present
on the blot detected with strep-PO in comparison to anti-biotin-antibody (see fig.
3.37).
To avoid contamination with other biotinylated proteins (especially Arc1p) that
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also are present on the western-blots (fig.3.36) the histones were purified by mak-
ing use of the 3HA-tags. Nuclear extracts were incubated with anti-HA-antibody,
purified over protein-A sepharose column and eluated fractions subsequently again
analysed by SDS-PAGE and western-blot detected with anti-HA- and anti-biotin-
antibody.
wt H2B H3 H4 wt H2B H3 H4
anti-HA anti-biotin
Figure 3.37: Western-blot of purified 3HA-tagged histones. Nuclear extracts
with 3HA-tagged histones were purfied via their epitope-tags as indi-
cated in the text and analysed by western-blot with anti-HA- and anti-
biotin-antibodies.
Bands corresponding to histones H2B, H3 and H4 were detected with anti-biotin
antibody. For detection with strep-PO no signal was found (data not shown).
Additionally a second approach was used to provide evidence for the biotinylation
of histones. Nuclear extracts were purified over a monomeric avidin column, where all
biotinylated proteins bind and the eluted fractions were analyzed on a western-blot
with anti-HA antibody. This experiment led to the detection of bands corresponding
to H2B-3HA, H3-3HA and H4-3HA on a western-blot with eluated fractions from
the avidin-column detected with anti-HA-antibody (fig. 3.38).
wt H2B H3 H4 wt H2B H3 H4
load avidin colunm eluates avidin colunm
Figure 3.38: Western-blot of 3HA-tagged histones after pruification over
an avidin column. Nuclear extracts with 3HA-tagged histones were
purfied over an avidin column and analysed by western-blot. Blots were
detected with anti-HA-antibody.
The above experiments clearly demonstrated that histones are biotinylated in S.
cerevisiae. To find the amino acids that are biotinylated in vivo histone purification
via monomeric avidin was upscaled. To avoid protein degradation during purifica-
tion, yeast strain c13-ABYS-86, lacking 4 proteases in comparison to W303 wt was
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used. Eluated fractions of the avidin-column were run on a 17 % SDS-gel (see fig.
3.39). The gel was stained with colloidal coomassie and bands in the MW -range of
histones (H1: 27.80 kDa, H2A: 13.99 kDa, H2B: 14.95 kDa, H3: 15.356 kDa, H4:
11.37 kDa) cut and analysed by fingerprint sequencing (performed by Prof. Dr. Axel
Imhof, Zentrallabor für Proteinanalytik, LMU München).
14.3
20.0
27.0
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Figure 3.39: Coomassie-gel of purified proteins for mass fingerprinting. Nu-
clear extracts were purified over an avidin column and eluates run on
an SDS-gel. Visible bands from the MW -range smaller than 27 kDa
were cut and analysed by fingerprint sequencing. PM: protein molecu-
lar weight marker. Molecular weights are indicated in kDa. Indicated
bands (1 - 7) were cut and analyzed by mass fingerprinting.
As shown in table 3.3 no histones were identified among the analyzed bands from
the gel. The identified proteins are not known to be biotinylated or to bind biotin.
To increase the yield and purity of histones in cell extracts different protocols like
precipitation with 0.5 M HCl or 33% TCA and high salt extraction [178] were tried
but this did not result in better detection of biotinylated histones (data not shown).
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band gene (systematic) name annotated function at SGD MW
1 RS21A (YKR057W) 40S ribosomal protein S21-A, cytosolic 9.7 kDa
2 COX6 (YHR051W) subunit VI of cytochrome c oxidase 17.3 kDa
SUI1 (YNL244C) translation initiation factor eIF1 12.2 kDa
3 CPR6 (YLR216C) peptidyl-prolyl cis-trans isomerase
(cyclophilin)
42.1 kDa
4 avidin
5 SOD1 (YJR104C) cytosolic copper-zinc superoxide dismutase 15.9 kDa
6 TSA1 (YML028W) thioredoxin peroxidase 21.6 kDa
GUK1 (YDR454C) guanylate kinase 20.5 kDa
7 EGD2 (YHR193C) nascent polypeptide-associated complex
α-polypeptide
18.7 kDa
SBA1 (YKL117W) co-chaperone that binds to and regulates
Hsp90 family chaperones
24.1 kDa
Table 3.3: Proteins identified by mass fingerprinting from purification of
nuclear extracts over an avidin column
4 Discussion
On the one hand the "classical" functions of biotin as a cofactor in carboxylases
are long established and in most parts well understood. Recently other functions of
the vitamin get into the focus of research. Important roles in cell signalling processes
and histone modification affecting gene expression are ascribed to biotin and some
biotin catabolites.
4.1 Biotin transport
4.1.1 The E. coli biotin transporter represents a new class of bacterial
biotin transporters
Most higher organisms depend on effective uptake mechanisms for biotin as they
are not capable of biosynthesis. Different plasma membrane transporters that have
different evolutionary backgrounds have been characterized. The sodium dependent
multivitamin transporter SMVT seems to take the major role for biotin transport in
mammals [152], [219], [95]. MCT1 (monocarboxylate transporter 1) is also proposed
to transport biotin in some tissues or cell types [43]. Both transporters share no
significant homology. Homology of SMVT1 to the sodium dependent pantothenate
transporter PanF of E. coli gives a hint that transporting this substance could have
been conserved, and the ability to transport also the in parts structurally related bi-
otin and lipoic acid gained later [92]. This might also explain why SMVT transports
pantothenate with higher affinity (KM = 4.9 µM) than biotin (KM = 15.1 µM) and
lipoic acid [152]. Transport of biotin by MCT1 seems to be a complete new feature,
as the standard or main substrates for other members of this transporter family are
lactate and pyruvate, aromatic amino acids and thyroid hormones [121], [59].
Biotin transporters that show no structural or sequence homologie to MCT1 and
SMVT1 can be found in yeasts. Vht1p in S. cerevisae [185] and Vht1p in Sz. pombe
[184] share almost identical biological properties like affinities in the submicromolar
range and similar substrate specificties [165]. Both have 12 transmembrane do-
mains, are members of the family of allantoate transporters, but are only distantly
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related. The closest homolog to S. cerevisiae Vht1P in Sz. pombe is the pantothen-
ate transporter Liz1p. Plants that are able to synthesize biotin de novo transport
the vitamin via sucrose-H+-symporters as shown for Arabidopsis thaliana AtSUC5
[113]. The affinity of the A. thaliana transport system could not be determined as a
saturation was not possible up to 2 mM biotin, that is at the upper limit of biotin
solubility in water.
In addition to their ability to synthesize biotin de novo, several microorganisms
have the capacitiy to take up the vitamin from the invironment. In procaryotes a
mechanistically new class of modular transporters was published by Rodionov et al.
in 2008 [157]. These occur in more than 400 modules from over 200 species. Among
them are transporters for metal ions (cobalt and nickel), amino acids (methionine and
precursors, tryptophane), vitamins (biotin, thiamine, cobalamin, riboflavin, folate,
niacin, pyridoxine, lipoate, pantothenate) and other substances (queosine, thiazole)
can be found. The transport systems contain three different components. The sub-
strate specificity is mediated by a distinct integral membrane protein (S-component)
with 155-230 amino acids and six transmembrane domains. This protein is able
to bind the substrate and in some cases can alone facilitate diffusion of the sub-
strate. An ATPase (A) subunit supplies the transport process with energy and a
special transmembrane protein (T) mediates the interaction between the S- and A-
components. A- and T-subunits can be specific for only one substrate and interact
with one S-component, or are shared by various S-proteins for different substrates in
one organism. Shared AT-copmlexes are called ECF (energy coupling factor). This
organization of a tripartite transport system has experimentally been shown for the
Rhobobacter capsulatus biotin uptake system [84]. Substrate affinity for biotin was
described to be 250 nM without ECF and 5 nM in presence of the ECF-components.
Comparative genome analysis predicted 54 biotin transport systems with dedicated
AT-modules and 81 with shared ECFs in different species from Firmicutes, Ther-
motogales, Proteobacteria, Archaea, Cyanobacteria, Actinobacteria and some others
[157]. Biotin transport systems of this class are present in various organisms men-
tioned above, mainly in gram-positives among them, but can not be found in most of
β-, γ- and ǫ-proteobacteria, including E. coli. Candidate genes for the E. coli biotin
transporter have not been found by homology searches with any of the known trans-
port proteins. This makes it likely that (a) new protein(s) that is/are not related to
any of the known biotin transport systems enables biotin transport in E. coli and
most likely other gram-negative bacteria.
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4.1.2 yigM encodes the E. coli biotin transport protein
The experiments in this work were based on the findings of Eisenberg et al. who
mapped mutations that drastically reduce biotin uptake and decrease the sensitivity
of E. coli cells towards the toxic analogon α-dehydrobiotin between the ilv-operon
and metE on the chromosome [55]. Annotated functions, as well as surrounding
genes did not give hints for or against a role in biotin transport of one of the three
candidate genes yifK, rarD and yigM identified in this region.
Several lines of evidence confirm the role of YigM as the plasmamembrane biotin
transport protein of E. coli:
A yigM-knockout strain does not show biotin uptake. Thus, YigM has to be an es-
sential component for biotin uptake. Additionally the experiments with a knockout-
mutant showed that YigM is the only high affinity uptake system for biotin in the
bacterium.
Overexpression of YigM led to increased uptake of biotin in E. coli cells, indicating
YigM is the limiting factor for transport. Expression from two different vectors and
promoters further showed dose dependency of uptake.
The yigM-gene of the biotin uptake deficient strain S1039 [199] contains two mu-
tations. These mutations result in the exchange of the well conserved serine at
position 28 just at the beginning of TMD2 against the basic amino acid arginine
and of the highly conserved proline at position 243 in TMD9 against serine. Both
mutations on their own were sufficient to decrease the biotin uptake activity signifi-
cantly to about 25 % of the wildtype level. Both mutations together even showed a
stronger, although not completely synergistic but significant effect compared to the
single mutations.
Kinetic parameters determined for YigM in this work are consistent with earlier
published data. Prakash and Eisenberg measured a KM -value of 140 nM and a vmax
of 6.6 pmol per min and mg dry cells [151] in comparison to a KM of 74 ± 14 nM
and vmax of 2.3 pmol per min and OD600, corresponding to 7.0 pmol per min and
mg dry cells measured in this work. Results of Piffeteau and coworkers (KM -value of
50 nM and a vmax of 7 pmol per min and mg dry cells for a biotin deficient mutant
and 27 nM and 6.8 pmol per min and mg dry cells for a K12 wt) also showed similar
values [143], [142]. This makes it very likely YigM is the protein responsible for
biotin transport observed by the groups mentioned above. The only values that are
different from the ones presented here were published by Cicmanec and Lichstein
with a vmax of 0.020 ± 0.016 pmol per min and mg dry cells [35]. This difference
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might be explained by the experimental conditions used by these authors. They
measured uptake up to 150 min and samples from 5 to 40 min were used to calculate
uptake rates. In contrast Prakashs and Eisenbergs, Piffeteaus et al. and the values
determined in this work are based on samples taken in a time range up to 5 or 10
minutes.
4.1.3 Transport mechanism of YigM
The energy requirements of biotin transport in E. coli were controversally dis-
cussed. Again Cicmanecs and Lichsteins [35] proposals are not consistent with the
results of most of the other groups. Altough Cicmanec and Lichstein expected the
transport to require energy as they found accumulation of biotin in the cells, they did
not see any decrease of biotin uptake in experiments made without glucose, or addi-
tion of inhibitors like NaN3, iodoacetate, sodium fluoride, sodium cyanide, sodium
arsenate and 2,4-dinitrophenol.
Other publicatons reported biotin uptake is energy dependent: Prakash and Eisen-
berg [151] as well as Piffeteau [143], [142] describe a twofold reduction in transport
velocity and a 35% reduction in the uptake plateau in the absence of glucose com-
pared to standard experiments in wt, as well as in a biosynthesis mutant. Piffeteau
also demonstrated biotin uptake to be sensitive to the uncoupler CCCP if the sub-
stance was added before biotin uptake experiments were started. Addition of CCCP
to preloaded cells resulted in biotin efflux [143], [142]. These results could not be
verified in this work. Addition of the protonophores CCCP and FCCP at the same
concentrations used by Piffeteau (10 µM) only resulted in a slight decrease of uptake
rate to about 60 or 70 %. The effect of NaN3 was even weaker and not signifi-
cant. Excluding glucose from the uptake assay resulted in a 20% and not significant
reduction in transport acitivity. However effects are much weaker than that ob-
served by the other groups and suggest a facilitated diffusion mechanism rather
than active uptake by a proton-symport mechanism as proposed by Prakash and
Piffeteau. Findings consistent with Piffeteaus data were observed in counterflow ex-
periments. These results also rather suggest a facilitated diffusion mechanism than
active uptake by proton symport, as further uptake or at least retension of biotin
than exchange would be expected after addition of unlabelled biotin to radioactively
preloaded cells, if cells would take up the vitamin actively against a concentration
gradient. Because Piffeteau [143], [142] and Prakash [151] propose a proton gra-
dient dependent transport, that could not be verified by the uptake experiments
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in intact cells, uptake assays were also performed with membrane vesicles. The
system was supplied with energy by reconstitution of bovine cyotchrome c oxidase
that produces a membrane potential and a proton gradient. Membranes from cells
overexpression YigM (BL21 with pET24-yigM) were compared to membranes from a
knockout strain (yigM∆). The rapid influx of radioactivity before energization of the
vesicles indicates influx of biotin via facilitated diffusion. After energizing the sys-
tem by addition of cytochrome c, no further increase in radioactivity was observed.
Preincubation of the vesicles with the protonophore FCCP or creating an artificial
Na+-gradient had no influence on the transport processes. All these results suggest
biotin uptake by facilitated diffusion and not via an active H+-dependent transport.
In general there are several possibilities for bacteria to energize transport across
biological membranes. One rather special case is the phosphotransferase system
that is used almoust exclusively for sugar and sugar alcohol uptake, is restricted to
bacteria and could not be identified in archaea or eukaryotes [6], [47]. There are no
hints that biotin could be transported by this mechanism.
Beyond the phosphotransferase system bacteria transport some substrates in a
sodium dependent manner. These transporters primarily appear in thermophilic
and alcaliphilic bacteria [126]. Substrates of these transporters include melibiose,
proline, glutamate, serine and threonine, pantothenate, citrate and branched chain
amino acids [209]. Except for the E. coli serine and threonine transporter SstT
that has 8 or 9 predicted TMDs [98], [132] all other mentioned systems contain
12 transmembrane-helices. In general sodium dependent transporters are classified
into eleven families [171], [154]. This families display only weak sequence simi-
larities towards each other, making it very difficult to predict if YigM is acting
in a sodium dependent way. Experiments to explore the sodium dependency of
transport by YigM gave no hints that biotin might be symported with sodium.
The third option for energizing transport is a proton-symport mechanism and most
active transport processes in bacteria use the proton motive force as energy source
[93]. Experiments with protonophores that destroy the proton gradient did only
show weak effects on biotin uptake so it seems unlikely YigM transports biotin via
a proton-symport mechanism, although this was proposed by several groups before
[151], [143], [142]. As biotin uptake across YigM by a phospho-transferase-system
seems to be very unlikely and all experiments with energizing transport in membrane
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vesicles by a proton-, as well as a sodium-gradient did not give positive results, an
uptake by facilitated diffusion is proposed. This mechanism is also consistent with
the results from experiments in intact cells.
Taken together, there are two possible scenarios how biotin transport by YigM can
work mechanistically. The rising radioactivity in experiments with membrane vesi-
cles prior to energization with cytochrome c oxidase might reflect uptake that is not
energy dependent and occurs via facilitated diffusion or simply binding of biotin to
YigM. The missing effects after addition of protonophores, provision of an artificial
sodium gradient and omission of glucose from the uptake experiments support this
model. The effects of uncouplers and missing glucose on biotin transport reported
by Prakash and Piffeteau might be secondary effects reflecting an unfavourable en-
ergy state of the cells. If the substances would really have a direct effect on biotin
transport by YigM an amplification of these effects would be expected in cells over-
expressing YigM in contrast to wt cells used by other groups, but that was not
observed in this work.
A second possibility is that YigM intercts with an unknown protein which changes
its transport properties. In this scenario YigM alone could act as a biotin binding
protein or a facilitator. This might explain why overexpression of YigM results in
increasing radioactivity in uptake experiments. However, in these experiments it
cannot be discriminated if biotin is taken up into the cells or merely bound at the
cell surface. This might also explain why no energy dependency was observed in the
experiments adressing this question. A second protein could be necessary for energiz-
ing transport. If the concentration of this protein is limiting for energy dependent
uptake the overexpression of YigM would overlie the effects of protonophores or
missing glucose in the uptake experiments, as binding to or facilitated diffusion over
YigM would not to be energy dependent. Evidence the protein alone is sufficient
for the uptake of biotin has not finally been shown, as heterologous expression of
YigM in a S. cerevisae vht1∆ biotin transport-mutant was not able to complement
the growth defect of the yeast on medium with low biotin concentrations. This can
have different reasons like unproper folding or membrane targeting of the bacterial
protein in the eucariotic cells. Expression studies with a GFP-fusion protein have
not been made, as YigM already lost about 50 % of its biotin transport ability with
a relatively small HA-tag. Retaining functionality could not be expected with the
much bigger GFP, so localization of the GFP-fusion protein could show artefacts.
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Another reason for missing activity in S. cerevisae might of course also be the lack
of a further essential component. Another organism where heterologous expression
could be examined is Bacillus subtilis, as biotin uptake and biosynthesis are char-
acterized in this this bacterium [17], [157]. Heterologous expression should ideally
been tried in a mutant defective in biosynthesis and transport in this bacterium.
4.1.4 Homologues of yigM might represent biotin transporters of other
gram negative bacteria
Some of the homologues of yigM are designAted madN and annotated as puta-
tive acetate efflux pumps. This annotation originates from a gene cluster encoding
proteins responsible for malonate decarboxylation in the anaerobic bacterium Mal-
onomonas rubra [13]. The cluster consists of 14 genes (madABCDEFGHKLMNYZ)
and functions of the genes A to F have been identified (see fig. 4.1). MadA en-
codes the acyl-carrier-transferase (reaction 2), madB the integral membrane protein
carboxybiotin decarboxylase (reaction 4), madC and madD two subunits of the car-
boxyltransferase (reaction 3), madE the acyl-carrier-protein and madF the biotin-
protein. The functions of madK, Y, Z and madN are still unknown [13]. Taking into
account that the decarboxylation reaction depends on biotin as a cofactor, presence
of a biotin transporter gene in the cluster makes sence from a biological standpoint.
MadN as a homolog to YigM might be this gene.
A
B
Figure 4.1: The mad gene-cluster of Malonomonas rubra (from [13]). A:
Reactions involved in generating a Na+-gradient from decarboxylation
of malonate in M. rubra. B: mad-operon of M. rubra. The enzymes
encoded by the genes in the operon and the reactions they catalyze are
described in the text.
Homologues of yigM can be found, apart from other E. coli strains, in other
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gram-negative bacteria like Salmonella, Klebsiella, Shigella, Citrobacter and Yersinia
(fig.3.4). The genes are all annotated as putative inner membrane proteins of the 10
TMS Drug/Metabolite Exporter (DME) family or as carboxylate/amino acid/amine
transporters, but none of them has been experimentally characterized.
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4.1.5 Expression of yigM is regulated by biotin
Dependency of biotin transport on biotin concentration in the medium where
cells were grown before the uptakes experiments have already been reported in
1974 by Prakash [151] and 1985 by Piffeteau and Gaudry [142]. No biotin uptake
could be measured in cells grown in rich medium in this work (data not shown).
Measurements with luciferase reporter-constructs under control of the promoters of
bioB and yigM both show biotin dependent regulation. Results of the luciferase as-
says with reduced uptake to about 50 % at 10 nM biotin in a wt-strain are comparable
with measurements of Prakash [151] and Piffeteau and Gaudry [142]. Higher concen-
trations of biotin were necessary to repress expression from PyigM than from PbioB.
Similar findings have already been made by Prakash and were confirmed in this work
[151]. With proposing different repressors for regulation of transport and biosynthe-
sis, Prakash, Eisenberg and Pai might be right, as well [138]. Promoter analysis of
yigM and bioB showed that a putative BirA binding-site is present in PyigM, how-
ever it contains only one half of the palindrome. Luciferase-reporter-assays in strains
with mutations in BirA show not only an impact on PbioB that was known before
[112], [1]. Also the activity of PyigM was changed. Expression from both promoters
increased. So BirA is not only involved in repression of biosynthesis genes, but also
of the transporter YigM. Evidence for binding of BirA to both promoters was sought
using EMSA. Binding of BirA to PbioB has been shown over a range of different
BirA-concentrations and a clear shift of the bioB-promoter in a distinct band was
obvious. Localization of BirA in this band was verified by western-blot. In the
same experiments no binding of BirA to PyigM was observed. Serveral reasons for
this are conceivable. Results of the reporter-assays described above suggest different
binding-behaviour of BirA to the two promoters with repression of PyigM at higher
biotin concentrations. Simulation of these conditions was tried by adding higher
amounts of biotin and ATP to the binding-buffer for the EMSA but no difference
has been observed (data not shown). Involvement of BirA in the repression of PyigM
is out of doubt as shown by reporter assays with BirA-mutants. If the increase in
reporter-activity is caused by missing binding of BirA, or by the lower abundancy of
biotinyl-AMP that might affect another transcription factor, remains unclear from
these experiments. Reduction of luminiscence levels with lower biotin concentra-
tions for PbioB compared to PyigM reported before already suggested differences
in regulation of both promoters. If these are caused by different affinities caused
by different promoter sequences, especially for one half site of the BirA-binding se-
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quence in PyigM or by involvement of a second protein can not be answered finally.
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4.2 Biotin in S. cerevisiae
Gene regulation by biotin is a well known and in some organisms good under-
stood process. Expression of biotin biosynthesis genes from the bio-operon in E. coli
is the best characterized example. The central role here is occupied by the BirA
protein that is not only the enzyme modifying the biotin carrying subunit of acetyl-
CoA-carboylase, but also the transription factor repressing expression of biosynthesis
genes at high biotin concentrations in the medium [22], [40], [12], [10], [11]. In mam-
malian cells evidence for a role of soluble guanylate cyclase and a cGMP-dependent
protein kinase have been shown [162], [135], [95]. Leon-Del-Rio published decrease
of mRNA levels for SMVT after biotin starvation in rat liver and kidney, while ex-
pression of the gene in the brain was not affected [109]. The author suggests this
regulation guarantees a sufficent supply of the brain with biotin. Regulation was also
studied in human-derived cell lines. In HepG2 cells biotin starvation leads to de-
crease in SMVT mRNA [136], [135]. Jurkat cells from different biotin concentrations
showed no differences in abundance of SMVT protein [114].
In the present work unknown parts of the biotin sensing pathway in S. cerevisae
were investigated. Several observations about regulation of genes involved in bi-
otin metabolisms were already made. Expression of the S.pombe biotin transporter
Vht1p increases with decreasing concentration of the vitamin in the medium and
leads to higher uptake rates in cells from low biotin concentrations [184]. Higher
biotin uptake rates have also been measured in S. cerevisiae cells from low biotin
concentrations compared to normal biotin concentrations, although here expression
of the VHT1 mRNA of the transporter decreases with decreasing biotin concentra-
tions [185]. Previously reported results of Pirner and Stolz [144] and Weider et al.
[201] demonstrated the existence of a UAS for biotin dependent regulation called
BRE or VHRE. Six genes of biotin metabolism (VHT1, BIO2, BIO5 and BPL1)
contain this regulation element in their promoters [144], [201]. Weider and cowork-
ers additionally found the transcription factor VHR1. These results were the basis
for the experiments presented here.
Altough above mentioned results shed some light on the sensing-pathway, essential
parts are still not known. What is still missing for complete understanding is the
low biotin signal Vhr1p recognizes. Further accordance of biotin proteins in sensing
could not be demonstrated, nor completely excluded. Comprehensive understanding
of the whole pathway could not be achieved within the scope of the present work,
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but evidence for an involvement of the biotin-proteins pyruvate-carboxylase 1 and
especially 2 in biotin sensing was provided.
4.2.1 VHR1 and biotin sensing
As reported by Weider et al., VHR1 plays an essential role in the biotin sensing
process [201]. According to the authors Vhr1p is necessary to induce expression of
VHT1 and BIO5 of yeasts growing in low concentrations of biotin and that there
is no enhanced level of the corresponding mRNAs in a vhr1-mutant. Further the
group showed a predominatly nuclear localization of the protein, but no dependence
of localization on biotin levels. Yeast one hybrid experiments were performed with
the N-terminal part of Vhr1p that contains a predicted helix-turn-helix motif and
with the transactivating domain of Gal4p. These fusion protein was able to induce
expression from a promoter containing the BRE indicating the presence of an DNA-
binding domain in this part of the protein. Vice versa one hybrid assays with a
fusion protein consisting of the DNA-binding domain of Gal4 in combination with
the C-terminal part of Vhr1p resulted in reporter expression, suggesting presence
of an activation domain. As VHR1 could not be grouped into a class of already
described transcription factors and homologues of the protein are only present in
closely related yeast species the authors proposed a new class of transcription factors
in Saccharomycetales involved in biotin sensing. Direct binding of Vhr1p to DNA
could not be shown with co-immunoprecipitation experiments by Weider [202]. The
signal recognized by Vhr1p is still unknown.
Experiments in this work revealed that the deletion of VHR1 resulted in a lack
of response to low biotin concentrations, shown by unaffected expression of Bio2p
in low biotin medium in a vhr1∆-mutant in contrast to increased expression of the
protein in wt (see fig. 3.21). Expression of Vhr1p from a plasmid under control
of the endogenous promoter resulted in at least partial restoration of biotin sensing
ability, confirming the results of Weider [201]. Further experiments with the protein
showed a negative influence of fusing the protein with different epitope tags (3HA,
ZZ) at the N- as well as the C-terminal end. These fusion proteins were not able
to complement the biotin sensing defect of a vhr1∆ mutant. An explanation for an
impact of epitope tags might be the highly conserved amino acids 11 to 117 within
the DUF6 domain of Vhr1p at the N-terminus, as well as the highly conserved last 10
amino acids at the C-terminal end of the protein [202]. This fact limits possibilities
for other important experiments such as purification of the protein and the search
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for possibly interacting proteins. Localization of Vhr1p in the nucleus was shown
with a GFP-fusion of the protein by Weider et al. [201]. According to results in
the present work this localization has to be seen critical as this fusion protein was
not functional in our hands and results with the unfunctional protein would not be
meaningful. Functionality of the fusion protein was not shown by Weider et al.. So
further details about the mechanism of Vhr1p, like the signal for low biotin status
sensed by the protein and if or how binding to the BRE takes place are still unclear.
Different scenarios are possible. The simplest one would be recognition of biotinyl-
AMP concentrations. This in E. coli is the critical substance indicating biotin status
of the cell and is bound by the bifunctional BirA [11], that mediates expression or
repression of biotin regulated genes. Another one would be the interaction with
one or different biotinylated proteins. The fact that Bpl1p is essential for a correct
sensing process [144] supports both possibilities, but more complex scenarios can not
be excluded.
Also, it is not known if Vhr1p binds directly to the BRE. This question could be
adressed by EMSA. One further interesting aspect are interactions between Vhr1p
and Snu13p, as well as Bpl1p an Snu13p found in a high throughput tandem affinity
purification assay by Krogan et al. [104]. Snu13p is annotated as an RNA binding
protein and part of U3 snoRNP involved in rRNA processing, as well as part of
U4/U6-U5 tri-snRNP involved in mRNA splicing [51], [116]. Snu13p is an essential
protein but a strain with the protein under control of a galactose inducible promoter
was provided to us by Dr. Ray O’Keefe (School of Biological Sciences, University
of Manchester, Manchester, M13 9PT, UK). Growing cells in medium with galac-
tose medium with normal expression of Snu13p and in glucose medium leading to
downregulation of Snu13p did not show any differences in biotin sensing (data not
shown).
Another possibility for further investigating Vhr1p would be to generate an an-
tibody against the protein. This tool would enable experiments like monitoring
expression level or detecting the protein in EMSAs by a supershift.
4.2.2 Pyruvate carboxylases and biotin sensing
Pyruvate carboxylases are essential for biotin sensing
Defects in biotin dependent reporter-expression was found in deletion mutants
lacking ARC1 and especially PYC1 and PYC2. The effect in the arc1∆ mutant
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can be explained by the fact that deletion of the protein leads to a higher cytoplas-
mic biotin concentration, thus buffering the effect of low biotin concentration in the
medium [144]. In contrast the effect of deleting PYC1 and 2 can not be explained
by elevated biotin concentrations in the cytoplasm, as both enzymes seem to carry
similar ammounts of biotin, but the response to low biotin concentrations in the
single knockouts of the proteins differs clearly.
Pyruvate carboxylases 1 and 2 resulted of a gene duplication of the whole S.
cerevisae genome [213]. The amino acid sequences show more than 90 % homology
over the whole sequence but are less related at the C-terminal end where the biotin
binding domain is located [190], [195]. Expression of both genes is not regulated by
biotin. Regulation of both genes in general is different, as their promoters contain
different regulatory elements and transcription factor binding sites [190], [19], [120].
What is out of doubt is that the two proteins, especially Pyc2p is essential for correct
biotin sensing as shown by western blots detecting Bio2p, as well as by GFP-reporter
assays in this work.
Pyruvate carboxylase biotinylation and enzyme activity are not critical for
sensing
Results observed with pyruvate carboxylase of Sz. pombe, pyr1+, exclude a role
for biotinylation and enzyme activity in sensing. pyr1+ is functionally expressed
in a pyc1∆pyc2∆ doubleknockout mutant in bakers yeast as cells expressing Pyr1p
do not require aspartate for growth as the mutant does. Biotinylation of Pyr1p
was shown by western-blot detected with strep-PO. Defects in sensing in the double
knockout mutant was not complemented by heterologous expression of Pyr1p. If
biotinylation or enzyme activity would be the (only) essential criteria in biotin sens-
ing, functional sensing should have been restored by heterologous expression. As this
was not the case, additional or other properties of the enzyme seem to be required.
The C-terminus of Pyc2p plays a role in biotin sensing
As C-terminally tagged Pyc2p showed a defect in biotin sensing different C-
terminally truncations were examined. These experiments were also inititated be-
cause the extreme C-termini of various pyruvate carboxylases indicated a high level
of variability, both in length and sequence.
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Striking is especially that both S. cerevisiae Pyc-proteins are about 10 amino
acids longer than most orthologs. Even in the most homolog proteins to S. cerevisiae
Pyc2p C-termini are in most cases shorter: e.g Candida galbrata 2 amino acids, Van-
derwaltozyma polyspora 10 amino acids, Lachancea thermotolerans 2 amino acids,
Kluyveromyces lactis 9 amino acids, Zygosaccharomyces rouxii 2 amino acids, Ash-
bia gossypii 10 amino acids, Pichia angusta 14 amino acids and Pichia guliermondii
9 amino acids. One C-terminus comparable in length can be found in Pichia pastoris
that has only one pyruvate carboxylase gene [120]. An interesting experiment in this
context would be heterologous expression of the P. pastoris pyruvate carboxylase in
S. cerevisiae, as the C-terminus of this protein is comparable to the bakers yeast ho-
mologue. Truncations of the C-terminus indeed showed an effect on biotin sensing.
The relative amounts of Pyc2p were not affected by truncations, shown by detection
of the N-terminally tagged proteins by western-blot. Altered biotinylation might be
caused by the truncations as the biotinlyted lysine residue can be found at the C-
terminal part, 45 amino acids before the end of the full length protein were excluded
by western-blots detected with strep-PO. Data of Polyak et al. support this finding,
as the C-terminus does not lie in spatial vicinity to the biotinylated lysin residue
that is located on the opposite side in the 3D-structure [147]. Conclusive analysis of
Pyc2p biotinylation would require the quantitative analysis of unbiotinylated apo-
Pyc2p and biotinylated holo-Pyc2p, as western-blots can hardly be quantified. It
can be excluded enzymatic activity of pyruvate carboxylases causes different reac-
tions on low biotin concentrations. Different activities for shorter versions of Pyc2p
in comparison to the full length protein were not found. Data observed with the
truncated versions of Pyc2p support the findings already made by complementation
of a pyc1∆pyc2∆ double mutant with Sz. pombe pyr1+ and show requirement of
factors beyond biotinylation, expression and ezyme activity for intact biotin sensing.
A possibility that would be consistent with the results in this work would be in-
teraction of Pyc2p with a still unknown protein. The presence of different charged
amino acid residues at the C-terminus (E1222, E1223, K1230 and K1231) suggests
this part of the protein to be a potential site for ionic interactions. Promising can-
didates about know interaction partners from the Saccharomyces Genome Database
(SGD http://www.yeastgenome.org/) that might be involved in the biotin sensing
pathway could not be identified. Directly finding a possible interaction partner by co-
immunopreciptiaton of Pyc2p did not meet with success, but this might have several
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reasons like the growth conditions of cells or buffer composition during preparation
and does not exclude the existence of an interaction. In any case, Pyc2p takes
influence on cells response to low biotin concentrations and is an interesting and
promising candidate for further experiments.
4.2.3 Histone biotinylation
Basis for histone biotinylation in S. cerevisiae
A relatively new field in research is covalent histone modification by biotinylation.
Early evidence about nuclear localization of biotin was found by Dakshinamurti and
coworkers in 1963, as they observed part of radiolabelled biotin injected to rats and
chicken in the nuclei of cells [45]. Hymes et al. found that biotinidase can in vitro
exchange biotin between biocytin and histones [89]. About 25 % of biotinidase can be
found in the nucleus of mammalian cells but the functional appearence of this finding
is unclear [145]. Stanley and coworkers detected that up to 1 % of the intracellular
biotin can be found in the nucleus and additionally showed biotinylation of all five
histone-proteins (H1, H2A, H2B, H3 and H4) from human lymphocytes by western-
blot using streptavidin and anti-biotin-antibodies [181]. But also HCS is a candidate
for histone biotinylation due to its nuclear localization that was observed by Narang
et al. in HeLa, Hep2 and fibroblast cells with use of anti-HCS-antibodies in western-
blots and with immuno-fluorescence [125]. They also showed that recombinantly
expressed and purified HCS is able to transfer biotin to all 5 histone proteins in
presence of ATP. As Narangs examination of samples from patients with MCD caused
by defects in HCS showed reduced histone biotinylation, HCS seems to be the enzyme
that biotinylates histones in vivo. For mammalian histones, modifications in H2A,
H3 and H4 have been identified by in vitro enzymatic biotinylation of synthetic
peptides by biotinidase and HCS and subsequent MS-analysis [80]. In S. cerevisiae
data about cytoplasmic [105] and also nuclear localization of Bpl1p [88] provide
a basis for histone biotinylation in yeast, so different efforts to clarify this point
were made. Also the fact that a canonical biotinylation domain is not absolutely
required for protein biotinylation [97] makes it possible that further yeast proteins
are biotinylated. In this work evidence is provided that histones H2B, H3 and H4 of
S. cerevisiae are biotinylated in vivo.
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Histones H2B, H3 and H4 are biotinylated in S. cerevisiae
On the one hand 3HA-tagged histones H2B, H3 and H4 were immunoprecipitated
and biotinylation detected by western-blot analysis with anti-biotin-antibody. On
the other hand nuclear extracts were purified over an avidin column and eluted by
boiling with SDS-sample buffer. The eluates were analyzed on western-blot with
anti-biotin-antibody. Bands for histones H2B, H3 and H4 were detected. Together
these results proove that in vivo biotinylation of histones in S. cerevisiae occurs.
Attempts to identify biotinylated histones directly by MS have not been success-
ful. This might be due to limited detection sensitivity in the coomassie stained gel
with eluates of the avidin column in comparison to western-blot where detection
was possible. Another reason could be insufficient purification of histones prior to
loading them on the avidin column. In the experiments nuclear extracts were used
that showed better results than whole cell extracts, but obviously further purifica-
tion is necessary. Histone biotinylation seems to be a rare event with estimations
of less than 0.03 % of all histone proteins being biotinylated [4]. So detection lev-
els seemed to be a problem with the methods tried in this work. Another point
is that yeast cells contain six other biotinylated proteins in much higher amounts
that can disturb purification and detection of biotinylated histones. A big problem
could be contamination of the nuclear extracts with proteins from other parts of
the cells. Indeed several proteins were found in the eluates of the avidin column
that are localized in cytoplasm (Rsa1p, Cpr6p, Tsa1p) or in mitochodria (Cox6p).
Thus nuclear proteins or histones should be enriched from nuclear preparations for
further experiments. Other methods to enrich histones from nuclear extracs like pre-
cipitation with H2SO4 [58], HCl (protocl from ABCAM; http://www.abcam.com/)
acid- and high-salt-extraction [178] and an alternative protocol [200] did not lead
to better results (data not shown). Another reason for identifying other proteins
than histones might be these proteins are more highly abundant. An example for
this problem seemed to be Sod1p that was described to be located amongst others
in the nucleus and in about 500,000 copies per cell [65]. Histone proteins appear
in 200,000 to 500,000 molecules per cell. Taking into account that only about 0.3
% of histones are estimated to be biotinylated, Sod1p is present in 300- to 500-fold
higher concentrations in the cell and might unspecifically bind to the column. In
vitro assays for biotinylation of synthetic peptides by S. cerevisae Bpl1p similar to
those used in the identification of biotinylated amino acids in mammalian histones
[25] have not been tried.
4 Discussion 118
Detection and function of in vivo biotinylated histones
The biotinylation of histones is not discussed without controversy. Bailey and
coworkers reported artifactual detection of histone biotinylation by streptavidin [4].
Healy et al. even claim biotinylation of histones is not a natural modification. They
were able to confirm results for biotinylation of histones in in vitro assays that were
used to identify biotinylated lysine residues, but were not able to detect in vivo
biotinylation of histones with different methodes e.g. modification of histones with
[3]H-labelled biotin as a very sensitive method [83]. They showed that less than 1 in
100,000 histone molecules carry biotin as a modification in vivo. This is even a factor
30 below estimations of Bailey et al. [4] and again shows that detection of in vivo
biotinylated histones is very challenging. Very sensitive methods have to be used in
detecting in vivo histone biotinylation. This might be the reason why in vivo biotiny-
lation of histones could not be shown directly by MS-analysis in this work. Current
techniques detect in vivo biotinylation with avidin- or streptavidin-conjugates or
specific antibodies against one distinct biotinyl-lysin-residue in a histone protein af-
ter a preceding histone enrichment, e.g. by acid precipitation [181], [140], [219],
[82]. Detection of in vivo histone biotinylation with anti-biotin-antibody was also
demonstrated for S. cerevisiae histones H2B, H3 and H4 in this work.
Nervertheless different functions are ascribed to biotinylated histones. InDrosophila
melanogaster HCS mediated histone biotinylation is reported to be necessary for
normal gene transcription patterns and life span, as well as heat tolerance [26], [29].
First results have also been published for mammalian cells, where biotinylation of
K12 in histone H4 is more abundant in heterochromatin [27]. Biotinylation of the
same lysine residue also decreased response to DNA double strand breaks [103]. In
the context of DNA damage increased biotinylation of histones after UV-light treat-
ment was shown in Jurkat cells [140]. Recently repression of transposable elements
by histone biotinylation in human, mouse and Drosophila melanogaster cells has
been described [34]. Another interesting finding is regulation of SMVT expression
by chromatin remodeling [69]. Gralla and coworkers proposed a biotin dependent
nuclear localization of HCS in Jurkat cells. Cells growing in 10 nmol/l biotin showed
more HCS in the nucleus and more biotinylated K12 in histone H4 in the region of
promoter 1 of SMVT compared to cells from 0.25 nmol/l biotin [153]. Biotinylation
of H4 K12 turned out to decrease expression of SMVT by 86 %. Additionally biotin
independent expression was shown to be driven by the transcription factors KLF-4
and AP-2 [153].
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Taking together these results suggests new possibilities for biotin sensing in yeast.
As first hints for histone biotinylation were provided in this work, further charac-
terization of the biotinylated lysine residues should follow. Direct gene regulation,
especially by silencing like shown in mammalian cells [69], [140], [27] through this
modifications seems to be possible in yeast cells, too. Another point that needs to
be addressed is if the biotin group can be removed from histones, as S. cerevisiae
contains no biotinidase like mammalian cells, but the exchange of modified against
unmodified histones seems to be a possible alternative. Besides for a requirement
of Bpl1p [144] and Vhr1p [201] and an involvement of Pyc2p (this work), the biotin
sensing process in S. cerevisiae is not fully understood and the signal the transcrip-
tion factor Vhr1p recognizes is still unknown. Especially the fact that interactions
of Vhr1p, histone H2A [104] and histone H2B.1 [63] were found supports a possible
function of biotinylated histones in biotin sensing. In this scenario it is conceiv-
able that Vhr1p binds to biotinylated histones, preventing the protein to act as a
transcription factor at BRE containing promoters. Biotin depletion would reduce
histone biotinylation and release Vhr1p from its immobilized, inactive state. There
is no experimental evidence for this hypothesis, but it is at least compatible with
the known function of Bpl1p and Vhr1p. Pyc2p for which an involvement in biotin
sensing is without doubt is in fact not included in this hypothesis. This interaction
of Vhr1p with the biotinylated histones might give hint to another important tessera
in the sensing-puzzle.
5 Summary
Biotin transport in E. coli was already observed in 1972. Results in this work
demonstrate yigM is the gene encoding the E. coli biotin transporter. The pro-
tein has 10 predicited transmembrane domains and shows homology to members of
the subfamiliy of carboxylate/amino acid/amine transporters. Deletion of yigM
led to complete loss, overexpression with different expression systems to a dose
dependent increase of biotin uptake. The function of YigM was shown in whole
cells and in reconstituted membrane vesicles. Weak inhibition of biotin uptake by
protonophores, the respiratory chain blocker NaN3, as well as uptake in not en-
ergized membrane vesicles suggest biotin uptake by a facilitated diffusion mech-
anism. E. coli cells overexpressing YigM displayed saturable biotin uptake ki-
netics (KM of 74 ± 14 nM). This value is similar to previously reported mea-
surements in wt cells, indicating that YigM is the only biotin transporter in E.
coli. The set of plasmamembrane biotin transporters is extended by yigM, as
transporters for mammals, eucaryotic unicellular organisms, gram-positive bacte-
ria and archea have already been described before. Biotin dependent regulation
of the yigM-gene was shown by experiments with a luciferase-reporter construct.
In S. cerevisiae evidence for a role of biotin dependent pyruvate carboxylases,
especially pyruvate carboxylase 2 in biotin sensing was provided. Single-knockouts of
of the two PYC genes reduce the response to low biotin concentrations, as shown by
GFP-reporter-assays and western-blot. A double-knockout mutant for both pyruvate
carboxylase genes even suppresses low biotin signals completely. The role of Pyc2p
in biotin sensing was demonstrated to be independent of changes in expression,
biotinylation and enzymatic activity. However experiments with fusing an epitope
tag and truncation of the protein at the C-terminus revealed this end of the protein
seems to influence sensing.
Additionally in vivo biotinylation of S. cerevisiae histones H2B, H3 and H4 was
demonstrated. A possible role of biotinylated histones in biotin sensing is discussed.
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Abbreviations
◦C degree celcius
µg microgram
µl microlitre
µM micromolar
AmpR ampicillin resistance gene
ATP adenosinetriphosphate
BCCP biotin-carboxyl-carrier-protein
bp basepair
BPL biotin-protein-ligase
BRE biotin response element
CCCP Carbonyl Cyanide m-Chlorophenyl-hydrazone
C-Terminus carboxyterminus
DAPA diaminopelargonic acid
DMSO dimethylsulfoxide
DNA desoxyribonucleic acid
dNTP desoxyribonucleotide-5-triphosphate
E. coli Escherichia coli
EDTA ethylendiaminetetraacetic acid
e.g. for example (lat. exempli gratia)
EMS ethylmethansulfonate
EtOH ethanol
FCCP carbonyl cyanide p-(tri-fluoromethoxy)phenylhydrazone
fig figure
Gal galactose
GFP green fluorescent protein
Glc glucose
h hour
HA hemagglutinin
HCS holocarboxylasesynthetase
His histidin
IPTG isopropyl-β-D-thiogalactopyranoside
KAPA 7-keto-8-aminopelargonic acid
kb kilobase
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kDa kilodalton
Km Michaelis-Menten-constant
KmR kanamycin resistance gene
l litre
LB Luria Bertani (medium)
lacZ/LacZ β-galactosidase
min minute
ml milliliter
mM millimolar
MMA synthetic minimal medium
mRNA messenger ribonucleic acid
NAD(P)+/NAD(P)H nicotinamidadenindinucleotide (phosphate), oxidized/reduced
Ni-NTA nickel-nitrilotriacetic acid matrix for affinity
chromatography of proteins with a 6His-tag
N-Terminus aminoterminus
ODX optical density at wavelenght λ = x nm
ONPG ortho-nitrophenyl-β-galactopyranoside
ORF open reading frame
PAGE polyacrylamide-gelelectrophoresis
PCC propionyl-CoA-carboxylase
PCR polymerase chain reaction
PMSF phenylmethylsulfonylfluoride
PYC, Pyc pyruvatcarboxylase
RNaseA ribonuclease A
rpm revolutions per minute
RT room temperature
SAM S-sdenosylmethionine
S. cerevisiae Saccharomyces cerevisiae
SDS sodium Ddodecylsulfate
sec second
SMVT sodium-dependent multivitamin transporter
Strep-PO streptavidin-peroxidase conjugate
Sz. pombe Schizosaccharomyces pombe
tab table
TEMED N,N,Nť,Nť-tetramethylethylendiamin
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Tris tris-(hydroxymethyl)-aminomethane
UAS upstream activating sequence
U unit (enzyme activity)
TMD transmembrane domain
UV ultra violet
v/v volume/volume
Vit vitamin
VHRE vitamin H response element
wt wildtype
w/v weight/volume
w/o without
X-Gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
YNB yeast nitrogen base
ZZ binding domain of Staphylococcus aureus protein A,
binding to Fc-domains of IgG in two copies used as epitope
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amino acids
A ala alanin M met methionin
C cys cystein N asn asparagin
D asp aspartate P pro prolin
E glu glutamate Q gln glutamin
F phe phenylalanin R arg arginin
G gly glycin S ser serin
H his histidin T thr threonin
I ile isoleucin V val valin
K lys lysin W trp tryptophane
L leu leucin Y tyr tyrosin
nucleobases
A ade adenin
C cytosin
G guanin
T thymin
U ura uracil
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